<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><?covid-19-tdm ?><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">82611</article-id><article-id pub-id-type="doi">10.7554/eLife.82611</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group></article-categories><title-group><article-title>The effect of variation of individual infectiousness on SARS-CoV-2 transmission in households</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-243712"><name><surname>Tsang</surname><given-names>Tim K</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5037-6776</contrib-id><email>timtsang@connect.hku.hk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-291063"><name><surname>Huang</surname><given-names>Xiaotong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-291064"><name><surname>Wang</surname><given-names>Can</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-291065"><name><surname>Chen</surname><given-names>Sijie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-291066"><name><surname>Yang</surname><given-names>Bingyi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-35791"><name><surname>Cauchemez</surname><given-names>Simon</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9186-4549</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-36262"><name><surname>Cowling</surname><given-names>Benjamin John</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6297-7154</contrib-id><email>bcowling@hku.hk</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02zhqgq86</institution-id><institution>WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong</institution></institution-wrap><addr-line><named-content content-type="city">Hong Kong</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02mbz1h25</institution-id><institution>Laboratory of Data Discovery for Health</institution></institution-wrap><addr-line><named-content content-type="city">Hong Kong</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0495fxg12</institution-id><institution>Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Wesolowski</surname><given-names>Amy</given-names></name><role>Reviewing Editor</role><aff><institution>Johns Hopkins Bloomberg School of Public Health</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Davenport</surname><given-names>Miles P</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03r8z3t63</institution-id><institution>University of New South Wales</institution></institution-wrap><country>Australia</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>07</day><month>03</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e82611</elocation-id><history><date date-type="received" iso-8601-date="2022-08-11"><day>11</day><month>08</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-02-20"><day>20</day><month>02</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-08-30"><day>30</day><month>08</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.08.30.22279377"/></event></pub-history><permissions><copyright-statement>© 2023, Tsang et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Tsang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-82611-v1.pdf"/><abstract><p>Quantifying variation of individual infectiousness is critical to inform disease control. Previous studies reported substantial heterogeneity in transmission of many infectious diseases including SARS-CoV-2. However, those results are difficult to interpret since the number of contacts is rarely considered in such approaches. Here, we analyze data from 17 SARS-CoV-2 household transmission studies conducted in periods dominated by ancestral strains, in which the number of contacts was known. By fitting individual-based household transmission models to these data, accounting for number of contacts and baseline transmission probabilities, the pooled estimate suggests that the 20% most infectious cases have 3.1-fold (95% confidence interval: 2.2- to 4.2-fold) higher infectiousness than average cases, which is consistent with the observed heterogeneity in viral shedding. Household data can inform the estimation of transmission heterogeneity, which is important for epidemic management.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>SARS-CoV-2</kwd><kwd>transmission</kwd><kwd>households</kwd><kwd>COVID-19</kwd><kwd>infectiousness variation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005407</institution-id><institution>Food and Health Bureau</institution></institution-wrap></funding-source><award-id>COVID190118</award-id><principal-award-recipient><name><surname>Cowling</surname><given-names>Benjamin John</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002920</institution-id><institution>Research Grants Council, University Grants Committee</institution></institution-wrap></funding-source><award-id>C7123-20G</award-id><principal-award-recipient><name><surname>Cowling</surname><given-names>Benjamin John</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100007156</institution-id><institution>Innovation and Technology Commission of Hong Kong Special Administrative Government</institution></institution-wrap></funding-source><award-id>AIR@innoHK</award-id><principal-award-recipient><name><surname>Cowling</surname><given-names>Benjamin John</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>Investissement d'Avenir</institution></institution-wrap></funding-source><award-id>ANR-10-LABX-62-IBEID</award-id><principal-award-recipient><name><surname>Cauchemez</surname><given-names>Simon</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>EMERGEN</institution></institution-wrap></funding-source><award-id>ANRS0151</award-id><principal-award-recipient><name><surname>Cauchemez</surname><given-names>Simon</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>INCEPTION</institution></institution-wrap></funding-source><award-id>PIA/ANR-16-CONV-0005</award-id><principal-award-recipient><name><surname>Cauchemez</surname><given-names>Simon</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001961</institution-id><institution>AXA Research Fund</institution></institution-wrap></funding-source><award-id>101003589 (RECOVER)</award-id><principal-award-recipient><name><surname>Cauchemez</surname><given-names>Simon</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution>Groupama</institution></institution-wrap></funding-source><award-id>874735 (VEO)</award-id><principal-award-recipient><name><surname>Cauchemez</surname><given-names>Simon</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003803</institution-id><institution>The University of Hong Kong</institution></institution-wrap></funding-source><award-id>202111159118</award-id><principal-award-recipient><name><surname>Tsang</surname><given-names>Tim K</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Household transmission modeling qualified variation of individual infectiousness among infected persons, which could be caused by both biological factors and host behaviors.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Characterizing transmission is critical to control the spread of an emerging infectious disease. The reproductive number is the widely adopted measure of infectiousness. However, it only measures the average number of secondary cases infected by an infected person, not the heterogeneity in the number of transmissions. Variation of individual infectiousness is particularly highlighted by superspreading events (SSEs), in which a minority of cases are responsible for a majority of transmission events. Such phenomena, illustrated by the ‘80/20 rule’ (i.e., 20% of cases responsible for 80% transmission; <xref ref-type="bibr" rid="bib1">Adam et al., 2020</xref>; <xref ref-type="bibr" rid="bib54">Sun et al., 2021</xref>), have been observed in emerging infectious disease outbreaks (<xref ref-type="bibr" rid="bib38">Lloyd-Smith et al., 2005</xref>), including severe acute respiratory syndrome (SARS) (<xref ref-type="bibr" rid="bib51">Shen et al., 2004</xref>), Middle East respiratory syndrome (<xref ref-type="bibr" rid="bib9">Cauchemez et al., 2016</xref>; <xref ref-type="bibr" rid="bib15">Cowling et al., 2015</xref>), and most recently the COVID-19 pandemic (<xref ref-type="bibr" rid="bib1">Adam et al., 2020</xref>; <xref ref-type="bibr" rid="bib32">Lau et al., 2020</xref>; <xref ref-type="bibr" rid="bib54">Sun et al., 2021</xref>; <xref ref-type="bibr" rid="bib67">Wong and Collins, 2020</xref>; <xref ref-type="bibr" rid="bib72">Zhao et al., 2021</xref>). In these outbreaks, the proportion of cases attributed to 80% transmission, and the dispersion parameter that is estimated by fitting the negative binomial distribution to the number of secondary cases (<xref ref-type="bibr" rid="bib38">Lloyd-Smith et al., 2005</xref>), are considered as measures of transmission heterogeneity.</p><p>However, the number of contacts per index cases is often not reported in SSE studies, and hence not incorporated in the analyses. In addition, SSE studies usually analyze clusters from different settings, in which the baseline transmission risk and density of exposure could be different (<xref ref-type="bibr" rid="bib57">Thompson, 2021</xref>). Finally, studies of transmission heterogeneity that focus on SSEs described in the literature may suffer from publication bias, with larger clusters having higher probability of being observed and reported (<xref ref-type="bibr" rid="bib72">Zhao et al., 2021</xref>). Therefore, the observed heterogeneity in the number of secondary cases could be the result of large number of contacts in SSE settings, or confounding from these factors (<xref ref-type="bibr" rid="bib3">Althouse et al., 2020</xref>; <xref ref-type="bibr" rid="bib4">Bagdasarian and Fisher, 2020</xref>), instead of variation in individual infectiousness.</p><p>Households are one of the most important settings for SARS-CoV-2 transmission, with 4- to 10-fold higher transmission risk than other places (<xref ref-type="bibr" rid="bib57">Thompson, 2021</xref>). Hence, household transmission studies provide an ideal setting to quantify variations in individual infectiousness. In a household transmission study, an index case is identified, and their household contacts are followed up for 1–2 weeks, during which there is high transmission potential (<xref ref-type="bibr" rid="bib60">Tsang et al., 2016</xref>). Therefore, the number of contacts is known while transmission risks and reporting biases can be controlled. We aim to characterize the variation of individual infectiousness by analyzing data from household transmission studies.</p></sec><sec id="s2" sec-type="results"><title>Results</title><p>We conducted a systematic review to gather information on the number of secondary cases with the number of household contacts for each household, in the form of number of households with <italic>X</italic> cases among households of size <italic>Y</italic>. In total, we identified 17 studies, comprising 13,098 index cases and 31,359 household contacts (<xref ref-type="fig" rid="app1fig1">Appendix 1—figure 1</xref>, <xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>; <xref ref-type="bibr" rid="bib5">Bernardes-Souza et al., 2021</xref>; <xref ref-type="bibr" rid="bib6">Carazo et al., 2022</xref>; <xref ref-type="bibr" rid="bib16">Dattner et al., 2021</xref>; <xref ref-type="bibr" rid="bib21">Han et al., 2022</xref>; <xref ref-type="bibr" rid="bib22">Hart et al., 2022</xref>; <xref ref-type="bibr" rid="bib26">Hsu et al., 2021</xref>; <xref ref-type="bibr" rid="bib27">Hubiche et al., 2021</xref>; <xref ref-type="bibr" rid="bib30">Koureas et al., 2021</xref>; <xref ref-type="bibr" rid="bib33">Laxminarayan et al., 2020</xref>; <xref ref-type="bibr" rid="bib34">Layan et al., 2022</xref>; <xref ref-type="bibr" rid="bib39">Lyngse et al., 2022</xref>; <xref ref-type="bibr" rid="bib41">Méndez-Echevarría et al., 2021</xref>; <xref ref-type="bibr" rid="bib47">Posfay-Barbe et al., 2020</xref>; <xref ref-type="bibr" rid="bib50">Reukers et al., 2021</xref>; <xref ref-type="bibr" rid="bib65">Wilkinson et al., 2021</xref>). Most studies covered a period from January to November 2020, which was dominated by ancestral strains, except for Layan et al. (from December 2020 to April 2021) and Hsu et al. (from January 2020 to February 2021), which covered both ancestral strains and the alpha variant.</p><p>We then developed a statistical model to quantify the degree and the impact of variation of infectiousness of cases on transmission dynamics. The individual-based household transmission model describes the probability of infection of household contacts as depending on the time since infection in other infected persons in the household, so that infections from outside the household (community infections), or infections via other household contacts rather than the index case (tertiary infections) are allowed (<xref ref-type="bibr" rid="bib7">Cauchemez et al., 2009</xref>; <xref ref-type="bibr" rid="bib59">Tsang et al., 2014</xref>; <xref ref-type="bibr" rid="bib61">Tsang et al., 2021</xref>). Therefore, the model could estimate the per-contact hazard of infection, which implicitly controls for number of household contacts in households. We extend this model by adding a random effect (<inline-formula><mml:math id="inf1"><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) on the individual infectiousness of cases. Here, the relative infectiousness of case <italic>i</italic> compared with case <italic>j</italic> is exp(<inline-formula><mml:math id="inf2"><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>)/exp(<inline-formula><mml:math id="inf3"><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>). The parameter for variation in individual infectiousness (hereafter denoted as infectiousness variation, <inline-formula><mml:math id="inf4"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) is the standard deviation (SD) of the random effect characterizing individual infectiousness, so that <inline-formula><mml:math id="inf5"><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> follows a normal distribution with mean equal to 0 and SD equal to <inline-formula><mml:math id="inf6"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> .</p><p>We separately fit the models to 14 studies with more than 150 contacts (<xref ref-type="bibr" rid="bib6">Carazo et al., 2022</xref>; <xref ref-type="bibr" rid="bib16">Dattner et al., 2021</xref>; <xref ref-type="bibr" rid="bib19">Dutta et al., 2020</xref>; <xref ref-type="bibr" rid="bib21">Han et al., 2022</xref>; <xref ref-type="bibr" rid="bib22">Hart et al., 2022</xref>; <xref ref-type="bibr" rid="bib27">Hubiche et al., 2021</xref>; <xref ref-type="bibr" rid="bib30">Koureas et al., 2021</xref>; <xref ref-type="bibr" rid="bib33">Laxminarayan et al., 2020</xref>; <xref ref-type="bibr" rid="bib34">Layan et al., 2022</xref>; <xref ref-type="bibr" rid="bib39">Lyngse et al., 2022</xref>; <xref ref-type="bibr" rid="bib41">Méndez-Echevarría et al., 2021</xref>; <xref ref-type="bibr" rid="bib50">Reukers et al., 2021</xref>; <xref ref-type="bibr" rid="bib63">Tsang et al., 2022</xref>; <xref ref-type="bibr" rid="bib65">Wilkinson et al., 2021</xref>; <xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="table" rid="app1table2">Appendix 1—table 2</xref>). For 12 studies out of 14, models with infectiousness variation perform substantially better (range of ∆DIC: 5.8–268) (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="table" rid="app1table2">Appendix 1—table 2</xref>). From these 12 studies, the estimated infectiousness variation (<inline-formula><mml:math id="inf7"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></inline-formula> ranged from 1.03 to 2.83. This suggests that, the 20% most infectious cases are 2.4- to 10-fold more infectious than the average case. Based on the two largest studies with 6782 and 3727 households (<xref ref-type="bibr" rid="bib6">Carazo et al., 2022</xref>; <xref ref-type="bibr" rid="bib39">Lyngse et al., 2022</xref>), the estimated infectiousness variation is 1.48 (95% credible interval [CrI]: 1.29, 1.7) and 1.41 (95% CrI: 1.19, 1.72), suggesting that, among all cases, the 20% most infectious are 3.5-fold (95% CrI: 3.0- to 4.2-fold) and 3.3-fold (95% CrI: 2.7- to 4.3-fold) more infectious than the average case. The estimated daily probability of infection from outside the household and estimated person-to-person transmission probability within households range from 0.0003 to 0.017, and from 0.06 to 0.51, respectively. The estimates of parameters for the relationship between number of contacts and transmission (larger value indicates stronger inverse association) range from 0.43 to 0.92, except for the study by <xref ref-type="bibr" rid="bib34">Layan et al., 2022</xref>, where it is equal to 0.2. For all studies, the predicted final size distribution is consistent with the observed data and the model fit is judged adequate (<xref ref-type="table" rid="app1table3 app1table4 app1table5 app1table6 app1table7">Appendix 1—Tables 3–7</xref>, <xref ref-type="fig" rid="app1fig2">Appendix 1—figure 2</xref>). Simulation studies demonstrated that there is no important systematic bias, with 88–100% (depending on the parameter) of the 95% credible intervals covering the simulation value (<xref ref-type="table" rid="app1table8">Appendix 1—table 8</xref>). This suggests that the algorithm could estimate adequately the posterior distribution. We conduct a sensitivity analysis that assumes the individual infectiousness of cases follows a Gamma distribution, but the fit worsens substantially (<xref ref-type="table" rid="app1table9">Appendix 1—table 9</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Summary of statistics for 17 identified studies.</title><p>Figure shows the average number of contacts and standard deviation (SD) of number of contact, SD of number of secondary cases per index cases (<inline-formula><mml:math id="inf8"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>), and secondary attack rate (SAR) for 17 identified studies.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82611-fig1-v1.tif"/></fig><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Modeling results of household transmission dynamics and infectiousness variation.</title><p>Figure shows the estimates of infectiousness variation (<inline-formula><mml:math id="inf9"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>), the estimated probability of infection from community and estimated probability of infection from households, and the reduction in deviance information criteriion (DIC) compared with the model without infectiousness variation. Models are fitted separately to 14 household transmission studies.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82611-fig2-v1.tif"/></fig><p>We conduct random effects meta-analyses on estimates of individual infectiousness from the 14 identified studies. The pooled estimate of infectiousness variation is 1.33 (95% confidence interval [CI]: 0.95, 1.70), suggesting that the 20% most infectious cases are 3.1-fold (95% CI: 2.2- to 4.2-fold) more infectious than the average case (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Based on this fitted distribution, we estimate that 5.9% (95% CI: 1.4%, 11.1%) and 14.9% (95% CI: 7.2%, 20.7%) of cases could be at least 8- and 4-fold more infectious than average cases, respectively.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Estimate distribution of relative infectiousness based on the pooled estimate.</title><p>Red line indicates the estimated distribution and the gray lines indicate the associated uncertainty. Black dashed line indicates average infectiousness (relative infectiousness equal to 1), while the purple and blue dashed lines indicate top 20% and 10% infectiousness, respectively.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82611-fig3-v1.tif"/></fig><p>We further explore if the secondary attack rate (SAR, the proportion of infected contacts), and the SD of the distribution of number of secondary cases (<inline-formula><mml:math id="inf10"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></inline-formula> (<xref ref-type="fig" rid="fig4">Figure 4</xref>; <xref ref-type="table" rid="app1table10">Appendix 1—table 10</xref>) may be correlated with the infectiousness variation. In meta-regression, we find the infectiousness variation is associated with SAR (<xref ref-type="table" rid="app1table11">Appendix 1—table 11</xref>). We estimate that doubling SAR are associated with 0.55 (95% CI: 0.21, 0.89) unit decrease in infectiousness variation, with R-squared equal to 67% respectively. In addition, we find that higher infectiousness variation is associated with only using PCR to ascertain secondary cases. Regarding other statistics, we find that <inline-formula><mml:math id="inf11"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is positively associated with mean and SD of number of contacts. Other than these associations, we find no association between these statistics and implementation of lockdown, ascertainment method of index and secondary cases, and the circulating virus of SARS-CoV-2 in the study period.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Relationship between infectiousness variation and statistic.</title><p>In each panel, numbers represent the observed corresponding relationship for the identified studies. Panels A and B show the relationship between infectiousness variation (<inline-formula><mml:math id="inf12"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) and secondary attack rate (SAR) and standard deviation (SD) of number of secondary cases per index cases (<inline-formula><mml:math id="inf13"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>). In the bottom, numbers in bracket indicate the number of household contacts in corresponding studies.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82611-fig4-v1.tif"/></fig></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we characterize the impact of variation of individual infectiousness on heterogeneity of transmission of COVID-19 in households. We demonstrate that it can be estimated from household data using a modeling approach. The pooled estimate of infectiousness variation from 14 studies suggests that the 20% most infectious cases have 3.1-fold (95% CI: 2.2- to 4.2-fold) higher infectiousness compared with average index cases. This implies there is substantial variation in individual infectiousness of cases in households. Given that we focused our analysis on households with known number of contacts in studies conducted in the early outbreaks caused by ancestral strains, the estimated infectiousness variations are corrected for the variations caused by number of contacts and transmission risks in different settings, difference in pre-existing immunity among contacts (almost everyone is naïve and unvaccinated), and the difference in transmissibility among variants. Hence, this estimated infectiousness variation measures the variation caused by difference in individuals, which may be contributed by both biological factors and host behaviors, but not other potential confounding factors mentioned above.</p><p>Regarding host behaviors, multiple contact patterns, particularly by age, could contribute to the variations in infectiousness of cases. For example, mother-child contacts are usually more intense than father-child contacts, and adult cases are more capable of self-isolation within a household compared with children. Furthermore, contact pattern studies suggested that school-age children and young adults tended to mix with people of the same age (<xref ref-type="bibr" rid="bib43">Mossong et al., 2008</xref>; <xref ref-type="bibr" rid="bib44">Mousa et al., 2021</xref>). Also, the duration of contact could vary, which could also contribute to the variations in infectiousness of cases (<xref ref-type="bibr" rid="bib58">Toth et al., 2015</xref>). It should be noted that contacts have different features, including their number, frequency, and duration that may contribute to variations in infectiousness. Previous studies also suggest that the relative importance of contact characteristics on transmission may be different among viruses (<xref ref-type="bibr" rid="bib17">De Cao et al., 2014</xref>). Individual behaviors may also be influenced by control measures and recommendation from public health agencies. For example, lockdown and stay-at-home orders may increase the time spending at home. Mask-wearing when in contact with other household members, using separate bedrooms and bathrooms, avoiding having meals together may reduce the transmission in households (<xref ref-type="bibr" rid="bib45">Ng et al., 2021</xref>). Also, social disparity such as occupation may increase or reduce the risk of transmission in households, including the availability of personal protective equipment (PPE), or being healthcare worker (<xref ref-type="bibr" rid="bib70">Yang et al., 2021</xref>). These factors may have impact of the transmission risk and hence SAR in households. In addition, heterogeneity in these different factors may have contributed infectiousness variation.</p><p>Biological factors may also contribute to such variations. For example, the SAR for index cases with fever and cough are 1.4- and 1.3-fold higher than index cases without fever and cough, respectively (<xref ref-type="bibr" rid="bib40">Madewell et al., 2021</xref>). Viral shedding is used as a proxy measure of infectiousness, and consistently it also has substantial variations, as suggested by 11 systematic reviews (<xref ref-type="table" rid="app1table12 app1table13 app1table14">Appendix 1—Tables 12–14</xref>). Regarding the magnitude of viral shedding, studies report high variations of temporal viral shedding patterns among individuals (<xref ref-type="bibr" rid="bib23">He et al., 2020</xref>; <xref ref-type="bibr" rid="bib29">Jones et al., 2021</xref>; <xref ref-type="bibr" rid="bib55">Sun et al., 2022</xref>). In addition, the duration of viral shedding can be highly heterogeneous, with pooled estimates of mean durations ranging from 11.1 to 30.3 days, and almost all reviews reporting high heterogeneity of estimates (<xref ref-type="bibr" rid="bib11">Cevik et al., 2021</xref>; <xref ref-type="bibr" rid="bib13">Chen et al., 2021b</xref>; <xref ref-type="bibr" rid="bib18">Díaz et al., 2022</xref>; <xref ref-type="bibr" rid="bib20">Fontana et al., 2021</xref>; <xref ref-type="bibr" rid="bib36">Li et al., 2020b</xref>; <xref ref-type="bibr" rid="bib46">Okita et al., 2022</xref>; <xref ref-type="bibr" rid="bib48">Qutub et al., 2022</xref>; <xref ref-type="bibr" rid="bib49">Rahmani et al., 2022</xref>; <xref ref-type="bibr" rid="bib68">Xu et al., 2020</xref>; <xref ref-type="bibr" rid="bib69">Yan et al., 2021</xref>; <xref ref-type="bibr" rid="bib71">Zhang et al., 2021</xref>). Such heterogeneities still exist in subgroup analyses by age and severity (<xref ref-type="bibr" rid="bib11">Cevik et al., 2021</xref>; <xref ref-type="bibr" rid="bib20">Fontana et al., 2021</xref>; <xref ref-type="bibr" rid="bib46">Okita et al., 2022</xref>; <xref ref-type="bibr" rid="bib48">Qutub et al., 2022</xref>; <xref ref-type="bibr" rid="bib49">Rahmani et al., 2022</xref>; <xref ref-type="bibr" rid="bib68">Xu et al., 2020</xref>; <xref ref-type="bibr" rid="bib69">Yan et al., 2021</xref>). The infectious period, proxied by duration of replicant competent virus isolation, is also heterogeneous (<xref ref-type="bibr" rid="bib49">Rahmani et al., 2022</xref>; <xref ref-type="table" rid="app1table14">Appendix 1—table 14</xref>). One review also suggests that heterogeneity in viral shedding is an intrinsic virological factor facilitating higher dispersion parameter for SARS-CoV-2 if we compare it with the corresponding patterns in SARS-CoV-1 and pandemic influenza A(H1N1)pdm09 (<xref ref-type="bibr" rid="bib12">Chen et al., 2021a</xref>).</p><p>The observed variation in individual infectiousness is consistent with past analyses of the dispersion parameter in a negative binomial distribution fitted to number of secondary cases per index case of COVID-19 (<xref ref-type="bibr" rid="bib54">Sun et al., 2021</xref>; <xref ref-type="bibr" rid="bib66">Wong et al., 2015</xref>). However, in these studies, the number of contacts was not considered. Therefore, the observed variations may not apply directly to households with limited number of contacts. It should be noted that the SD of the distribution of number of secondary cases (<inline-formula><mml:math id="inf14"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) is only weakly correlated with infectiousness variation. This is because <inline-formula><mml:math id="inf15"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is highly correlated with the mean and SD of the number of contacts, suggesting that it may depend on distribution of number of contacts, and hence may not be comparable among studies. Infectiousness variation is also correlated with the SAR. When SAR is higher, it is expected that more contacts are infected and therefore the observed number of secondary cases is less heterogeneous (<xref ref-type="bibr" rid="bib2">Adam et al., 2022</xref>). We find higher infectiousness variation is associated with only using PCR to confirm secondary cases. One potential reason is that using other methods may lower the sensitivity of detecting infection, resulting in lower estimates of SAR and hence higher estimates of infectiousness variation. Further investigations are needed to explore roles of other potential factors affecting infectiousness variation, such as contact frequency among different regions (<xref ref-type="bibr" rid="bib44">Mousa et al., 2021</xref>).</p><p>An important limitation of our study is that we do not have individual-level data. Therefore, we are unable to determine the impact of demographic factors like age and sex on infectiousness variation. Also, we cannot disentangle the host behaviors from biological factors. Previous analysis suggested no evidence of the impact of age on infectiousness of cases (<xref ref-type="bibr" rid="bib32">Lau et al., 2020</xref>; <xref ref-type="bibr" rid="bib54">Sun et al., 2021</xref>). In addition, we could not include factors affecting susceptibility to infection. Our estimates of infectiousness variation should be interpreted in light of these limitations: they capture heterogeneity in infectiousness due to demographic, host, and biological factors. However, in one study that included susceptibility component in the estimation of individual infectiousness, substantial heterogeneity remained with 20% of cases estimated to contribute to 80% of transmission (<xref ref-type="bibr" rid="bib63">Tsang et al., 2022</xref>). Second, the recruitment methods among studies are different. This may affect the comparability of the results, although all index cases are laboratory-confirmed in all studies (<xref ref-type="bibr" rid="bib61">Tsang et al., 2021</xref>). Third, we assumed that risks of infection from community for all households are the same, but there were different factors that may affecting this, including occupations, such as healthcare workers, social economic status that related to assess to PPEs (<xref ref-type="bibr" rid="bib70">Yang et al., 2021</xref>). Finally, most of our identified studies were conducted in the period of circulation of ancestral strains, and therefore the identified infectiousness variation may not be directly applicable to other variants.</p><p>In conclusion, we developed a modeling approach to estimate variation in individual infectiousness from household data. Result indicates that there is substantial variation in individual infectiousness, which is important for epidemic management.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Study design</title><p>The aim of this study was to develop a statistical model to quantify the variation of individual infectiousness in households, based on publicly available information. An index case was defined as the first detected case in a household, while secondary cases were defined as the identified infected household contacts of the index case. We conducted a systematic review to collect household studies with at least 30 households, reporting the number of secondary cases with number of household contacts for each household for COVID-19, in the form of number of households with <italic>X</italic> cases among households of size <italic>Y</italic>. For each study, we also extracted the study period, the coverage of tests of household contacts, the case ascertainment methods, the circulating virus of SARS-CoV-2, and the public health and social measures in the study period. This information was used as an input of modeling analyses in this study. Details of systematic review could be found in Appendix 1.</p></sec><sec id="s4-2"><title>Estimation of variation of individual infectiousness in households</title><p>To determine if there are variations of individual infectiousness of cases<bold><italic>,</italic></bold> we used an individual-based household transmission model (; <xref ref-type="bibr" rid="bib59">Tsang et al., 2014</xref>; <xref ref-type="bibr" rid="bib61">Tsang et al., 2021</xref>). The model described the probability of infection of household contacts as depending on the time since infection in other infected people in the household, while infections from outside the household (community infections), or infections via other household contacts rather than the index case (tertiary infections) are allowed. We extended the model by adding a random effect parameter (<inline-formula><mml:math id="inf16"><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) on the individual infectiousness of each case. In the model, the hazard of infection of individual <italic>j</italic> at time <italic>t</italic> from an infected household member <italic>i,</italic> with infection time <italic>t<sub>i</sub></italic> in household <italic>k</italic>, was<disp-formula id="equ1"><mml:math id="m1"><mml:msub><mml:mrow><mml:mi>λ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>→</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>λ</mml:mi></mml:mrow><mml:mrow><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>β</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac><mml:mi> </mml:mi><mml:mi>*</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">exp</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mrow><mml:mi>*</mml:mi><mml:mi>f</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf17"><mml:msub><mml:mrow><mml:mi>λ</mml:mi></mml:mrow><mml:mrow><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> was the baseline hazard, <inline-formula><mml:math id="inf18"><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> followed a normal distribution with mean 0 and SD <inline-formula><mml:math id="inf19"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> , which quantified the variation of individual infectiousness (hereafter denoted as infectiousness variation). The relative infectiousness of case <italic>i</italic> compared with case <italic>j</italic> was exp(<inline-formula><mml:math id="inf20"><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>)/exp(<inline-formula><mml:math id="inf21"><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>).</p><p><inline-formula><mml:math id="inf22"><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> was the number of household contacts. <inline-formula><mml:math id="inf23"><mml:mi>β</mml:mi></mml:math></inline-formula> was the parameter describing the relationship between number of household contacts and transmission rate. It ranged from 0 to 1, with 0 indicating that the transmission rate was independent of number of household contacts while 1 indicated that the transmission rate was inversely proportional to number of household contacts (i.e. dilution effect of the contact time per contact which was lower when the number of household contacts is higher). <italic>f</italic>(·) was the infectiousness profile since infection generated from the assumed incubation period (mean equal to 5 days) and infectious period (mean equal to 13) (<xref ref-type="bibr" rid="bib23">He et al., 2020</xref>; <xref ref-type="bibr" rid="bib28">Jing et al., 2020</xref>; <xref ref-type="bibr" rid="bib35">Li et al., 2020a</xref>; <xref ref-type="table" rid="app1table15">Appendix 1—table 15</xref>). Extracted distribution were summarized in <xref ref-type="table" rid="app1table15">Appendix 1—table 15</xref>, and the shape of the assumed function was plotted on <xref ref-type="fig" rid="app1fig3">Appendix 1—figure 3</xref>.</p><p>Since the data were extracted from publication, the infection time of all cases was unavailable for all studies. Also, the individual infectiousness parameters <inline-formula><mml:math id="inf24"><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> for cases were augmented variables. Therefore, we conducted our inference under a Bayesian framework using data augmentation Markov chain Monte Carlo (MCMC) algorithm to joint estimate the model parameters, the missing infection time, and augmented variables using metropolis-hasting algorithm. We separately fitted this model to identified studies. We assessed the model adequacy by comparing the observed and expected number of infections in households by household size. We compared the model with or without the random effect for variation of individual infectiousness by using deviance information criterion (DIC) (<xref ref-type="bibr" rid="bib53">Spiegelhalter et al., 2002</xref>). Smaller DIC indicated a better model fit. DIC difference &gt;5 was considered as substantial improvement (<xref ref-type="bibr" rid="bib52">Spiegelhalter et al., 2000</xref>). Details of the model and inference could be found in Appendix 1. We conducted a sensitivity analysis that used a Gamma distribution, instead of exponential of normal distribution (Appendix 1).</p></sec><sec id="s4-3"><title>Meta-analysis and meta-regression</title><p>We conducted random effects meta-analyses on identified studies to obtain pooled estimates of individual infectiousness, using the inverse variance method and restricted maximum likelihood estimator for heterogeneity (<xref ref-type="bibr" rid="bib24">Hedges and Vevea, 1998</xref>; <xref ref-type="bibr" rid="bib31">Langan et al., 2019</xref>; <xref ref-type="bibr" rid="bib56">Thompson and Sharp, 1999</xref>; <xref ref-type="bibr" rid="bib64">Veroniki et al., 2019</xref>). Cochran <italic>Q</italic> test and the <italic>I<sup>2</sup></italic> statistic were used to identify and quantify heterogeneity among included studies (<xref ref-type="bibr" rid="bib14">Cochran, 1954</xref>; <xref ref-type="bibr" rid="bib25">Higgins et al., 2003</xref>). An <italic>I<sup>2</sup></italic> value more than 75% indicates high heterogeneity (<xref ref-type="bibr" rid="bib25">Higgins et al., 2003</xref>). We conducted a meta-regression analysis to explore the association between infectiousness variation (<inline-formula><mml:math id="inf25"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>, SD) of the distribution of number of secondary cases (<inline-formula><mml:math id="inf26"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>, and SAR), and further including the following factors: the mean and SD of number of household contacts, implementation of lockdown, ascertainment method of index and secondary cases, only ancestral strains are circulating in study period, and all household contacts were tested.</p></sec><sec id="s4-4"><title>Data availability</title><p>All data in this study are publicly available since they are extracted from published articles. Summarized data for analysis could be downloaded from <ext-link ext-link-type="uri" xlink:href="https://github.com/timktsang/covid19_transmission_heterogeneity">https://github.com/timktsang/covid19_transmission_heterogeneity</ext-link>, (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:4d4436affc6aa5ddf265a9a9acb638f66eb0cd5d;origin=https://github.com/timktsang/covid19_transmission_heterogeneity;visit=swh:1:snp:6e5eab4d82393ee3420ab8827a701a0129569d57;anchor=swh:1:rev:634390fa66a4bfb998da691e7cd81cf45e38c6db">swh:1:rev:634390fa66a4bfb998da691e7cd81cf45e38c6db</ext-link>; <xref ref-type="bibr" rid="bib62">Tsang, 2022</xref>).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>consults for AstraZeneca, Fosun Pharma, GlaxoSmithKline, Moderna, Pfizer, Roche and Sanofi Pasteur. The authors report no other potential conflicts of interest</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Investigation, Visualization</p></fn><fn fn-type="con" id="con3"><p>Data curation, Investigation</p></fn><fn fn-type="con" id="con4"><p>Investigation, Visualization</p></fn><fn fn-type="con" id="con5"><p>Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Supervision, Funding acquisition, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Supervision, Funding acquisition, Methodology, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-82611-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The data and computer code (in R language) for conducting the data analysis can be downloaded from <ext-link ext-link-type="uri" xlink:href="https://github.com/timktsang/covid19_transmission_heterogeneity">https://github.com/timktsang/covid19_transmission_heterogeneity</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:4d4436affc6aa5ddf265a9a9acb638f66eb0cd5d;origin=https://github.com/timktsang/covid19_transmission_heterogeneity;visit=swh:1:snp:6e5eab4d82393ee3420ab8827a701a0129569d57;anchor=swh:1:rev:634390fa66a4bfb998da691e7cd81cf45e38c6db">swh:1:rev:634390fa66a4bfb998da691e7cd81cf45e38c6db</ext-link>).</p></sec><ack id="ack"><title>Acknowledgements</title><p>The authors thank Maylis Layan for helpful discussion and Jiayi Zhou for technical assistance. This project was supported by the Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong Special Administrative Region (grant no. COVID190118; BJC) and the Collaborative Research Fund (Project No. C7123-20G; BJC) of the Research Grants Council of the Hong Kong SAR Government. BJC is supported by the AIR@innoHK program of the Innovation and Technology Commission of the Hong Kong SAR Government. SC acknowledges financial support from the Investissement d’Avenir program, the Laboratoire d’Excellence Integrative Biology of Emerging Infectious Diseases program (grant ANR-10-LABX-62-IBEID), the EMERGEN project (ANRS0151), the INCEPTION project (PIA/ANR-16-CONV-0005), the European Union’s Horizon 2020 research and innovation program under grant 101003589 (RECOVER) and 874735 (VEO), AXA and Groupama. TKT acknowledges the Seed Fund for Basic Research (202111159118) from the University of Hong Kong.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adam</surname><given-names>DC</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Wong</surname><given-names>JY</given-names></name><name><surname>Lau</surname><given-names>EHY</given-names></name><name><surname>Tsang</surname><given-names>TK</given-names></name><name><surname>Cauchemez</surname><given-names>S</given-names></name><name><surname>Leung</surname><given-names>GM</given-names></name><name><surname>Cowling</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Clustering and superspreading potential of SARS-cov-2 infections in hong kong</article-title><source>Nature Medicine</source><volume>26</volume><fpage>1714</fpage><lpage>1719</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-1092-0</pub-id><pub-id pub-id-type="pmid">32943787</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Adam</surname><given-names>D</given-names></name><name><surname>Gostic</surname><given-names>K</given-names></name><name><surname>Tsang</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Lim</surname><given-names>WW</given-names></name><name><surname>Yeung</surname><given-names>A</given-names></name><name><surname>Wong</surname><given-names>J</given-names></name><name><surname>Lau</surname><given-names>E</given-names></name><name><surname>Du</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Ho</surname><given-names>LM</given-names></name><name><surname>Martín-Sánchez</surname><given-names>M</given-names></name><name><surname>Cauchemez</surname><given-names>S</given-names></name><name><surname>Cobey</surname><given-names>S</given-names></name><name><surname>Leung</surname><given-names>G</given-names></name><name><surname>Cowling</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Time-Varying Transmission Heterogeneity of SARS and COVID-19 in Hong Kong</article-title><source>Research Square</source><pub-id pub-id-type="doi">10.21203/rs.3.rs-1407962/v1</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Althouse</surname><given-names>BM</given-names></name><name><surname>Wenger</surname><given-names>EA</given-names></name><name><surname>Miller</surname><given-names>JC</given-names></name><name><surname>Scarpino</surname><given-names>SV</given-names></name><name><surname>Allard</surname><given-names>A</given-names></name><name><surname>Hébert-Dufresne</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Superspreading events in the transmission dynamics of SARS-cov-2: opportunities for interventions and control</article-title><source>PLOS Biology</source><volume>18</volume><elocation-id>e3000897</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3000897</pub-id><pub-id pub-id-type="pmid">33180773</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagdasarian</surname><given-names>N</given-names></name><name><surname>Fisher</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Heterogenous COVID-19 transmission dynamics within singapore: a clearer picture of future national responses</article-title><source>BMC Medicine</source><volume>18</volume><elocation-id>164</elocation-id><pub-id pub-id-type="doi">10.1186/s12916-020-01625-7</pub-id><pub-id pub-id-type="pmid">32493311</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernardes-Souza</surname><given-names>B</given-names></name><name><surname>Júnior</surname><given-names>SRC</given-names></name><name><surname>Santos</surname><given-names>CA</given-names></name><name><surname>Neto</surname><given-names>R</given-names></name><name><surname>Bottega</surname><given-names>FDC</given-names></name><name><surname>Godoy</surname><given-names>DC</given-names></name><name><surname>Freitas</surname><given-names>BL</given-names></name><name><surname>Silva</surname><given-names>DLG</given-names></name><name><surname>Brinker</surname><given-names>TJ</given-names></name><name><surname>Nascimento</surname><given-names>RA</given-names></name><name><surname>Tupinambás</surname><given-names>U</given-names></name><name><surname>Reis</surname><given-names>AB</given-names></name><name><surname>Coura-Vital</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Logistics workers are a key factor for SARS-cov-2 spread in brazilian small towns: case-control study</article-title><source>JMIR Public Health and Surveillance</source><volume>7</volume><elocation-id>e30406</elocation-id><pub-id pub-id-type="doi">10.2196/30406</pub-id><pub-id pub-id-type="pmid">34388105</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carazo</surname><given-names>S</given-names></name><name><surname>Laliberté</surname><given-names>D</given-names></name><name><surname>Villeneuve</surname><given-names>J</given-names></name><name><surname>Martin</surname><given-names>R</given-names></name><name><surname>Deshaies</surname><given-names>P</given-names></name><name><surname>Denis</surname><given-names>G</given-names></name><name><surname>Adib</surname><given-names>G</given-names></name><name><surname>Tissot</surname><given-names>F</given-names></name><name><surname>Dionne</surname><given-names>M</given-names></name><name><surname>De Serres</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Characterization and evolution of infection control practices among severe acute respiratory coronavirus virus 2 (SARS-cov-2)-infected healthcare workers in acute-care hospitals and long-term care facilities in québec, canada, spring 2020</article-title><source>Infection Control and Hospital Epidemiology</source><volume>43</volume><fpage>481</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1017/ice.2021.160</pub-id><pub-id pub-id-type="pmid">33853702</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cauchemez</surname><given-names>S</given-names></name><name><surname>Donnelly</surname><given-names>CA</given-names></name><name><surname>Reed</surname><given-names>C</given-names></name><name><surname>Ghani</surname><given-names>AC</given-names></name><name><surname>Fraser</surname><given-names>C</given-names></name><name><surname>Kent</surname><given-names>CK</given-names></name><name><surname>Finelli</surname><given-names>L</given-names></name><name><surname>Ferguson</surname><given-names>NM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Household transmission of 2009 pandemic influenza A (H1N1) virus in the united states</article-title><source>The New England Journal of Medicine</source><volume>361</volume><fpage>2619</fpage><lpage>2627</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0905498</pub-id><pub-id pub-id-type="pmid">20042753</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cauchemez</surname><given-names>S</given-names></name><name><surname>Ferguson</surname><given-names>NM</given-names></name><name><surname>Fox</surname><given-names>A</given-names></name><name><surname>Mai</surname><given-names>LQ</given-names></name><name><surname>Thanh</surname><given-names>LT</given-names></name><name><surname>Thai</surname><given-names>PQ</given-names></name><name><surname>Thoang</surname><given-names>DD</given-names></name><name><surname>Duong</surname><given-names>TN</given-names></name><name><surname>Minh Hoa</surname><given-names>LN</given-names></name><name><surname>Tran Hien</surname><given-names>N</given-names></name><name><surname>Horby</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Determinants of influenza transmission in south east asia: insights from a household cohort study in vietnam</article-title><source>PLOS Pathogens</source><volume>10</volume><elocation-id>e1004310</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004310</pub-id><pub-id pub-id-type="pmid">25144780</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cauchemez</surname><given-names>S</given-names></name><name><surname>Nouvellet</surname><given-names>P</given-names></name><name><surname>Cori</surname><given-names>A</given-names></name><name><surname>Jombart</surname><given-names>T</given-names></name><name><surname>Garske</surname><given-names>T</given-names></name><name><surname>Clapham</surname><given-names>H</given-names></name><name><surname>Moore</surname><given-names>S</given-names></name><name><surname>Mills</surname><given-names>HL</given-names></name><name><surname>Salje</surname><given-names>H</given-names></name><name><surname>Collins</surname><given-names>C</given-names></name><name><surname>Rodriquez-Barraquer</surname><given-names>I</given-names></name><name><surname>Riley</surname><given-names>S</given-names></name><name><surname>Truelove</surname><given-names>S</given-names></name><name><surname>Algarni</surname><given-names>H</given-names></name><name><surname>Alhakeem</surname><given-names>R</given-names></name><name><surname>AlHarbi</surname><given-names>K</given-names></name><name><surname>Turkistani</surname><given-names>A</given-names></name><name><surname>Aguas</surname><given-names>RJ</given-names></name><name><surname>Cummings</surname><given-names>DAT</given-names></name><name><surname>Van Kerkhove</surname><given-names>MD</given-names></name><name><surname>Donnelly</surname><given-names>CA</given-names></name><name><surname>Lessler</surname><given-names>J</given-names></name><name><surname>Fraser</surname><given-names>C</given-names></name><name><surname>Al-Barrak</surname><given-names>A</given-names></name><name><surname>Ferguson</surname><given-names>NM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Unraveling the drivers of MERS-cov transmission</article-title><source>PNAS</source><volume>113</volume><fpage>9081</fpage><lpage>9086</lpage><pub-id pub-id-type="doi">10.1073/pnas.1519235113</pub-id><pub-id pub-id-type="pmid">27457935</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celeux</surname><given-names>G</given-names></name><name><surname>Forbes</surname><given-names>F</given-names></name><name><surname>Robert</surname><given-names>CP</given-names></name><name><surname>Titterington</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Deviance information criteria for missing data models</article-title><source>Bayesian Analysis</source><volume>1</volume><fpage>651</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1214/06-BA122</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cevik</surname><given-names>M</given-names></name><name><surname>Tate</surname><given-names>M</given-names></name><name><surname>Lloyd</surname><given-names>O</given-names></name><name><surname>Maraolo</surname><given-names>AE</given-names></name><name><surname>Schafers</surname><given-names>J</given-names></name><name><surname>Ho</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>SARS-cov-2, SARS-cov, and MERS-cov viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis</article-title><source>The Lancet. Microbe</source><volume>2</volume><fpage>e13</fpage><lpage>e22</lpage><pub-id pub-id-type="doi">10.1016/S2666-5247(20)30172-5</pub-id><pub-id pub-id-type="pmid">33521734</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>PZ</given-names></name><name><surname>Bobrovitz</surname><given-names>N</given-names></name><name><surname>Premji</surname><given-names>Z</given-names></name><name><surname>Koopmans</surname><given-names>M</given-names></name><name><surname>Fisman</surname><given-names>DN</given-names></name><name><surname>Gu</surname><given-names>FX</given-names></name></person-group><year iso-8601-date="2021">2021a</year><article-title>Heterogeneity in transmissibility and shedding SARS-cov-2 via droplets and aerosols</article-title><source>eLife</source><volume>10</volume><elocation-id>e65774</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.65774</pub-id><pub-id pub-id-type="pmid">33861198</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>C</given-names></name><name><surname>Yan</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>C</given-names></name><name><surname>Tian</surname><given-names>G</given-names></name><name><surname>Lan</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Hecht</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021b</year><article-title>The epidemiological and radiographical characteristics of asymptomatic infections with the novel coronavirus (COVID-19): a systematic review and meta-analysis</article-title><source>International Journal of Infectious Diseases</source><volume>104</volume><fpage>458</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2021.01.017</pub-id><pub-id pub-id-type="pmid">33444755</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cochran</surname><given-names>WG</given-names></name></person-group><year iso-8601-date="1954">1954</year><article-title>The combination of estimates from different experiments</article-title><source>Biometrics</source><volume>10</volume><elocation-id>101</elocation-id><pub-id pub-id-type="doi">10.2307/3001666</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowling</surname><given-names>BJ</given-names></name><name><surname>Park</surname><given-names>M</given-names></name><name><surname>Fang</surname><given-names>VJ</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Leung</surname><given-names>GM</given-names></name><name><surname>Wu</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Preliminary epidemiological assessment of MERS-cov outbreak in south korea, may to june 2015</article-title><source>Euro Surveillance</source><volume>20</volume><fpage>7</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.2807/1560-7917.es2015.20.25.21163</pub-id><pub-id pub-id-type="pmid">26132767</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dattner</surname><given-names>I</given-names></name><name><surname>Goldberg</surname><given-names>Y</given-names></name><name><surname>Katriel</surname><given-names>G</given-names></name><name><surname>Yaari</surname><given-names>R</given-names></name><name><surname>Gal</surname><given-names>N</given-names></name><name><surname>Miron</surname><given-names>Y</given-names></name><name><surname>Ziv</surname><given-names>A</given-names></name><name><surname>Sheffer</surname><given-names>R</given-names></name><name><surname>Hamo</surname><given-names>Y</given-names></name><name><surname>Huppert</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The role of children in the spread of COVID-19: using household data from bnei BRAK, israel, to estimate the relative susceptibility and infectivity of children</article-title><source>PLOS Computational Biology</source><volume>17</volume><elocation-id>e1008559</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1008559</pub-id><pub-id pub-id-type="pmid">33571188</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Cao</surname><given-names>E</given-names></name><name><surname>Zagheni</surname><given-names>E</given-names></name><name><surname>Manfredi</surname><given-names>P</given-names></name><name><surname>Melegaro</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The relative importance of frequency of contacts and duration of exposure for the spread of directly transmitted infections</article-title><source>Biostatistics</source><volume>15</volume><fpage>470</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1093/biostatistics/kxu008</pub-id><pub-id pub-id-type="pmid">24705143</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Díaz</surname><given-names>LA</given-names></name><name><surname>García-Salum</surname><given-names>T</given-names></name><name><surname>Fuentes-López</surname><given-names>E</given-names></name><name><surname>Reyes</surname><given-names>D</given-names></name><name><surname>Ortiz</surname><given-names>J</given-names></name><name><surname>Chahuan</surname><given-names>J</given-names></name><name><surname>Levican</surname><given-names>J</given-names></name><name><surname>Almonacid</surname><given-names>LI</given-names></name><name><surname>Valenzuela</surname><given-names>GH</given-names></name><name><surname>Serrano</surname><given-names>E</given-names></name><name><surname>Budnik</surname><given-names>S</given-names></name><name><surname>Gandara</surname><given-names>V</given-names></name><name><surname>Gallardo</surname><given-names>A</given-names></name><name><surname>Seydewitz</surname><given-names>MF</given-names></name><name><surname>Ferrés</surname><given-names>M</given-names></name><name><surname>Cofré</surname><given-names>C</given-names></name><name><surname>Álvarez</surname><given-names>M</given-names></name><name><surname>Pavez</surname><given-names>C</given-names></name><name><surname>Candia</surname><given-names>R</given-names></name><name><surname>Monrroy</surname><given-names>H</given-names></name><name><surname>Espino</surname><given-names>A</given-names></name><name><surname>Rada</surname><given-names>G</given-names></name><name><surname>Ortiz</surname><given-names>L</given-names></name><name><surname>Valderrama</surname><given-names>S</given-names></name><name><surname>Salinas</surname><given-names>E</given-names></name><name><surname>Toro</surname><given-names>A</given-names></name><name><surname>Ortega</surname><given-names>M</given-names></name><name><surname>Pizarro</surname><given-names>M</given-names></name><name><surname>Medina</surname><given-names>RA</given-names></name><name><surname>Riquelme</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>High prevalence of SARS-cov-2 detection and prolonged viral shedding in stools: a systematic review and cohort study</article-title><source>Gastroenterologia y Hepatologia</source><volume>45</volume><fpage>593</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1016/j.gastrohep.2021.12.009</pub-id><pub-id pub-id-type="pmid">35077722</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname><given-names>S</given-names></name><name><surname>Kaur</surname><given-names>RJ</given-names></name><name><surname>Bhardwaj</surname><given-names>P</given-names></name><name><surname>Charan</surname><given-names>J</given-names></name><name><surname>Bist</surname><given-names>SKS</given-names></name><name><surname>Detha</surname><given-names>MD</given-names></name><name><surname>Kanchan</surname><given-names>T</given-names></name><name><surname>Sharma</surname><given-names>P</given-names></name><name><surname>Misra</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Household transmission of COVID-19: a cross-sectional study</article-title><source>Infection and Drug Resistance</source><volume>13</volume><fpage>4637</fpage><lpage>4642</lpage><pub-id pub-id-type="doi">10.2147/IDR.S285446</pub-id><pub-id pub-id-type="pmid">33380813</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>LM</given-names></name><name><surname>Villamagna</surname><given-names>AH</given-names></name><name><surname>Sikka</surname><given-names>MK</given-names></name><name><surname>McGregor</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-cov-2): review of current literature</article-title><source>Infection Control and Hospital Epidemiology</source><volume>42</volume><fpage>659</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1017/ice.2020.1273</pub-id><pub-id pub-id-type="pmid">33077007</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>WGH</given-names></name><name><surname>Swart</surname><given-names>A</given-names></name><name><surname>Bonačić Marinović</surname><given-names>A</given-names></name><name><surname>Eggink</surname><given-names>D</given-names></name><name><surname>Reimerink</surname><given-names>J</given-names></name><name><surname>Wijsman</surname><given-names>LA</given-names></name><name><surname>van der Veer</surname><given-names>B</given-names></name><name><surname>van den Brink</surname><given-names>S</given-names></name><name><surname>van den Brandt</surname><given-names>A-M</given-names></name><name><surname>van Tol</surname><given-names>S</given-names></name><name><surname>Godeke</surname><given-names>G-J</given-names></name><name><surname>Brouwer</surname><given-names>F</given-names></name><name><surname>Hoogerwerf</surname><given-names>M</given-names></name><name><surname>Reukers</surname><given-names>DFM</given-names></name><name><surname>Rots</surname><given-names>N</given-names></name><name><surname>Reusken</surname><given-names>C</given-names></name><name><surname>Meijer</surname><given-names>A</given-names></name><collab>Dutch F. F. X.-COVID-19 Research Group</collab></person-group><year iso-8601-date="2022">2022</year><article-title>SARS-cov-2 RNA and antibody dynamics in a dutch household study with dense sampling frame</article-title><source>Scientific Reports</source><volume>12</volume><elocation-id>7937</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-022-11480-6</pub-id><pub-id pub-id-type="pmid">35562380</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>WS</given-names></name><name><surname>Abbott</surname><given-names>S</given-names></name><name><surname>Endo</surname><given-names>A</given-names></name><name><surname>Hellewell</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>E</given-names></name><name><surname>Andrews</surname><given-names>N</given-names></name><name><surname>Maini</surname><given-names>PK</given-names></name><name><surname>Funk</surname><given-names>S</given-names></name><name><surname>Thompson</surname><given-names>RN</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Inference of the SARS-cov-2 generation time using UK household data</article-title><source>eLife</source><volume>11</volume><elocation-id>e70767</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.70767</pub-id><pub-id pub-id-type="pmid">35138250</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>X</given-names></name><name><surname>Lau</surname><given-names>EHY</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Hao</surname><given-names>X</given-names></name><name><surname>Lau</surname><given-names>YC</given-names></name><name><surname>Wong</surname><given-names>JY</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name><name><surname>Tan</surname><given-names>X</given-names></name><name><surname>Mo</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Liao</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Hu</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Zhong</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Cowling</surname><given-names>BJ</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Leung</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Temporal dynamics in viral shedding and transmissibility of COVID-19</article-title><source>Nature Medicine</source><volume>26</volume><fpage>672</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-0869-5</pub-id><pub-id pub-id-type="pmid">32296168</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedges</surname><given-names>LV</given-names></name><name><surname>Vevea</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Fixed- and random-effects models in meta-analysis</article-title><source>Psychological Methods</source><volume>3</volume><fpage>486</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1037/1082-989X.3.4.486</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>JPT</given-names></name><name><surname>Thompson</surname><given-names>SG</given-names></name><name><surname>Deeks</surname><given-names>JJ</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Measuring inconsistency in meta-analyses</article-title><source>BMJ</source><volume>327</volume><fpage>557</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1136/bmj.327.7414.557</pub-id><pub-id pub-id-type="pmid">12958120</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>CY</given-names></name><name><surname>Wang</surname><given-names>JT</given-names></name><name><surname>Huang</surname><given-names>KC</given-names></name><name><surname>Fan</surname><given-names>ACH</given-names></name><name><surname>Yeh</surname><given-names>YP</given-names></name><name><surname>Chen</surname><given-names>SLS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Household transmission but without the community-acquired outbreak of COVID-19 in taiwan</article-title><source>Journal of the Formosan Medical Association</source><volume>120 Suppl 1</volume><fpage>S38</fpage><lpage>S45</lpage><pub-id pub-id-type="doi">10.1016/j.jfma.2021.04.021</pub-id><pub-id pub-id-type="pmid">33994234</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubiche</surname><given-names>T</given-names></name><name><surname>Phan</surname><given-names>A</given-names></name><name><surname>Leducq</surname><given-names>S</given-names></name><name><surname>Rapp</surname><given-names>J</given-names></name><name><surname>Fertitta</surname><given-names>L</given-names></name><name><surname>Aubert</surname><given-names>H</given-names></name><name><surname>Barbarot</surname><given-names>S</given-names></name><name><surname>Chiaverini</surname><given-names>C</given-names></name><name><surname>Giraudeau</surname><given-names>B</given-names></name><name><surname>Lasek</surname><given-names>A</given-names></name><name><surname>Mallet</surname><given-names>S</given-names></name><name><surname>Labarelle</surname><given-names>A</given-names></name><name><surname>Piram</surname><given-names>M</given-names></name><name><surname>McCuaig</surname><given-names>C</given-names></name><name><surname>Martin</surname><given-names>L</given-names></name><name><surname>Monitor</surname><given-names>L</given-names></name><name><surname>Nicol</surname><given-names>I</given-names></name><name><surname>Bissuel</surname><given-names>M</given-names></name><name><surname>Bellissen</surname><given-names>A</given-names></name><name><surname>Jullien</surname><given-names>D</given-names></name><name><surname>Lesort</surname><given-names>C</given-names></name><name><surname>Vabres</surname><given-names>P</given-names></name><name><surname>Maruani</surname><given-names>A</given-names></name><collab>Research Group of the Société Française de Dermatologie Pédiatrique (French Society of Pediatric Dermatology)</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Acute acral eruptions in children during the COVID-19 pandemic: characteristics of 103 children and their family clusters</article-title><source>Annales de Dermatologie et de Venereologie</source><volume>148</volume><fpage>94</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.annder.2020.11.005</pub-id><pub-id pub-id-type="pmid">33551211</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jing</surname><given-names>QL</given-names></name><name><surname>Liu</surname><given-names>MJ</given-names></name><name><surname>Zhang</surname><given-names>ZB</given-names></name><name><surname>Fang</surname><given-names>LQ</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>AR</given-names></name><name><surname>Dean</surname><given-names>NE</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>MM</given-names></name><name><surname>Longini</surname><given-names>I</given-names></name><name><surname>Kenah</surname><given-names>E</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Jalali</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>ZC</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Household secondary attack rate of COVID-19 and associated determinants in guangzhou, china: a retrospective cohort study</article-title><source>The Lancet. Infectious Diseases</source><volume>20</volume><fpage>1141</fpage><lpage>1150</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30471-0</pub-id><pub-id pub-id-type="pmid">32562601</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>TC</given-names></name><name><surname>Biele</surname><given-names>G</given-names></name><name><surname>Mühlemann</surname><given-names>B</given-names></name><name><surname>Veith</surname><given-names>T</given-names></name><name><surname>Schneider</surname><given-names>J</given-names></name><name><surname>Beheim-Schwarzbach</surname><given-names>J</given-names></name><name><surname>Bleicker</surname><given-names>T</given-names></name><name><surname>Tesch</surname><given-names>J</given-names></name><name><surname>Schmidt</surname><given-names>ML</given-names></name><name><surname>Sander</surname><given-names>LE</given-names></name><name><surname>Kurth</surname><given-names>F</given-names></name><name><surname>Menzel</surname><given-names>P</given-names></name><name><surname>Schwarzer</surname><given-names>R</given-names></name><name><surname>Zuchowski</surname><given-names>M</given-names></name><name><surname>Hofmann</surname><given-names>J</given-names></name><name><surname>Krumbholz</surname><given-names>A</given-names></name><name><surname>Stein</surname><given-names>A</given-names></name><name><surname>Edelmann</surname><given-names>A</given-names></name><name><surname>Corman</surname><given-names>VM</given-names></name><name><surname>Drosten</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Estimating infectiousness throughout SARS-cov-2 infection course</article-title><source>Science</source><volume>373</volume><elocation-id>eabi5273</elocation-id><pub-id pub-id-type="doi">10.1126/science.abi5273</pub-id><pub-id pub-id-type="pmid">34035154</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koureas</surname><given-names>M</given-names></name><name><surname>Speletas</surname><given-names>M</given-names></name><name><surname>Bogogiannidou</surname><given-names>Z</given-names></name><name><surname>Babalis</surname><given-names>D</given-names></name><name><surname>Pinakas</surname><given-names>V</given-names></name><name><surname>Pinaka</surname><given-names>O</given-names></name><name><surname>Komnos</surname><given-names>A</given-names></name><name><surname>Tsoutsa</surname><given-names>S</given-names></name><name><surname>Papadamou</surname><given-names>G</given-names></name><name><surname>Kyritsi</surname><given-names>MA</given-names></name><name><surname>Vontas</surname><given-names>A</given-names></name><name><surname>Nakoulas</surname><given-names>V</given-names></name><name><surname>Sapoynas</surname><given-names>S</given-names></name><name><surname>Kanellopoulos</surname><given-names>N</given-names></name><name><surname>Kalompatsios</surname><given-names>D</given-names></name><name><surname>Papadouli</surname><given-names>V</given-names></name><name><surname>Dadouli</surname><given-names>K</given-names></name><name><surname>Soteriades</surname><given-names>S</given-names></name><name><surname>Mina</surname><given-names>P</given-names></name><name><surname>Mouchtouri</surname><given-names>VA</given-names></name><name><surname>Anagnostopoulos</surname><given-names>L</given-names></name><name><surname>Stamoulis</surname><given-names>KE</given-names></name><name><surname>Agorastos</surname><given-names>K</given-names></name><name><surname>Petinaki</surname><given-names>EA</given-names></name><name><surname>Prezerakos</surname><given-names>P</given-names></name><name><surname>Tsiodras</surname><given-names>S</given-names></name><name><surname>Hadjichristodoulou</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Transmission dynamics of SARS-cov-2 during an outbreak in a roma community in thessaly, greece-control measures and lessons learned</article-title><source>International Journal of Environmental Research and Public Health</source><volume>18</volume><elocation-id>2878</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph18062878</pub-id><pub-id pub-id-type="pmid">33799791</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langan</surname><given-names>D</given-names></name><name><surname>Higgins</surname><given-names>JPT</given-names></name><name><surname>Jackson</surname><given-names>D</given-names></name><name><surname>Bowden</surname><given-names>J</given-names></name><name><surname>Veroniki</surname><given-names>AA</given-names></name><name><surname>Kontopantelis</surname><given-names>E</given-names></name><name><surname>Viechtbauer</surname><given-names>W</given-names></name><name><surname>Simmonds</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses</article-title><source>Research Synthesis Methods</source><volume>10</volume><fpage>83</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1002/jrsm.1316</pub-id><pub-id pub-id-type="pmid">30067315</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>MSY</given-names></name><name><surname>Grenfell</surname><given-names>B</given-names></name><name><surname>Thomas</surname><given-names>M</given-names></name><name><surname>Bryan</surname><given-names>M</given-names></name><name><surname>Nelson</surname><given-names>K</given-names></name><name><surname>Lopman</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Characterizing superspreading events and age-specific infectiousness of SARS-cov-2 transmission in georgia, USA</article-title><source>PNAS</source><volume>117</volume><fpage>22430</fpage><lpage>22435</lpage><pub-id pub-id-type="doi">10.1073/pnas.2011802117</pub-id><pub-id pub-id-type="pmid">32820074</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laxminarayan</surname><given-names>R</given-names></name><name><surname>Wahl</surname><given-names>B</given-names></name><name><surname>Dudala</surname><given-names>SR</given-names></name><name><surname>Gopal</surname><given-names>K</given-names></name><name><surname>Mohan B</surname><given-names>C</given-names></name><name><surname>Neelima</surname><given-names>S</given-names></name><name><surname>Jawahar Reddy</surname><given-names>KS</given-names></name><name><surname>Radhakrishnan</surname><given-names>J</given-names></name><name><surname>Lewnard</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Epidemiology and transmission dynamics of COVID-19 in two indian states</article-title><source>Science</source><volume>370</volume><fpage>691</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1126/science.abd7672</pub-id><pub-id pub-id-type="pmid">33154136</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Layan</surname><given-names>M</given-names></name><name><surname>Gilboa</surname><given-names>M</given-names></name><name><surname>Gonen</surname><given-names>T</given-names></name><name><surname>Goldenfeld</surname><given-names>M</given-names></name><name><surname>Meltzer</surname><given-names>L</given-names></name><name><surname>Andronico</surname><given-names>A</given-names></name><name><surname>Hozé</surname><given-names>N</given-names></name><name><surname>Cauchemez</surname><given-names>S</given-names></name><name><surname>Regev-Yochay</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Impact of bnt162b2 vaccination and isolation on SARS-cov-2 transmission in israeli households: an observational study</article-title><source>American Journal of Epidemiology</source><volume>191</volume><fpage>1224</fpage><lpage>1234</lpage><pub-id pub-id-type="doi">10.1093/aje/kwac042</pub-id><pub-id pub-id-type="pmid">35238329</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Guan</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Tong</surname><given-names>Y</given-names></name><name><surname>Ren</surname><given-names>R</given-names></name><name><surname>Leung</surname><given-names>KSM</given-names></name><name><surname>Lau</surname><given-names>EHY</given-names></name><name><surname>Wong</surname><given-names>JY</given-names></name><name><surname>Xing</surname><given-names>X</given-names></name><name><surname>Xiang</surname><given-names>N</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Tu</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Shao</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Tao</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Deng</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>G</given-names></name><name><surname>Lam</surname><given-names>TTY</given-names></name><name><surname>Wu</surname><given-names>JT</given-names></name><name><surname>Gao</surname><given-names>GF</given-names></name><name><surname>Cowling</surname><given-names>BJ</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Leung</surname><given-names>GM</given-names></name><name><surname>Feng</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Early transmission dynamics in wuhan, china, of novel coronavirus-infected pneumonia</article-title><source>The New England Journal of Medicine</source><volume>382</volume><fpage>1199</fpage><lpage>1207</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2001316</pub-id><pub-id pub-id-type="pmid">31995857</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Epidemiological and clinical characteristics of COVID-19 in children: A systematic review and meta-analysis</article-title><source>Frontiers in Pediatrics</source><volume>8</volume><elocation-id>591132</elocation-id><pub-id pub-id-type="doi">10.3389/fped.2020.591132</pub-id><pub-id pub-id-type="pmid">33224909</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2001">2001</year><source>Monte Carlo Strategies in Scientific Computing</source><publisher-name>Springer-Verlag</publisher-name></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lloyd-Smith</surname><given-names>JO</given-names></name><name><surname>Schreiber</surname><given-names>SJ</given-names></name><name><surname>Kopp</surname><given-names>PE</given-names></name><name><surname>Getz</surname><given-names>WM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Superspreading and the effect of individual variation on disease emergence</article-title><source>Nature</source><volume>438</volume><fpage>355</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nature04153</pub-id><pub-id pub-id-type="pmid">16292310</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyngse</surname><given-names>FP</given-names></name><name><surname>Kirkeby</surname><given-names>C</given-names></name><name><surname>Halasa</surname><given-names>T</given-names></name><name><surname>Andreasen</surname><given-names>V</given-names></name><name><surname>Skov</surname><given-names>RL</given-names></name><name><surname>Møller</surname><given-names>FT</given-names></name><name><surname>Krause</surname><given-names>TG</given-names></name><name><surname>Mølbak</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Nationwide study on SARS-cov-2 transmission within households from lockdown to reopening, denmark, 27 february 2020 to 1 august 2020</article-title><source>Euro Surveillance</source><volume>27</volume><elocation-id>2001800</elocation-id><pub-id pub-id-type="doi">10.2807/1560-7917.ES.2022.27.6.2001800</pub-id><pub-id pub-id-type="pmid">35144726</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madewell</surname><given-names>ZJ</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Longini</surname><given-names>IM</given-names></name><name><surname>Halloran</surname><given-names>ME</given-names></name><name><surname>Dean</surname><given-names>NE</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Factors associated with household transmission of SARS-cov-2: an updated systematic review and meta-analysis</article-title><source>JAMA Network Open</source><volume>4</volume><elocation-id>e2122240</elocation-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.22240</pub-id><pub-id pub-id-type="pmid">34448865</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Méndez-Echevarría</surname><given-names>A</given-names></name><name><surname>Sainz</surname><given-names>T</given-names></name><name><surname>de Felipe</surname><given-names>B</given-names></name><name><surname>Alcolea</surname><given-names>S</given-names></name><name><surname>Olbrich</surname><given-names>P</given-names></name><name><surname>Goycochea-Valdivia</surname><given-names>WA</given-names></name><name><surname>Escosa-García</surname><given-names>L</given-names></name><name><surname>Cobo</surname><given-names>L</given-names></name><name><surname>Calvo</surname><given-names>C</given-names></name><name><surname>Neth</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>High rates of SARS-cov-2 family transmission in children of healthcare workers during the first pandemic wave in madrid, spain: serologic study</article-title><source>The Pediatric Infectious Disease Journal</source><volume>40</volume><fpage>e185</fpage><lpage>e188</lpage><pub-id pub-id-type="doi">10.1097/INF.0000000000003088</pub-id><pub-id pub-id-type="pmid">33591078</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Liberati</surname><given-names>A</given-names></name><name><surname>Tetzlaff</surname><given-names>J</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Group</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title><source>BMJ</source><volume>339</volume><elocation-id>b2535</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.b2535</pub-id><pub-id pub-id-type="pmid">19622551</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mossong</surname><given-names>J</given-names></name><name><surname>Hens</surname><given-names>N</given-names></name><name><surname>Jit</surname><given-names>M</given-names></name><name><surname>Beutels</surname><given-names>P</given-names></name><name><surname>Auranen</surname><given-names>K</given-names></name><name><surname>Mikolajczyk</surname><given-names>R</given-names></name><name><surname>Massari</surname><given-names>M</given-names></name><name><surname>Salmaso</surname><given-names>S</given-names></name><name><surname>Tomba</surname><given-names>GS</given-names></name><name><surname>Wallinga</surname><given-names>J</given-names></name><name><surname>Heijne</surname><given-names>J</given-names></name><name><surname>Sadkowska-Todys</surname><given-names>M</given-names></name><name><surname>Rosinska</surname><given-names>M</given-names></name><name><surname>Edmunds</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Social contacts and mixing patterns relevant to the spread of infectious diseases</article-title><source>PLOS Medicine</source><volume>5</volume><elocation-id>e74</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.0050074</pub-id><pub-id pub-id-type="pmid">18366252</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mousa</surname><given-names>A</given-names></name><name><surname>Winskill</surname><given-names>P</given-names></name><name><surname>Watson</surname><given-names>OJ</given-names></name><name><surname>Ratmann</surname><given-names>O</given-names></name><name><surname>Monod</surname><given-names>M</given-names></name><name><surname>Ajelli</surname><given-names>M</given-names></name><name><surname>Diallo</surname><given-names>A</given-names></name><name><surname>Dodd</surname><given-names>PJ</given-names></name><name><surname>Grijalva</surname><given-names>CG</given-names></name><name><surname>Kiti</surname><given-names>MC</given-names></name><name><surname>Krishnan</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Kwok</surname><given-names>KO</given-names></name><name><surname>Lanata</surname><given-names>CF</given-names></name><name><surname>de Waroux</surname><given-names>OLP</given-names></name><name><surname>Leung</surname><given-names>K</given-names></name><name><surname>Mahikul</surname><given-names>W</given-names></name><name><surname>Melegaro</surname><given-names>A</given-names></name><name><surname>Morrow</surname><given-names>CD</given-names></name><name><surname>Mossong</surname><given-names>J</given-names></name><name><surname>Neal</surname><given-names>EF</given-names></name><name><surname>Nokes</surname><given-names>DJ</given-names></name><name><surname>Pan-Ngum</surname><given-names>W</given-names></name><name><surname>Potter</surname><given-names>GE</given-names></name><name><surname>Russell</surname><given-names>FM</given-names></name><name><surname>Saha</surname><given-names>S</given-names></name><name><surname>Sugimoto</surname><given-names>JD</given-names></name><name><surname>Wei</surname><given-names>WI</given-names></name><name><surname>Wood</surname><given-names>RR</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Walker</surname><given-names>P</given-names></name><name><surname>Whittaker</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Social contact patterns and implications for infectious disease transmission - a systematic review and meta-analysis of contact surveys</article-title><source>eLife</source><volume>10</volume><elocation-id>e70294</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.70294</pub-id><pub-id pub-id-type="pmid">34821551</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>OT</given-names></name><name><surname>Marimuthu</surname><given-names>K</given-names></name><name><surname>Koh</surname><given-names>V</given-names></name><name><surname>Pang</surname><given-names>J</given-names></name><name><surname>Linn</surname><given-names>KZ</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>De Wang</surname><given-names>L</given-names></name><name><surname>Chia</surname><given-names>WN</given-names></name><name><surname>Tiu</surname><given-names>C</given-names></name><name><surname>Chan</surname><given-names>M</given-names></name><name><surname>Ling</surname><given-names>LM</given-names></name><name><surname>Vasoo</surname><given-names>S</given-names></name><name><surname>Abdad</surname><given-names>MY</given-names></name><name><surname>Chia</surname><given-names>PY</given-names></name><name><surname>Lee</surname><given-names>TH</given-names></name><name><surname>Lin</surname><given-names>RJ</given-names></name><name><surname>Sadarangani</surname><given-names>SP</given-names></name><name><surname>Chen</surname><given-names>MI-C</given-names></name><name><surname>Said</surname><given-names>Z</given-names></name><name><surname>Kurupatham</surname><given-names>L</given-names></name><name><surname>Pung</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>L-F</given-names></name><name><surname>Cook</surname><given-names>AR</given-names></name><name><surname>Leo</surname><given-names>Y-S</given-names></name><name><surname>Lee</surname><given-names>VJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>SARS-cov-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study</article-title><source>The Lancet. Infectious Diseases</source><volume>21</volume><fpage>333</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30833-1</pub-id><pub-id pub-id-type="pmid">33152271</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okita</surname><given-names>Y</given-names></name><name><surname>Morita</surname><given-names>T</given-names></name><name><surname>Kumanogoh</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Duration of SARS-cov-2 RNA positivity from various specimens and clinical characteristics in patients with COVID-19: a systematic review and meta-analysis</article-title><source>Inflammation and Regeneration</source><volume>42</volume><elocation-id>16</elocation-id><pub-id pub-id-type="doi">10.1186/s41232-022-00205-x</pub-id><pub-id pub-id-type="pmid">35642011</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Posfay-Barbe</surname><given-names>KM</given-names></name><name><surname>Wagner</surname><given-names>N</given-names></name><name><surname>Gauthey</surname><given-names>M</given-names></name><name><surname>Moussaoui</surname><given-names>D</given-names></name><name><surname>Loevy</surname><given-names>N</given-names></name><name><surname>Diana</surname><given-names>A</given-names></name><name><surname>L’Huillier</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>COVID-19 in children and the dynamics of infection in families</article-title><source>Pediatrics</source><volume>146</volume><elocation-id>e20201576</elocation-id><pub-id pub-id-type="doi">10.1542/peds.2020-1576</pub-id><pub-id pub-id-type="pmid">32457213</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qutub</surname><given-names>M</given-names></name><name><surname>Aldabbagh</surname><given-names>Y</given-names></name><name><surname>Mehdawi</surname><given-names>F</given-names></name><name><surname>Alraddadi</surname><given-names>A</given-names></name><name><surname>Alhomsy</surname><given-names>M</given-names></name><name><surname>Alnahdi</surname><given-names>A</given-names></name><name><surname>Fakeeh</surname><given-names>M</given-names></name><name><surname>Maghrabi</surname><given-names>A</given-names></name><name><surname>Alwagdani</surname><given-names>M</given-names></name><name><surname>Bahabri</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Duration of viable SARS-cov-2 shedding from respiratory tract in different human hosts and its impact on isolation discontinuation polices revision; a narrative review</article-title><source>Clinical Infection in Practice</source><volume>13</volume><elocation-id>100140</elocation-id><pub-id pub-id-type="doi">10.1016/j.clinpr.2022.100140</pub-id><pub-id pub-id-type="pmid">35190799</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahmani</surname><given-names>A</given-names></name><name><surname>Dini</surname><given-names>G</given-names></name><name><surname>Leso</surname><given-names>V</given-names></name><name><surname>Montecucco</surname><given-names>A</given-names></name><name><surname>Kusznir Vitturi</surname><given-names>B</given-names></name><name><surname>Iavicoli</surname><given-names>I</given-names></name><name><surname>Durando</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Duration of SARS-cov-2 shedding and infectivity in the working age population: a systematic review and meta-analysis</article-title><source>La Medicina Del Lavoro</source><volume>113</volume><elocation-id>e2022014</elocation-id><pub-id pub-id-type="doi">10.23749/mdl.v113i2.12724</pub-id><pub-id pub-id-type="pmid">35481581</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reukers</surname><given-names>DFM</given-names></name><name><surname>van Boven</surname><given-names>M</given-names></name><name><surname>Meijer</surname><given-names>A</given-names></name><name><surname>Rots</surname><given-names>N</given-names></name><name><surname>Reusken</surname><given-names>C</given-names></name><name><surname>Roof</surname><given-names>I</given-names></name><name><surname>van Gageldonk-Lafeber</surname><given-names>AB</given-names></name><name><surname>van der Hoek</surname><given-names>W</given-names></name><name><surname>van den Hof</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>High infection attack rates of SARS-cov-2 in dutch households revealed by dense sampling</article-title><source>Infectious Diseases</source><volume>74</volume><fpage>52</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1101/2021.01.26.21250512</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Z</given-names></name><name><surname>Ning</surname><given-names>F</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Chin</surname><given-names>DP</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Schuchat</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Superspreading SARS events, Beijing, 2003</article-title><source>Emerging Infectious Diseases</source><volume>10</volume><fpage>256</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.3201/eid1002.030732</pub-id><pub-id pub-id-type="pmid">15030693</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Spiegelhalter</surname><given-names>DJ</given-names></name><name><surname>Thomas</surname><given-names>A</given-names></name><name><surname>Best</surname><given-names>NG</given-names></name></person-group><year iso-8601-date="2000">2000</year><source>WinBUGS Version 1.3 User Manual</source><publisher-loc>Cambridge</publisher-loc><publisher-name>Medical Research Council Biostatistics Unit</publisher-name></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spiegelhalter</surname><given-names>DJ</given-names></name><name><surname>Best</surname><given-names>NG</given-names></name><name><surname>Carlin</surname><given-names>BP</given-names></name><name><surname>van der Linde</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Bayesian measures of model complexity and fit</article-title><source>Journal of the Royal Statistical Society</source><volume>64</volume><fpage>583</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1111/1467-9868.00353</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>K</given-names></name><name><surname>Ren</surname><given-names>L</given-names></name><name><surname>Zhan</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Litvinova</surname><given-names>M</given-names></name><name><surname>Vespignani</surname><given-names>A</given-names></name><name><surname>Ajelli</surname><given-names>M</given-names></name><name><surname>Viboud</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Transmission heterogeneities, kinetics, and controllability of SARS-cov-2</article-title><source>Science</source><volume>371</volume><elocation-id>eabe2424</elocation-id><pub-id pub-id-type="doi">10.1126/science.abe2424</pub-id><pub-id pub-id-type="pmid">33234698</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>K</given-names></name><name><surname>Tempia</surname><given-names>S</given-names></name><name><surname>Kleynhans</surname><given-names>J</given-names></name><name><surname>von Gottberg</surname><given-names>A</given-names></name><name><surname>McMorrow</surname><given-names>ML</given-names></name><name><surname>Wolter</surname><given-names>N</given-names></name><name><surname>Bhiman</surname><given-names>JN</given-names></name><name><surname>Moyes</surname><given-names>J</given-names></name><name><surname>du Plessis</surname><given-names>M</given-names></name><name><surname>Carrim</surname><given-names>M</given-names></name><name><surname>Buys</surname><given-names>A</given-names></name><name><surname>Martinson</surname><given-names>NA</given-names></name><name><surname>Kahn</surname><given-names>K</given-names></name><name><surname>Tollman</surname><given-names>S</given-names></name><name><surname>Lebina</surname><given-names>L</given-names></name><name><surname>Wafawanaka</surname><given-names>F</given-names></name><name><surname>du Toit</surname><given-names>JD</given-names></name><name><surname>Gómez-Olivé</surname><given-names>FX</given-names></name><name><surname>Mkhencele</surname><given-names>T</given-names></name><name><surname>Viboud</surname><given-names>C</given-names></name><name><surname>Cohen</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>SARS-cov-2 transmission, persistence of immunity, and estimates of omicron’s impact in south african population cohorts</article-title><source>Science Translational Medicine</source><volume>14</volume><elocation-id>eabo7081</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.abo7081</pub-id><pub-id pub-id-type="pmid">35638937</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>SG</given-names></name><name><surname>Sharp</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Explaining heterogeneity in meta-analysis: a comparison of methods</article-title><source>Statistics in Medicine</source><volume>18</volume><fpage>2693</fpage><lpage>2708</lpage><pub-id pub-id-type="doi">10.1002/(sici)1097-0258(19991030)18:20&lt;2693::aid-sim235&gt;3.0.co;2-v</pub-id><pub-id pub-id-type="pmid">10521860</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>HA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>SARS-cov-2 setting-specific transmission rates: a systematic review and meta-analysis</article-title><source>Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America</source><volume>73</volume><fpage>e754</fpage><lpage>e764</lpage><pub-id pub-id-type="doi">10.1093/cid/ciab100</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toth</surname><given-names>DJA</given-names></name><name><surname>Leecaster</surname><given-names>M</given-names></name><name><surname>Pettey</surname><given-names>WBP</given-names></name><name><surname>Gundlapalli</surname><given-names>AV</given-names></name><name><surname>Gao</surname><given-names>H</given-names></name><name><surname>Rainey</surname><given-names>JJ</given-names></name><name><surname>Uzicanin</surname><given-names>A</given-names></name><name><surname>Samore</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The role of heterogeneity in contact timing and duration in network models of influenza spread in schools</article-title><source>Journal of the Royal Society, Interface</source><volume>12</volume><elocation-id>20150279</elocation-id><pub-id pub-id-type="doi">10.1098/rsif.2015.0279</pub-id><pub-id pub-id-type="pmid">26063821</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsang</surname><given-names>TK</given-names></name><name><surname>Cauchemez</surname><given-names>S</given-names></name><name><surname>Perera</surname><given-names>RAPM</given-names></name><name><surname>Freeman</surname><given-names>G</given-names></name><name><surname>Fang</surname><given-names>VJ</given-names></name><name><surname>Ip</surname><given-names>DKM</given-names></name><name><surname>Leung</surname><given-names>GM</given-names></name><name><surname>Malik Peiris</surname><given-names>JS</given-names></name><name><surname>Cowling</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Association between antibody titers and protection against influenza virus infection within households</article-title><source>The Journal of Infectious Diseases</source><volume>210</volume><fpage>684</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiu186</pub-id><pub-id pub-id-type="pmid">24676208</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsang</surname><given-names>TK</given-names></name><name><surname>Lau</surname><given-names>LLH</given-names></name><name><surname>Cauchemez</surname><given-names>S</given-names></name><name><surname>Cowling</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Household transmission of influenza virus</article-title><source>Trends in Microbiology</source><volume>24</volume><fpage>123</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2015.10.012</pub-id><pub-id pub-id-type="pmid">26612500</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsang</surname><given-names>TK</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Cauchemez</surname><given-names>S</given-names></name><name><surname>Cowling</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Using secondary cases to characterize the severity of an emerging or re-emerging infection</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>6372</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-26709-7</pub-id><pub-id pub-id-type="pmid">34737277</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Tsang</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Covid19_transmission_heterogeneity</data-title><version designator="swh:1:rev:634390fa66a4bfb998da691e7cd81cf45e38c6db">swh:1:rev:634390fa66a4bfb998da691e7cd81cf45e38c6db</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:4d4436affc6aa5ddf265a9a9acb638f66eb0cd5d;origin=https://github.com/timktsang/covid19_transmission_heterogeneity;visit=swh:1:snp:6e5eab4d82393ee3420ab8827a701a0129569d57;anchor=swh:1:rev:634390fa66a4bfb998da691e7cd81cf45e38c6db">https://archive.softwareheritage.org/swh:1:dir:4d4436affc6aa5ddf265a9a9acb638f66eb0cd5d;origin=https://github.com/timktsang/covid19_transmission_heterogeneity;visit=swh:1:snp:6e5eab4d82393ee3420ab8827a701a0129569d57;anchor=swh:1:rev:634390fa66a4bfb998da691e7cd81cf45e38c6db</ext-link></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsang</surname><given-names>TK</given-names></name><name><surname>Fang</surname><given-names>LQ</given-names></name><name><surname>Zhang</surname><given-names>A</given-names></name><name><surname>Jiang</surname><given-names>FC</given-names></name><name><surname>Ruan</surname><given-names>SM</given-names></name><name><surname>Liu</surname><given-names>LZ</given-names></name><name><surname>Cowling</surname><given-names>BJ</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Variability in transmission risk of SARS-cov-2 in close contact settings: A contact tracing study in shandong province, china</article-title><source>Epidemics</source><volume>39</volume><elocation-id>100553</elocation-id><pub-id pub-id-type="doi">10.1016/j.epidem.2022.100553</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veroniki</surname><given-names>AA</given-names></name><name><surname>Jackson</surname><given-names>D</given-names></name><name><surname>Bender</surname><given-names>R</given-names></name><name><surname>Kuss</surname><given-names>O</given-names></name><name><surname>Langan</surname><given-names>D</given-names></name><name><surname>Higgins</surname><given-names>JPT</given-names></name><name><surname>Knapp</surname><given-names>G</given-names></name><name><surname>Salanti</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Methods to calculate uncertainty in the estimated overall effect size from a random-effects meta-analysis</article-title><source>Research Synthesis Methods</source><volume>10</volume><fpage>23</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1002/jrsm.1319</pub-id><pub-id pub-id-type="pmid">30129707</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Shaw</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Secondary attack rate of COVID-19 in household contacts in the winnipeg health region, canada</article-title><source>Canadian Journal of Public Health = Revue Canadienne de Sante Publique</source><volume>112</volume><fpage>12</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.17269/s41997-020-00451-x</pub-id><pub-id pub-id-type="pmid">33205377</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Bi</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>GF</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>MERS, SARS, and ebola: the role of super-spreaders in infectious disease</article-title><source>Cell Host &amp; Microbe</source><volume>18</volume><fpage>398</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2015.09.013</pub-id><pub-id pub-id-type="pmid">26468744</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>F</given-names></name><name><surname>Collins</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Evidence that coronavirus superspreading is fat-tailed</article-title><source>PNAS</source><volume>117</volume><fpage>29416</fpage><lpage>29418</lpage><pub-id pub-id-type="doi">10.1073/pnas.2018490117</pub-id><pub-id pub-id-type="pmid">33139561</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>CLH</given-names></name><name><surname>Raval</surname><given-names>M</given-names></name><name><surname>Schnall</surname><given-names>JA</given-names></name><name><surname>Kwong</surname><given-names>JC</given-names></name><name><surname>Holmes</surname><given-names>NE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Duration of respiratory and gastrointestinal viral shedding in children with SARS-cov-2: A systematic review and synthesis of data</article-title><source>The Pediatric Infectious Disease Journal</source><volume>39</volume><fpage>e249</fpage><lpage>e256</lpage><pub-id pub-id-type="doi">10.1097/INF.0000000000002814</pub-id><pub-id pub-id-type="pmid">32618932</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Guan</surname><given-names>Z</given-names></name><name><surname>Ding</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Lan</surname><given-names>L</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Characteristics of viral shedding time in SARS-cov-2 infections: A systematic review and meta-analysis</article-title><source>Frontiers in Public Health</source><volume>9</volume><elocation-id>652842</elocation-id><pub-id pub-id-type="doi">10.3389/fpubh.2021.652842</pub-id><pub-id pub-id-type="pmid">33816427</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Lau</surname><given-names>EHY</given-names></name><name><surname>Wong</surname><given-names>JY</given-names></name><name><surname>Ho</surname><given-names>F</given-names></name><name><surname>Gao</surname><given-names>H</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Adam</surname><given-names>DC</given-names></name><name><surname>Ng</surname><given-names>TWY</given-names></name><name><surname>Quan</surname><given-names>J</given-names></name><name><surname>Tsang</surname><given-names>TK</given-names></name><name><surname>Liao</surname><given-names>Q</given-names></name><name><surname>Cowling</surname><given-names>BJ</given-names></name><name><surname>Leung</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Changing disparities in coronavirus disease 2019 (COVID-19) burden in the ethnically homogeneous population of hong kong through pandemic waves: an observational study</article-title><source>Clinical Infectious Diseases</source><volume>73</volume><fpage>2298</fpage><lpage>2305</lpage><pub-id pub-id-type="doi">10.1093/cid/ciab002</pub-id><pub-id pub-id-type="pmid">33406238</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Cen</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>M</given-names></name><name><surname>Du</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>JJ</given-names></name><name><surname>Dai</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Prevalence and persistent shedding of fecal SARS-cov-2 RNA in patients with COVID-19 infection: A systematic review and meta-analysis</article-title><source>Clinical and Translational Gastroenterology</source><volume>12</volume><elocation-id>e00343</elocation-id><pub-id pub-id-type="doi">10.14309/ctg.0000000000000343</pub-id><pub-id pub-id-type="pmid">33835096</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Shen</surname><given-names>M</given-names></name><name><surname>Musa</surname><given-names>SS</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Ran</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Chong</surname><given-names>MKC</given-names></name><name><surname>He</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Inferencing superspreading potential using zero-truncated negative binomial model: exemplification with COVID-19</article-title><source>BMC Medical Research Methodology</source><volume>21</volume><elocation-id>30</elocation-id><pub-id pub-id-type="doi">10.1186/s12874-021-01225-w</pub-id><pub-id pub-id-type="pmid">33568100</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><sec sec-type="appendix" id="s8"><title>Systematic review</title><p>We conducted a systematic review following the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) statement (<xref ref-type="bibr" rid="bib42">Moher et al., 2009</xref>). A standardized search was done in PubMed, Embase, and Web of Science, using the search term ‘(“COVID-19” OR “SARS-CoV-2”) AND (“household” OR “family”) AND (“transmission”)’. The search was done on 22 June, 2022, with no language restrictions. Additional relevant articles from the reference sections were also reviewed.</p><p>Two authors (XH and CW) independently screened the titles and extracted data from the included studies, with disagreement resolved by consensus together with a third author (TKT). Studies identified from different databases were de-duplicated.</p></sec><sec sec-type="appendix" id="s9"><title>Household transmission model</title><p>Our aim was to explore the role of variation of individual infectiousness on transmission, with accounting for the variation and number of contacts, and the transmission probability. Therefore, we extended the household transmission model to account for variation of individual infectiousness of index cases (<xref ref-type="bibr" rid="bib7">Cauchemez et al., 2009</xref>). We added a random effect on infectiousness of cases (<xref ref-type="bibr" rid="bib59">Tsang et al., 2014</xref>). In the model, the hazard of infection of individual <italic>j</italic> at time <italic>t</italic> from an infected household member <italic>i,</italic> with infection time <italic>t<sub>i</sub></italic> in household <italic>k</italic>, was<disp-formula id="equ2"><mml:math id="m2"><mml:msub><mml:mrow><mml:mi>λ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>→</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>λ</mml:mi></mml:mrow><mml:mrow><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>β</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac><mml:mi> </mml:mi><mml:mi>*</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">exp</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mrow><mml:mi>*</mml:mi><mml:mi>f</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf27"><mml:msub><mml:mrow><mml:mi>λ</mml:mi></mml:mrow><mml:mrow><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> was the baseline hazard, <inline-formula><mml:math id="inf28"><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> was the relative individual infectiousness of cases, which followed a normal distribution with mean 0 and SD <inline-formula><mml:math id="inf29"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> .</p><p><inline-formula><mml:math id="inf30"><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> was the number of household contacts. <inline-formula><mml:math id="inf31"><mml:mi>β</mml:mi></mml:math></inline-formula> was the parameter describing the relationship between number of household contacts and transmission rate. It ranged from 0 to 1, with 0 indicating that the transmission rate is independent of number of household contacts while 1 indicates that the transmission rate is inversely proportional to number of household contacts (i.e. dilution effect of the contact time per contact which is lower when the number of household contacts is higher). <italic>f</italic>(·) was the infectiousness profile since infection generated from the assumed incubation period (mean equal to 5 days) and infectious period (mean equal to 13) (<xref ref-type="bibr" rid="bib23">He et al., 2020</xref>; <xref ref-type="bibr" rid="bib28">Jing et al., 2020</xref>; <xref ref-type="bibr" rid="bib36">Li et al., 2020b</xref>).</p><p>The daily hazard of infection from outside the household is assumed to be <inline-formula><mml:math id="inf32"><mml:msub><mml:mrow><mml:mi>λ</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>λ</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> . Hence, the total hazard infection of individual <italic>j</italic> on day <italic>t</italic> was<disp-formula id="equ3"><mml:math id="m3"><mml:msub><mml:mrow><mml:mi>λ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>λ</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>:</mml:mo><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>f</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:munder><mml:mrow><mml:msub><mml:mrow><mml:mi>λ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>→</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>Based on the transmission model, the probability that an individual <italic>i</italic> was infected with infection time <inline-formula><mml:math id="inf33"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> was<disp-formula id="equ4"><mml:math id="m4"><mml:mrow><mml:mi>P</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>exp</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo>−</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mo>∗</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">x</mml:mi><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo>−</mml:mo><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munderover><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>d</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf34"><mml:msub><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> was the start of the follow-up day of individual <italic>i</italic>. Denote the total follow-up time for an individual <italic>i</italic> as <inline-formula><mml:math id="inf35"><mml:msub><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> , then the probability that an individual <italic>i</italic> did not get infected within the follow-up period was<disp-formula id="equ5"><mml:math id="m5"><mml:mrow><mml:mi>P</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">x</mml:mi><mml:mi mathvariant="normal">p</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo>−</mml:mo><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munderover><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>d</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>Hence the log-likelihood function <italic>L</italic> was<disp-formula id="equ6"><mml:math id="m6"><mml:mrow><mml:mi>L</mml:mi><mml:mo>=</mml:mo><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>:</mml:mo><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munder><mml:mrow><mml:mi mathvariant="normal">l</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">o</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">g</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>exp</mml:mi><mml:mo>⁡</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:munder><mml:mo>∑</mml:mo><mml:mi>i</mml:mi></mml:munder><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munderover><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>d</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>Index cases did not contribute to the likelihood and hence the summation was only on household contacts.</p></sec><sec sec-type="appendix" id="s10"><title>Inference, model comparison, and validation</title><p>The infection time for cases were unavailable in the data extracted from publication. Also, the individual infectiousness parameter <inline-formula><mml:math id="inf36"><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> was an augmented variable. Therefore, we conducted our inference under a Bayesian framework with using data augmentation MCMC algorithm to joint estimate the model parameters, the missing infection time, and the relative individual infectiousness with using metropolis-hasting algorithm. For the parameter that only takes positive value, we used a vague Uniform(0,10) prior. For the parameter for relationship between number of household contacts and transmission, we used Uniform(0,1). The algorithm runs for 50,000 iterations after a burn-in of 50,000 iterations. Converge was visually assessed. One run takes about 3 hr on our typical desktop computer. We fitted the model to all studies, but only 14 of them could converge and provide robust estimates of individual infectiousness.</p><p>We assessed the model adequacy by comparing the observed and expected number of infections in households by household size. We simulated 10,000 datasets with a structure identical to that of the observed data (in terms of number of household contacts), with parameters randomly drawn from the posterior distribution of model parameter.</p><p>We compared the model with or without the random effect for variation of individual infectiousness by using DIC (<xref ref-type="bibr" rid="bib53">Spiegelhalter et al., 2002</xref>). Smaller DIC indicated a better model fit. DIC difference &gt;5 was considered as substantial improvement (<xref ref-type="bibr" rid="bib52">Spiegelhalter et al., 2000</xref>). Since the likelihood of observed data could not be directly evaluated for a given model (<xref ref-type="bibr" rid="bib10">Celeux et al., 2006</xref>), we used an importance sampling approach to estimate the likelihood for the observed data and evaluate the DIC (<xref ref-type="bibr" rid="bib8">Cauchemez et al., 2014</xref>; <xref ref-type="bibr" rid="bib37">Liu, 2001</xref>). For each household, we simulated 2000 datasets, with parameters randomly drawn from the posterior distribution. Then we compared the observed data and simulated data. The contribution to the likelihood of a household was equal to the proportion of simulated data with infection status that exactly matched the observed data, for all household members. To avoid the problem of 0-valued likelihood, we used the approach developed by <xref ref-type="bibr" rid="bib8">Cauchemez et al., 2014</xref>, and assumed the sensitivity and specificity for diagnosing a case were both 99.99%.</p></sec><sec sec-type="appendix" id="s11"><title>Comparison of modeling approach</title><p>Given that the infection time (or information that could inform infection time, such as symptom onset time) were not available for all studies, it may be possible to consider them as final size data, which may be analyzed by chain binomial model {Longini, 1988 #693;Longini, 1982 #335;Klick, 2011 #338;O'Neill, 2000 #368}. Including covariates affecting susceptibility is still possible, but showed to be difficult since the number of parameters increases exponentially by groups and type of infection {Klick, 2011 #338}. However, the model equation is about the escape probability of infection, which did not include the characteristic of infectee and therefore it is not possible to add covariates affecting infectiousness.</p></sec><sec sec-type="appendix" id="s12"><title>Sensitivity analysis</title><p>Our model assumed that the individual infectiousness parameter <inline-formula><mml:math id="inf37"><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> followed a normal distribution, and it was multiplied to the hazard in the form of <inline-formula><mml:math id="inf38"><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">x</mml:mi><mml:mi mathvariant="normal">p</mml:mi><mml:mo>⁡</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></inline-formula>, therefore, the individual infectiousness essentially followed a lognormal distribution, which had a long tail. Therefore, we conducted a sensitivity analysis as follows:<disp-formula id="equ7"><mml:math id="m7"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo stretchy="false">→</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>h</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mi>X</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>β</mml:mi></mml:mrow></mml:msubsup></mml:mfrac><mml:mtext> </mml:mtext><mml:mo>∗</mml:mo><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>∗</mml:mo><mml:mi>f</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>Here, <inline-formula><mml:math id="inf39"><mml:msub><mml:mrow><mml:mi mathvariant="normal">δ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> followed a gamma distribution with mean 1, and SD <inline-formula><mml:math id="inf40"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> , which had a shorter tail compared with lognormal distribution. Model comparison suggested that assuming gamma distribution for individual infectiousness parameter performed substantially worse, compared with the lognormal distribution in the main analysis (<xref ref-type="table" rid="app1table9">Appendix 1—table 9</xref>).</p><fig id="app1fig1" position="float"><label>Appendix 1—figure 1.</label><caption><title>Process of systematic review.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82611-app1-fig1-v1.tif"/></fig><fig id="app1fig2" position="float"><label>Appendix 1—figure 2.</label><caption><title>Correlation plots for the posterior distribution of model parameters in Lyngse et al., Carazo et al., Laxminarayan et al., and Dattner et al.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82611-app1-fig2-v1.tif"/></fig><fig id="app1fig3" position="float"><label>Appendix 1—figure 3.</label><caption><title>The density plot of the distribution of infectiousness profile since infections, used in the modeling analysis.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-82611-app1-fig3-v1.tif"/></fig><table-wrap id="app1table1" position="float"><label>Appendix 1—table 1.</label><caption><title>Summary of characteristic of identified studies.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Author (year)</th><th align="left" valign="bottom">Location</th><th align="left" valign="bottom">Study period</th><th align="left" valign="bottom">Case ascertainment method</th><th align="left" valign="bottom">Test coverage of identified contacts</th><th align="left" valign="bottom">SARS-COV-2 variant</th><th align="left" valign="bottom">Public health and social measures</th></tr></thead><tbody><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib39">Lyngse et al., 2022</xref></td><td align="left" valign="bottom">Denmark</td><td align="left" valign="bottom">February 2020 to August 2020</td><td align="left" valign="bottom">Index: RT-PCR<break/>Secondary: RT-PCR</td><td align="left" valign="bottom">All contacts were tested</td><td align="left" valign="bottom">Ancestral strains</td><td align="left" valign="bottom">Lockdown</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib6">Carazo et al., 2022</xref></td><td align="left" valign="bottom">Canada</td><td align="left" valign="bottom">March 2020 to June 2020</td><td align="left" valign="bottom">Index: RT-PCR<break/>Secondary: Symptom-based</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">Ancestral strains</td><td align="left" valign="bottom">Handwashing, mask-wearing, and physical distancing</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib33">Laxminarayan et al., 2020</xref></td><td align="left" valign="bottom">India</td><td align="left" valign="bottom">March 2020 to July 2020</td><td align="left" valign="bottom">Index: RT-PCR<break/>Secondary: RT-PCR</td><td align="left" valign="bottom">All contacts were tested</td><td align="left" valign="bottom">Ancestral strains</td><td align="left" valign="bottom">Lockdown, social distancing, contact tracing</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib16">Dattner et al., 2021</xref></td><td align="left" valign="bottom">Israel</td><td align="left" valign="bottom">March 2020 to June 2020</td><td align="left" valign="bottom">Index: RT-PCR and Serology<break/>Secondary: RT-PCR and Serology</td><td align="left" valign="bottom">All contacts were tested</td><td align="left" valign="bottom">Ancestral strains</td><td align="left" valign="bottom">Lockdown</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib34">Layan et al., 2022</xref></td><td align="left" valign="bottom">Israel</td><td align="left" valign="bottom">December 2020 to April 2021</td><td align="left" valign="bottom">Index: RT-PCR<break/>Secondary: RT-PCR</td><td align="left" valign="bottom">All contacts were tested</td><td align="left" valign="bottom">Ancestral strains, alpha</td><td align="left" valign="bottom">Vaccination</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib22">Hart et al., 2022</xref></td><td align="left" valign="bottom">UK</td><td align="left" valign="bottom">March 2020 to November 2020</td><td align="left" valign="bottom">Index: RT-PCR<break/>Secondary: RT-PCR and antibody test</td><td align="left" valign="bottom">All contacts were tested</td><td align="left" valign="bottom">Ancestral strains</td><td align="left" valign="bottom">Isolation</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib27">Hubiche et al., 2021</xref></td><td align="left" valign="bottom">Canada</td><td align="left" valign="bottom">April 2020 to June 2020</td><td align="left" valign="bottom">Index: Symptom-based and RT-PCR and serology<break/>Secondary: Symptom-based and RT-PCR and serology</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">Ancestral strains</td><td align="left" valign="bottom">Closure of school</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib65">Wilkinson et al., 2021</xref></td><td align="left" valign="bottom">Manitoba, Canada</td><td align="left" valign="bottom">Mid-January 2020 to late<break/>March 2020</td><td align="left" valign="bottom">Index: NAAT assay<break/>Secondary: NAAT assay</td><td align="left" valign="bottom">Only symptomatic contacts were tested</td><td align="left" valign="bottom">Ancestral strains</td><td align="left" valign="bottom">Isolation and contact tracing</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib63">Tsang et al., 2022</xref></td><td align="left" valign="bottom">Shandong Province, China</td><td align="left" valign="bottom">January 2020 to May 2020</td><td align="left" valign="bottom">Index: RT-PCR<break/>Secondary: RT-PCR</td><td align="left" valign="bottom">All contacts were tested</td><td align="left" valign="bottom">Ancestral strains</td><td align="left" valign="bottom">Isolation, mask-waring, social distancing</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib50">Reukers et al., 2021</xref></td><td align="left" valign="bottom">Netherlands</td><td align="left" valign="bottom">March 2020 to May 2020</td><td align="left" valign="bottom">Index: RT-PCR<break/>Secondary: RT-PCR</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">Ancestral strains</td><td align="left" valign="bottom">Social distancing</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib21">Han et al., 2022</xref></td><td align="left" valign="bottom">Netherlands</td><td align="left" valign="bottom">March 2020 to April 2020</td><td align="left" valign="bottom">Index: RT-PCR and serology<break/>Secondary: RT-PCR and serology</td><td align="left" valign="bottom">All contacts were tested</td><td align="left" valign="bottom">Ancestral strains</td><td align="left" valign="bottom">Social distancing, self-quarantine and self-isolation orders, closure of schools, bars and restaurants, and urging people to work from home</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib41">Méndez-Echevarría et al., 2021</xref></td><td align="left" valign="bottom">Madrid, Spain</td><td align="left" valign="bottom">March 2020 to May 2020</td><td align="left" valign="bottom">Index: RT-PCR and serology<break/>Secondary: RT-PCR and serology</td><td align="left" valign="bottom">All contacts were tested</td><td align="left" valign="bottom">Ancestral strains</td><td align="left" valign="bottom">Lockdown</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib19">Dutta et al., 2020</xref></td><td align="left" valign="bottom">Rajasthan, India</td><td align="left" valign="bottom">May 2020 to July 2020</td><td align="left" valign="bottom">Index: RT‐PCR<break/>Secondary: RT‐PCR</td><td align="left" valign="bottom">All contacts were tested</td><td align="left" valign="bottom">Ancestral strains</td><td align="left" valign="bottom">Lockdown and stay-at-home orders, physical distancing</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib30">Koureas et al., 2021</xref></td><td align="left" valign="bottom">Greece</td><td align="left" valign="bottom">April 2020 to June 2020</td><td align="left" valign="bottom">Index: RT-PCR<break/>Secondary: RT-PCR</td><td align="left" valign="bottom">All contacts were tested</td><td align="left" valign="bottom">Ancestral strains</td><td align="left" valign="bottom">Quarantine, screening, movement restrictions and gathering prohibition, isolation</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib5">Bernardes-Souza et al., 2021</xref>; <xref ref-type="bibr" rid="bib41">Méndez-Echevarría et al., 2021</xref></td><td align="left" valign="bottom">Brazil</td><td align="left" valign="bottom">May 2020 to June<break/>2020</td><td align="left" valign="bottom">Index: Serology and RT-PCR<break/>Secondary: Serology</td><td align="left" valign="bottom">All contacts were tested</td><td align="left" valign="bottom">Ancestral strains</td><td align="left" valign="bottom">Lockdown, gathering restrictions and face mask mandates</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib47">Posfay-Barbe et al., 2020</xref></td><td align="left" valign="bottom">Switzerland</td><td align="left" valign="bottom">March 2020 to April 2020</td><td align="left" valign="bottom">Index: RT-PCR<break/>Secondary: RT-PCR</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">Ancestral strains</td><td align="left" valign="bottom">Closure of schools, daycares, restaurants, bars, and shops, social distancing</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib26">Hsu et al., 2021</xref></td><td align="left" valign="bottom">Taiwan, China</td><td align="left" valign="bottom">January 2020 to February 2021</td><td align="left" valign="bottom">Index: RT-PCR<break/>Secondary: RT-PCR</td><td align="left" valign="bottom">Only symptomatic contacts were tested</td><td align="left" valign="bottom">Ancestral strains, alpha</td><td align="left" valign="bottom">Mask-wearing, hand washing, and social distancing</td></tr></tbody></table></table-wrap><table-wrap id="app1table2" position="float"><label>Appendix 1—table 2.</label><caption><title>Summary of model estimates.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Article</th><th align="left" valign="bottom">Estimates of infectiousness variation</th><th align="left" valign="bottom">Estimates of probability of infection from community (10<sup>–2</sup>)</th><th align="left" valign="bottom">Estimates of probability of infection from household</th><th align="left" valign="bottom">Relationship between transmission and number of contacts (<inline-formula><mml:math id="inf41"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow/></mml:msub><mml:mo>)</mml:mo></mml:math></inline-formula></th></tr></thead><tbody><tr><td align="left" valign="bottom">Lyngse et al.</td><td align="left" valign="bottom">1.48 (1.29, 1.7)</td><td align="left" valign="bottom">0.06 (0, 0.16)</td><td align="left" valign="bottom">0.1 (0.08, 0.12)</td><td align="left" valign="bottom">0.72 (0.59, 0.89)</td></tr><tr><td align="left" valign="bottom">Carazo et al.</td><td align="left" valign="bottom">1.41 (1.19, 1.72)</td><td align="left" valign="bottom">0.2 (0.01, 0.43)</td><td align="left" valign="bottom">0.3 (0.24, 0.34)</td><td align="left" valign="bottom">0.75 (0.62, 0.93)</td></tr><tr><td align="left" valign="bottom">Laxminarayan et al.</td><td align="left" valign="bottom">2.44 (1.98, 3.23)</td><td align="left" valign="bottom">0.03 (0, 0.11)</td><td align="left" valign="bottom">0.04 (0.01, 0.07)</td><td align="left" valign="bottom">0.92 (0.69, 1)</td></tr><tr><td align="left" valign="bottom">Dattner et al.</td><td align="left" valign="bottom">1.12 (0.65, 1.69)</td><td align="left" valign="bottom">0.63 (0.12, 1.06)</td><td align="left" valign="bottom">0.31 (0.19, 0.42)</td><td align="left" valign="bottom">0.65 (0.45, 0.91)</td></tr><tr><td align="left" valign="bottom">Layan et al.</td><td align="left" valign="bottom">1.12 (0.74, 1.76)</td><td align="left" valign="bottom">0.3 (0.02, 0.96)</td><td align="left" valign="bottom">0.26 (0.15, 0.39)</td><td align="left" valign="bottom">0.2 (0.01, 0.6)</td></tr><tr><td align="left" valign="bottom">Hart et al.</td><td align="left" valign="bottom">0.35 (0.11, 0.96)</td><td align="left" valign="bottom">0.74 (0.05, 2.12)</td><td align="left" valign="bottom">0.51 (0.32, 0.65)</td><td align="left" valign="bottom">0.72 (0.32, 0.98)</td></tr><tr><td align="left" valign="bottom">Hubiche et al.</td><td align="left" valign="bottom">1.03 (0.45, 2.68)</td><td align="left" valign="bottom">1.24 (0.14, 2.48)</td><td align="left" valign="bottom">0.32 (0.06, 0.57)</td><td align="left" valign="bottom">0.67 (0.13, 0.98)</td></tr><tr><td align="left" valign="bottom">Wilkinson et al.</td><td align="left" valign="bottom">1.05 (0.12, 3.51)</td><td align="left" valign="bottom">0.32 (0.02, 0.91)</td><td align="left" valign="bottom">0.07 (0, 0.18)</td><td align="left" valign="bottom">0.43 (0.02, 0.97)</td></tr><tr><td align="left" valign="bottom">Tsang et al.</td><td align="left" valign="bottom">2.83 (1.48, 4.73)</td><td align="left" valign="bottom">0.45 (0.05, 1.03)</td><td align="left" valign="bottom">0.06 (0, 0.26)</td><td align="left" valign="bottom">0.66 (0.06, 0.99)</td></tr><tr><td align="left" valign="bottom">Reukers et al.</td><td align="left" valign="bottom">1.79 (0.72, 4.5)</td><td align="left" valign="bottom">1.53 (0.18, 2.93)</td><td align="left" valign="bottom">0.22 (0.01, 0.6)</td><td align="left" valign="bottom">0.67 (0.07, 0.98)</td></tr><tr><td align="left" valign="bottom">Han et al.</td><td align="left" valign="bottom">1.71 (0.51, 4.13)</td><td align="left" valign="bottom">1.67 (0.19, 2.99)</td><td align="left" valign="bottom">0.21 (0.02, 0.61)</td><td align="left" valign="bottom">0.69 (0.07, 0.99)</td></tr><tr><td align="left" valign="bottom">Méndez-Echevarría et al.</td><td align="left" valign="bottom">0.51 (0.13, 1.7)</td><td align="left" valign="bottom">0.91 (0.05, 2.53)</td><td align="left" valign="bottom">0.28 (0.06, 0.52)</td><td align="left" valign="bottom">0.57 (0.04, 0.98)</td></tr><tr><td align="left" valign="bottom">Dutta et al.</td><td align="left" valign="bottom">1.53 (0.5, 4.2)</td><td align="left" valign="bottom">1.1 (0.12, 2.26)</td><td align="left" valign="bottom">0.24 (0.01, 0.63)</td><td align="left" valign="bottom">0.78 (0.15, 0.99)</td></tr><tr><td align="left" valign="bottom">Koureas et al.</td><td align="left" valign="bottom">1.88 (0.6, 3.66)</td><td align="left" valign="bottom">0.84 (0.1, 1.76)</td><td align="left" valign="bottom">0.13 (0.01, 0.42)</td><td align="left" valign="bottom">0.44 (0.02, 0.96)</td></tr></tbody></table></table-wrap><table-wrap id="app1table3" position="float"><label>Appendix 1—table 3.</label><caption><title>Model adequacy check for Lyngse et al.</title><p>Each element of the table has the format observed frequency – expected (posterior mean) frequency (95% credible interval).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2">Number of household contacts</th><th align="center" valign="bottom" colspan="6">Number of infected household contacts</th></tr><tr><th align="char" char="." valign="bottom">0</th><th align="char" char="." valign="bottom">1</th><th align="char" char="." valign="bottom">2</th><th align="char" char="." valign="bottom">3</th><th align="char" char="." valign="bottom">4</th><th align="char" char="." valign="bottom">5</th></tr></thead><tbody><tr><td align="char" char="." valign="bottom"><bold>1</bold></td><td align="char" char="ndash" valign="bottom">2366–2377 (2319, 2433)</td><td align="char" char="ndash" valign="bottom">569–558 (502, 616)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>2</bold></td><td align="char" char="ndash" valign="bottom">1117–1105 (1070, 1138)</td><td align="char" char="ndash" valign="bottom">227–227 (198, 259)</td><td align="char" char="ndash" valign="bottom">77–88 (69, 109)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>3</bold></td><td align="char" char="ndash" valign="bottom">1135–1118 (1077, 1156)</td><td align="char" char="ndash" valign="bottom">214–235 (203, 267)</td><td align="char" char="ndash" valign="bottom">89–86 (67, 106)</td><td align="char" char="ndash" valign="bottom">41–41 (27, 56)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>4</bold></td><td align="char" char="ndash" valign="bottom">521–528 (501, 555)</td><td align="char" char="ndash" valign="bottom">119–115 (94, 137)</td><td align="char" char="ndash" valign="bottom">40–42 (30, 56)</td><td align="char" char="ndash" valign="bottom">25–19 (11, 30)</td><td align="char" char="ndash" valign="bottom">11–10 (4, 18)</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>5</bold></td><td align="char" char="ndash" valign="bottom">161–167 (152, 181)</td><td align="char" char="ndash" valign="bottom">42–38 (27, 50)</td><td align="char" char="ndash" valign="bottom">14–14 (7, 22)</td><td align="char" char="ndash" valign="bottom">7–7 (2, 12)</td><td align="char" char="ndash" valign="bottom">7–3 (0, 8)</td><td align="char" char="ndash" valign="bottom">0–2 (0, 5)</td></tr></tbody></table></table-wrap><table-wrap id="app1table4" position="float"><label>Appendix 1—table 4.</label><caption><title>Model adequacy check for Carazo et al.</title><p>Each element of the table has the format observed frequency – expected (posterior mean) frequency (95% credible interval).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2">Number of household contacts</th><th align="center" valign="bottom" colspan="6">Number of infected household contacts</th></tr><tr><th align="char" char="." valign="bottom">0</th><th align="char" char="." valign="bottom">1</th><th align="char" char="." valign="bottom">2</th><th align="char" char="." valign="bottom">3</th><th align="char" char="." valign="bottom">4</th><th align="char" char="." valign="bottom">5</th></tr></thead><tbody><tr><td align="char" char="." valign="bottom"><bold>1</bold></td><td align="left" valign="bottom">803–814 (765, 862)</td><td align="left" valign="bottom">532–521 (473, 570)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>2</bold></td><td align="left" valign="bottom">476–454 (423, 485)</td><td align="left" valign="bottom">179–186 (160, 212)</td><td align="left" valign="bottom">154–169 (144, 195)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>3</bold></td><td align="left" valign="bottom">518–520 (483, 557)</td><td align="left" valign="bottom">201–202 (175, 232)</td><td align="left" valign="bottom">132–130 (107, 155)</td><td align="left" valign="bottom">133–131 (106, 158)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>4</bold></td><td align="left" valign="bottom">217–221 (197, 245)</td><td align="left" valign="bottom">85–87 (70, 106)</td><td align="left" valign="bottom">52–52 (39, 67)</td><td align="left" valign="bottom">43–39 (27, 52)</td><td align="left" valign="bottom">45–41 (28, 56)</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>5</bold></td><td align="left" valign="bottom">76–74 (61, 88)</td><td align="left" valign="bottom">30–30 (20, 41)</td><td align="left" valign="bottom">20–18 (10, 26)</td><td align="left" valign="bottom">13–12 (6, 20)</td><td align="left" valign="bottom">7–10 (5, 17)</td><td align="left" valign="bottom">10–11 (5, 18)</td></tr></tbody></table></table-wrap><table-wrap id="app1table5" position="float"><label>Appendix 1—table 5.</label><caption><title>Model adequacy check for Laxminarayan et al.</title><p>Each element of the table has the format observed frequency – expected (posterior mean) frequency (95% credible interval).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2">Number of household contacts</th><th align="center" valign="bottom" colspan="10">Number of infected household contacts</th></tr><tr><th align="char" char="." valign="bottom">0</th><th align="char" char="." valign="bottom">1</th><th align="char" char="." valign="bottom">2</th><th align="char" char="." valign="bottom">3</th><th align="char" char="." valign="bottom">4</th><th align="char" char="." valign="bottom">5</th><th align="char" char="." valign="bottom">6</th><th align="char" char="." valign="bottom">7</th><th align="char" char="." valign="bottom">8</th><th align="char" char="." valign="bottom">9</th></tr></thead><tbody><tr><td align="char" char="." valign="bottom"><bold>1</bold></td><td align="char" char="ndash" valign="bottom">124–134 (122, 144)</td><td align="char" char="ndash" valign="bottom">37–27 (17, 39)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>2</bold></td><td align="char" char="ndash" valign="bottom">135–137 (125, 147)</td><td align="char" char="ndash" valign="bottom">12–18 (10, 27)</td><td align="char" char="ndash" valign="bottom">20–12 (6, 20)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>3</bold></td><td align="char" char="ndash" valign="bottom">188–176 (163, 188)</td><td align="char" char="ndash" valign="bottom">13–22 (13, 33)</td><td align="char" char="ndash" valign="bottom">11–9 (4, 16)</td><td align="char" char="ndash" valign="bottom">5–9 (4, 17)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>4</bold></td><td align="char" char="ndash" valign="bottom">127–118 (108, 128)</td><td align="char" char="ndash" valign="bottom">11–15 (8, 23)</td><td align="char" char="ndash" valign="bottom">5–5 (1, 11)</td><td align="char" char="ndash" valign="bottom">3–3 (0, 7)</td><td align="char" char="ndash" valign="bottom">1–4 (1, 10)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>5</bold></td><td align="char" char="ndash" valign="bottom">75–76 (67, 84)</td><td align="char" char="ndash" valign="bottom">12–10 (4, 16)</td><td align="char" char="ndash" valign="bottom">3–3 (0, 8)</td><td align="char" char="ndash" valign="bottom">1–2 (0, 5)</td><td align="char" char="ndash" valign="bottom">1–1 (0, 4)</td><td align="char" char="ndash" valign="bottom">3–2 (0, 6)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>6</bold></td><td align="char" char="ndash" valign="bottom">41–40 (34, 46)</td><td align="char" char="ndash" valign="bottom">7–5 (1, 10)</td><td align="char" char="ndash" valign="bottom">2–2 (0, 5)</td><td align="char" char="ndash" valign="bottom">0–1 (0, 3)</td><td align="char" char="ndash" valign="bottom">0–0 (0, 3)</td><td align="char" char="ndash" valign="bottom">0–0 (0, 2)</td><td align="left" valign="bottom">1–1 (0, 3)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>7</bold></td><td align="char" char="ndash" valign="bottom">32–31 (25, 36)</td><td align="char" char="ndash" valign="bottom">3–4 (1, 9)</td><td align="char" char="ndash" valign="bottom">2–1 (0, 4)</td><td align="char" char="ndash" valign="bottom">1–1 (0, 3)</td><td align="char" char="ndash" valign="bottom">1–0 (0, 2)</td><td align="char" char="ndash" valign="bottom">0–0 (0, 2)</td><td align="left" valign="bottom">0–0 (0, 2)</td><td align="char" char="ndash" valign="bottom">0–0 (0, 3)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>8</bold></td><td align="char" char="ndash" valign="bottom">10–13 (10, 16)</td><td align="char" char="ndash" valign="bottom">2–2 (0, 5)</td><td align="char" char="ndash" valign="bottom">3–0 (0, 2)</td><td align="char" char="ndash" valign="bottom">1–0 (0, 2)</td><td align="char" char="ndash" valign="bottom">0–0 (0, 1)</td><td align="char" char="ndash" valign="bottom">1–0 (0, 1)</td><td align="left" valign="bottom">0–0 (0, 1)</td><td align="char" char="ndash" valign="bottom">0–0 (0, 1)</td><td align="char" char="ndash" valign="bottom">0–0 (0, 1)</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>9</bold></td><td align="char" char="ndash" valign="bottom">14–16 (12, 20)</td><td align="char" char="ndash" valign="bottom">2–2 (0, 6)</td><td align="char" char="ndash" valign="bottom">1–1 (0, 3)</td><td align="char" char="ndash" valign="bottom">2–0 (0, 2)</td><td align="char" char="ndash" valign="bottom">1–0 (0, 2)</td><td align="char" char="ndash" valign="bottom">0–0 (0, 1)</td><td align="left" valign="bottom">0–0 (0, 1)</td><td align="char" char="ndash" valign="bottom">0–0 (0, 1)</td><td align="char" char="ndash" valign="bottom">0–0 (0, 1)</td><td align="char" char="ndash" valign="bottom">1–0 (0, 2)</td></tr></tbody></table></table-wrap><table-wrap id="app1table6" position="float"><label>Appendix 1—table 6.</label><caption><title>Model adequacy check for Dattner et al.</title><p>Each element of the table has the format observed frequency – expected (posterior mean) frequency (95% credible interval).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2">Number of household contacts</th><th align="left" valign="bottom" colspan="10">Number of infected household contacts</th></tr><tr><th align="char" char="." valign="bottom">0</th><th align="char" char="." valign="bottom">1</th><th align="char" char="." valign="bottom">2</th><th align="char" char="." valign="bottom">3</th><th align="char" char="." valign="bottom">4</th><th align="char" char="." valign="bottom">5</th><th align="char" char="." valign="bottom">6</th><th align="char" char="." valign="bottom">7</th><th align="char" char="." valign="bottom">8</th><th align="char" char="." valign="bottom">9</th></tr></thead><tbody><tr><td align="char" char="." valign="bottom"><bold>1</bold></td><td align="char" char="ndash" valign="bottom">85–93 (77, 108)</td><td align="char" char="ndash" valign="bottom">73–65 (50, 81)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>2</bold></td><td align="char" char="ndash" valign="bottom">46–42 (32, 52)</td><td align="char" char="ndash" valign="bottom">21–25 (17, 34)</td><td align="char" char="ndash" valign="bottom">19–19 (11, 28)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>3</bold></td><td align="char" char="ndash" valign="bottom">38–29 (21, 38)</td><td align="char" char="ndash" valign="bottom">13–18 (11, 25)</td><td align="char" char="ndash" valign="bottom">9–12 (6, 19)</td><td align="char" char="ndash" valign="bottom">8–9 (4, 15)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>4</bold></td><td align="char" char="ndash" valign="bottom">24–24 (16, 32)</td><td align="char" char="ndash" valign="bottom">19–15 (9, 23)</td><td align="char" char="ndash" valign="bottom">11–10 (5, 17)</td><td align="char" char="ndash" valign="bottom">8–7 (3, 13)</td><td align="char" char="ndash" valign="bottom">1–5 (1, 11)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>5</bold></td><td align="char" char="ndash" valign="bottom">25–21 (14, 30)</td><td align="char" char="ndash" valign="bottom">15–15 (9, 22)</td><td align="char" char="ndash" valign="bottom">12–10 (5, 17)</td><td align="char" char="ndash" valign="bottom">7–7 (3, 13)</td><td align="char" char="ndash" valign="bottom">3–5 (2, 10)</td><td align="char" char="ndash" valign="bottom">2–4 (1, 9)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>6</bold></td><td align="char" char="ndash" valign="bottom">13–16 (9, 23)</td><td align="char" char="ndash" valign="bottom">19–12 (6, 18)</td><td align="char" char="ndash" valign="bottom">3–8 (3, 14)</td><td align="char" char="ndash" valign="bottom">5–6 (2, 11)</td><td align="char" char="ndash" valign="bottom">3–5 (1, 9)</td><td align="char" char="ndash" valign="bottom">5–3 (0, 7)</td><td align="char" char="ndash" valign="bottom">5–2 (0, 6)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>7</bold></td><td align="char" char="ndash" valign="bottom">5–9 (4, 15)</td><td align="char" char="ndash" valign="bottom">6–7 (3, 13)</td><td align="char" char="ndash" valign="bottom">5–5 (2, 10)</td><td align="char" char="ndash" valign="bottom">7–4 (1, 8)</td><td align="char" char="ndash" valign="bottom">4–3 (0, 7)</td><td align="char" char="ndash" valign="bottom">4–2 (0, 6)</td><td align="char" char="ndash" valign="bottom">4–2 (0, 5)</td><td align="char" char="ndash" valign="bottom">0–1 (0, 4)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>8</bold></td><td align="char" char="ndash" valign="bottom">10–8 (3, 14)</td><td align="char" char="ndash" valign="bottom">7–7 (3, 12)</td><td align="char" char="ndash" valign="bottom">3–5 (1, 10)</td><td align="char" char="ndash" valign="bottom">4–4 (1, 8)</td><td align="char" char="ndash" valign="bottom">0–3 (0, 7)</td><td align="char" char="ndash" valign="bottom">3–2 (0, 6)</td><td align="char" char="ndash" valign="bottom">3–2 (0, 5)</td><td align="char" char="ndash" valign="bottom">4–1 (0, 4)</td><td align="char" char="ndash" valign="bottom">0–1 (0, 4)</td><td align="left" valign="bottom">NA</td></tr><tr><td align="char" char="." valign="bottom"><bold>9</bold></td><td align="char" char="ndash" valign="bottom">6–6 (2, 12)</td><td align="char" char="ndash" valign="bottom">3–6 (2, 10)</td><td align="char" char="ndash" valign="bottom">4–4 (1, 9)</td><td align="char" char="ndash" valign="bottom">6–3 (0, 7)</td><td align="char" char="ndash" valign="bottom">4–3 (0, 6)</td><td align="char" char="ndash" valign="bottom">1–2 (0, 5)</td><td align="char" char="ndash" valign="bottom">2–2 (0, 5)</td><td align="char" char="ndash" valign="bottom">2–1 (0, 4)</td><td align="char" char="ndash" valign="bottom">2–1 (0, 3)</td><td align="char" char="ndash" valign="bottom">0–0 (0, 3)</td></tr></tbody></table></table-wrap><table-wrap id="app1table7" position="float"><label>Appendix 1—table 7.</label><caption><title>Comparison of model estimates from 100k Markov chain Monte Carlo (MCMC) iterations and 500k MCMC iterations.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Article</th><th align="left" valign="bottom">Number of MCMC iterations</th><th align="left" valign="bottom">Estimates of infectiousness variation</th><th align="left" valign="bottom">Estimates of probability of infection from community (10<sup>–2</sup>)</th><th align="left" valign="bottom">Estimates of probability of infection from household</th><th align="left" valign="bottom">Relationship between transmission and number of contacts (<inline-formula><mml:math id="inf42"><mml:mi>β</mml:mi><mml:mo>)</mml:mo></mml:math></inline-formula></th></tr></thead><tbody><tr><td align="left" valign="bottom">Lyngse et al.</td><td align="char" char="." valign="bottom">100,000</td><td align="char" char="." valign="bottom">1.48 (1.29, 1.7)</td><td align="char" char="." valign="bottom">0.06 (0, 0.16)</td><td align="char" char="." valign="bottom">0.11 (0.08, 0.13)</td><td align="char" char="." valign="bottom">0.72 (0.59, 0.89)</td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">500,000</td><td align="char" char="." valign="bottom">1.49 (1.29, 1.84)</td><td align="char" char="." valign="bottom">0.07 (0, 0.2)</td><td align="char" char="." valign="bottom">0.1 (0.07, 0.13)</td><td align="char" char="." valign="bottom">0.74 (0.6, 0.92)</td></tr><tr><td align="left" valign="bottom">Carazo et al.</td><td align="char" char="." valign="bottom">100,000</td><td align="char" char="." valign="bottom">1.41 (1.19, 1.72)</td><td align="char" char="." valign="bottom">0.2 (0.01, 0.43)</td><td align="char" char="." valign="bottom">0.35 (0.27, 0.42)</td><td align="char" char="." valign="bottom">0.75 (0.62, 0.93)</td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">500,000</td><td align="char" char="." valign="bottom">1.44 (1.19, 1.78)</td><td align="char" char="." valign="bottom">0.21 (0.02, 0.46)</td><td align="char" char="." valign="bottom">0.34 (0.26, 0.41)</td><td align="char" char="." valign="bottom">0.77 (0.62, 0.95)</td></tr><tr><td align="left" valign="bottom">Laxminarayan et al.</td><td align="char" char="." valign="bottom">100,000</td><td align="char" char="." valign="bottom">2.44 (1.98, 3.23)</td><td align="char" char="." valign="bottom">0.03 (0, 0.11)</td><td align="char" char="." valign="bottom">0.04 (0.01, 0.08)</td><td align="char" char="." valign="bottom">0.92 (0.69, 1)</td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">500,000</td><td align="char" char="." valign="bottom">2.47 (1.99, 3.23)</td><td align="char" char="." valign="bottom">0.03 (0, 0.11)</td><td align="char" char="." valign="bottom">0.04 (0.01, 0.07)</td><td align="char" char="." valign="bottom">0.92 (0.67, 1)</td></tr><tr><td align="left" valign="bottom">Dattner et al.</td><td align="char" char="." valign="bottom">100,000</td><td align="char" char="." valign="bottom">1.12 (0.65, 1.69)</td><td align="char" char="." valign="bottom">0.63 (0.12, 1.06)</td><td align="char" char="." valign="bottom">0.37 (0.21, 0.54)</td><td align="char" char="." valign="bottom">0.65 (0.45, 0.91)</td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">500,000</td><td align="char" char="." valign="bottom">1.06 (0.65, 1.55)</td><td align="char" char="." valign="bottom">0.57 (0.1, 1)</td><td align="char" char="." valign="bottom">0.38 (0.24, 0.54)</td><td align="char" char="." valign="bottom">0.63 (0.43, 0.88)</td></tr></tbody></table></table-wrap><table-wrap id="app1table8" position="float"><label>Appendix 1—table 8.</label><caption><title>Simulation study for validating the estimates and the corresponding power.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Parameter</th><th align="left" valign="bottom">Simulation value</th><th align="left" valign="bottom">Mean estimate</th><th align="left" valign="bottom">Proportion covered (over 50)</th></tr></thead><tbody><tr><td align="left" valign="bottom">Lyngse et al.</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> <inline-formula><mml:math id="inf43"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">σ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">v</mml:mi><mml:mi mathvariant="bold-italic">a</mml:mi><mml:mi mathvariant="bold-italic">r</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>: Infectiousness variation</td><td align="char" char="." valign="bottom">1.48</td><td align="char" char="." valign="bottom">1.57</td><td align="char" char="." valign="bottom">0.94</td></tr><tr><td align="left" valign="bottom"> <inline-formula><mml:math id="inf44"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">λ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">c</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>: hazard of infection from outside the household (10<sup>–2</sup>)</td><td align="char" char="." valign="bottom">0.06</td><td align="char" char="." valign="bottom">0.12</td><td align="char" char="." valign="bottom">0.88</td></tr><tr><td align="left" valign="bottom"> <inline-formula><mml:math id="inf45"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">λ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">h</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>: hazard of infection from an infected household member</td><td align="char" char="." valign="bottom">0.11</td><td align="char" char="." valign="bottom">0.09</td><td align="char" char="." valign="bottom">0.92</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf46"><mml:mi mathvariant="bold-italic">β</mml:mi><mml:mo>:</mml:mo></mml:math></inline-formula> relationship between number of household contacts and transmission rate</td><td align="char" char="." valign="bottom">0.72</td><td align="char" char="." valign="bottom">0.75</td><td align="char" char="." valign="bottom">0.96</td></tr><tr><td align="left" valign="bottom">Carazo et al.</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> <inline-formula><mml:math id="inf47"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">σ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">v</mml:mi><mml:mi mathvariant="bold-italic">a</mml:mi><mml:mi mathvariant="bold-italic">r</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>: Infectiousness variation</td><td align="char" char="." valign="bottom">1.41</td><td align="char" char="." valign="bottom">1.49</td><td align="char" char="." valign="bottom">0.94</td></tr><tr><td align="left" valign="bottom"> <inline-formula><mml:math id="inf48"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">λ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">c</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>: hazard of infection from outside the household (10<sup>–2</sup>)</td><td align="char" char="." valign="bottom">0.2</td><td align="char" char="." valign="bottom">0.24</td><td align="char" char="." valign="bottom">0.96</td></tr><tr><td align="left" valign="bottom"> <inline-formula><mml:math id="inf49"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">λ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">h</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>: hazard of infection from an infected household member</td><td align="char" char="." valign="bottom">0.35</td><td align="char" char="." valign="bottom">0.33</td><td align="char" char="." valign="bottom">0.92</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf50"><mml:mi mathvariant="bold-italic">β</mml:mi><mml:mo>:</mml:mo></mml:math></inline-formula> relationship between number of household contacts and transmission rate</td><td align="char" char="." valign="bottom">0.75</td><td align="char" char="." valign="bottom">0.77</td><td align="char" char="." valign="bottom">0.96</td></tr><tr><td align="left" valign="bottom">Laxminarayan et al.</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> <inline-formula><mml:math id="inf51"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">σ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">v</mml:mi><mml:mi mathvariant="bold-italic">a</mml:mi><mml:mi mathvariant="bold-italic">r</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>: Infectiousness variation</td><td align="char" char="." valign="bottom">2.44</td><td align="char" char="." valign="bottom">2.6</td><td align="char" char="." valign="bottom">0.94</td></tr><tr><td align="left" valign="bottom"> <inline-formula><mml:math id="inf52"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">λ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">c</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>: hazard of infection from outside the household (10<sup>–2</sup>)</td><td align="char" char="." valign="bottom">0.03</td><td align="char" char="." valign="bottom">0.05</td><td align="char" char="." valign="bottom">0.96</td></tr><tr><td align="left" valign="bottom"> <inline-formula><mml:math id="inf53"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">λ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">h</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>: hazard of infection from an infected household member</td><td align="char" char="." valign="bottom">0.04</td><td align="char" char="." valign="bottom">0.03</td><td align="char" char="." valign="bottom">0.9</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf54"><mml:mi mathvariant="bold-italic">β</mml:mi><mml:mo>:</mml:mo></mml:math></inline-formula> relationship between number of household contacts and transmission rate</td><td align="char" char="." valign="bottom">0.92</td><td align="char" char="." valign="bottom">0.82</td><td align="char" char="." valign="bottom">1</td></tr><tr><td align="left" valign="bottom">Dattner et al.</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> <inline-formula><mml:math id="inf55"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">σ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">v</mml:mi><mml:mi mathvariant="bold-italic">a</mml:mi><mml:mi mathvariant="bold-italic">r</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>: Infectiousness variation</td><td align="char" char="." valign="bottom">1.12</td><td align="char" char="." valign="bottom">1.18</td><td align="char" char="." valign="bottom">0.92</td></tr><tr><td align="left" valign="bottom"> <inline-formula><mml:math id="inf56"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">λ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">c</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>: hazard of infection from outside the household (10<sup>–2</sup>)</td><td align="char" char="." valign="bottom">0.63</td><td align="char" char="." valign="bottom">0.69</td><td align="char" char="." valign="bottom">0.92</td></tr><tr><td align="left" valign="bottom"> <inline-formula><mml:math id="inf57"><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">λ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">h</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>: hazard of infection from an infected household member</td><td align="char" char="." valign="bottom">0.37</td><td align="char" char="." valign="bottom">0.36</td><td align="char" char="." valign="bottom">0.96</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf58"><mml:mi mathvariant="bold-italic">β</mml:mi><mml:mo>:</mml:mo></mml:math></inline-formula> relationship between number of household contacts and transmission rate</td><td align="char" char="." valign="bottom">0.65</td><td align="char" char="." valign="bottom">0.68</td><td align="char" char="." valign="bottom">0.98</td></tr></tbody></table></table-wrap><table-wrap id="app1table9" position="float"><label>Appendix 1—table 9.</label><caption><title>A sensitivity analysis of using normal distribution (main analysis) instead of lognormal distribution (sensitivity analysis) for individual infectiousness.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Article</th><th align="left" valign="bottom">Model</th><th align="left" valign="bottom">Estimates of infectiousness variation</th><th align="left" valign="bottom">Estimates of probability of infection from community (10<sup>–2</sup>)</th><th align="left" valign="bottom">Estimates of probability of infection from household</th><th align="left" valign="bottom">Relationship between transmission and number of contacts (<inline-formula><mml:math id="inf59"><mml:mi>β</mml:mi><mml:mo>)</mml:mo></mml:math></inline-formula></th><th align="left" valign="bottom">Difference in DIC</th></tr></thead><tbody><tr><td align="left" valign="bottom">Lyngse et al.</td><td align="left" valign="bottom">Main analysis</td><td align="char" char="." valign="bottom">1.48 (1.29, 1.7)</td><td align="char" char="." valign="bottom">0.06 (0, 0.16)</td><td align="char" char="." valign="bottom">0.11 (0.08, 0.13)</td><td align="char" char="." valign="bottom">0.72 (0.59, 0.89)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Sensitivity analysis</td><td align="char" char="." valign="bottom">0.93 (0.84, 1.03)</td><td align="char" char="." valign="bottom">0.03 (0, 0.11)</td><td align="char" char="." valign="bottom">0.06 (0.05, 0.07)</td><td align="char" char="." valign="bottom">0.7 (0.58, 0.83)</td><td align="char" char="." valign="bottom">2821</td></tr><tr><td align="left" valign="bottom">Carazo et al.</td><td align="left" valign="bottom">Main analysis</td><td align="char" char="." valign="bottom">1.41 (1.19, 1.72)</td><td align="char" char="." valign="bottom">0.2 (0.01, 0.43)</td><td align="char" char="." valign="bottom">0.35 (0.27, 0.42)</td><td align="char" char="." valign="bottom">0.75 (0.62, 0.93)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Sensitivity analysis</td><td align="char" char="." valign="bottom">1.05 (0.92, 1.21)</td><td align="char" char="." valign="bottom">0.06 (0, 0.24)</td><td align="char" char="." valign="bottom">0.18 (0.16, 0.2)</td><td align="char" char="." valign="bottom">0.71 (0.59, 0.84)</td><td align="char" char="." valign="bottom">2569</td></tr><tr><td align="left" valign="bottom">Laxminarayan et al.</td><td align="left" valign="bottom">Main analysis</td><td align="char" char="." valign="bottom">2.44 (1.98, 3.23)</td><td align="char" char="." valign="bottom">0.03 (0, 0.11)</td><td align="char" char="." valign="bottom">0.04 (0.01, 0.08)</td><td align="char" char="." valign="bottom">0.92 (0.69, 1)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Sensitivity analysis</td><td align="char" char="." valign="bottom">1.31 (1.14, 1.48)</td><td align="char" char="." valign="bottom">0.02 (0, 0.08)</td><td align="char" char="." valign="bottom">0.05 (0.03, 0.06)</td><td align="char" char="." valign="bottom">0.91 (0.66, 1)</td><td align="char" char="." valign="bottom">818</td></tr><tr><td align="left" valign="bottom">Dattner et al.</td><td align="left" valign="bottom">Main analysis</td><td align="char" char="." valign="bottom">1.12 (0.65, 1.69)</td><td align="char" char="." valign="bottom">0.63 (0.12, 1.06)</td><td align="char" char="." valign="bottom">0.37 (0.21, 0.54)</td><td align="char" char="." valign="bottom">0.65 (0.45, 0.91)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Sensitivity analysis</td><td align="char" char="." valign="bottom">0.66 (0.47, 0.88)</td><td align="char" char="." valign="bottom">0.3 (0.02, 0.71)</td><td align="char" char="." valign="bottom">0.18 (0.13, 0.22)</td><td align="char" char="." valign="bottom">0.56 (0.4, 0.75)</td><td align="char" char="." valign="bottom">908</td></tr></tbody></table></table-wrap><table-wrap id="app1table10" position="float"><label>Appendix 1—table 10.</label><caption><title>Summary of characteristic of identified studies.</title><p>SD: standard deviation.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Article</th><th align="left" valign="bottom">Number of households</th><th align="left" valign="bottom">Number of contacts</th><th align="left" valign="bottom">Number of secondary cases</th><th align="left" valign="bottom">Mean number of contacts</th><th align="left" valign="bottom">SD of number of contact</th><th align="left" valign="bottom">Secondary attack rate (SAR)</th><th align="left" valign="bottom">SD of number of secondary cases (<inline-formula><mml:math id="inf60"><mml:msub><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>)</th></tr></thead><tbody><tr><td align="left" valign="bottom">Lyngse et al.</td><td align="char" char="." valign="bottom">6782</td><td align="char" char="." valign="bottom">14,233</td><td align="char" char="." valign="bottom">1902</td><td align="char" char="." valign="bottom">2.1 (2.07, 2.13)</td><td align="char" char="." valign="bottom">1.17 (1.15, 1.19)</td><td align="char" char="." valign="bottom">0.13 (0.13, 0.14)</td><td align="char" char="." valign="bottom">0.6 (0.59, 0.61)</td></tr><tr><td align="left" valign="bottom">Carazo et al.</td><td align="char" char="." valign="bottom">3727</td><td align="char" char="." valign="bottom">8460</td><td align="char" char="." valign="bottom">2574</td><td align="char" char="." valign="bottom">2.27 (2.23, 2.31)</td><td align="char" char="." valign="bottom">1.19 (1.16, 1.21)</td><td align="char" char="." valign="bottom">0.3 (0.29, 0.31)</td><td align="char" char="." valign="bottom">0.97 (0.95, 0.99)</td></tr><tr><td align="left" valign="bottom">Laxminarayan et al.</td><td align="char" char="." valign="bottom">915</td><td align="char" char="." valign="bottom">3113</td><td align="char" char="." valign="bottom">283</td><td align="char" char="." valign="bottom">3.4 (3.28, 3.53)</td><td align="char" char="." valign="bottom">1.94 (1.86, 2.04)</td><td align="char" char="." valign="bottom">0.09 (0.08, 0.1)</td><td align="char" char="." valign="bottom">0.81 (0.77, 0.85)</td></tr><tr><td align="left" valign="bottom">Dattner et al.</td><td align="char" char="." valign="bottom">591</td><td align="char" char="." valign="bottom">2211</td><td align="char" char="." valign="bottom">720</td><td align="char" char="." valign="bottom">3.74 (3.54, 3.94)</td><td align="char" char="." valign="bottom">2.5 (2.36, 2.65)</td><td align="char" char="." valign="bottom">0.33 (0.31, 0.35)</td><td align="char" char="." valign="bottom">1.6 (1.51, 1.7)</td></tr><tr><td align="left" valign="bottom">Layan et al.</td><td align="char" char="." valign="bottom">208</td><td align="char" char="." valign="bottom">670</td><td align="char" char="." valign="bottom">264</td><td align="char" char="." valign="bottom">3.22 (3.01, 3.44)</td><td align="char" char="." valign="bottom">1.58 (1.45, 1.75)</td><td align="char" char="." valign="bottom">0.39 (0.36, 0.43)</td><td align="char" char="." valign="bottom">1.59 (1.45, 1.76)</td></tr><tr><td align="left" valign="bottom">Hart et al.</td><td align="char" char="." valign="bottom">172</td><td align="char" char="." valign="bottom">433</td><td align="char" char="." valign="bottom">194</td><td align="char" char="." valign="bottom">2.52 (2.34, 2.69)</td><td align="char" char="." valign="bottom">1.16 (1.05, 1.29)</td><td align="char" char="." valign="bottom">0.45 (0.4, 0.5)</td><td align="char" char="." valign="bottom">1.11 (1, 1.24)</td></tr><tr><td align="left" valign="bottom">Hubiche et al.</td><td align="char" char="." valign="bottom">103</td><td align="char" char="." valign="bottom">291</td><td align="char" char="." valign="bottom">119</td><td align="char" char="." valign="bottom">2.83 (2.6, 3.05)</td><td align="char" char="." valign="bottom">1.18 (1.04, 1.37)</td><td align="char" char="." valign="bottom">0.41 (0.35, 0.47)</td><td align="char" char="." valign="bottom">1.14 (1, 1.32)</td></tr><tr><td align="left" valign="bottom">Wilkinson et al.</td><td align="char" char="." valign="bottom">95</td><td align="char" char="." valign="bottom">220</td><td align="char" char="." valign="bottom">26</td><td align="char" char="." valign="bottom">2.32 (2.02, 2.61)</td><td align="char" char="." valign="bottom">1.47 (1.28, 1.71)</td><td align="char" char="." valign="bottom">0.12 (0.08, 0.17)</td><td align="char" char="." valign="bottom">0.66 (0.58, 0.77)</td></tr><tr><td align="left" valign="bottom">Tsang et al.</td><td align="char" char="." valign="bottom">47</td><td align="char" char="." valign="bottom">189</td><td align="char" char="." valign="bottom">38</td><td align="char" char="." valign="bottom">4.02 (3.39, 4.66)</td><td align="char" char="." valign="bottom">2.22 (1.85, 2.79)</td><td align="char" char="." valign="bottom">0.2 (0.15, 0.27)</td><td align="char" char="." valign="bottom">1.31 (1.09, 1.65)</td></tr><tr><td align="left" valign="bottom">Reukers et al.</td><td align="char" char="." valign="bottom">55</td><td align="char" char="." valign="bottom">187</td><td align="char" char="." valign="bottom">78</td><td align="char" char="." valign="bottom">3.4 (3.11, 3.69)</td><td align="char" char="." valign="bottom">1.1 (0.93, 1.35)</td><td align="char" char="." valign="bottom">0.42 (0.35, 0.49)</td><td align="char" char="." valign="bottom">1.33 (1.12, 1.64)</td></tr><tr><td align="left" valign="bottom">Han et al.</td><td align="char" char="." valign="bottom">55</td><td align="char" char="." valign="bottom">185</td><td align="char" char="." valign="bottom">78</td><td align="char" char="." valign="bottom">3.36 (3.08, 3.65)</td><td align="char" char="." valign="bottom">1.08 (0.91, 1.33)</td><td align="char" char="." valign="bottom">0.42 (0.35, 0.5)</td><td align="char" char="." valign="bottom">1.27 (1.07, 1.57)</td></tr><tr><td align="left" valign="bottom">Méndez-Echevarría et al.</td><td align="char" char="." valign="bottom">63</td><td align="char" char="." valign="bottom">174</td><td align="char" char="." valign="bottom">57</td><td align="char" char="." valign="bottom">2.76 (2.57, 2.95)</td><td align="char" char="." valign="bottom">0.78 (0.66, 0.94)</td><td align="char" char="." valign="bottom">0.33 (0.26, 0.4)</td><td align="char" char="." valign="bottom">0.96 (0.82, 1.17)</td></tr><tr><td align="left" valign="bottom">Dutta et al.</td><td align="char" char="." valign="bottom">32</td><td align="char" char="." valign="bottom">170</td><td align="char" char="." valign="bottom">55</td><td align="char" char="." valign="bottom">5.31 (4.52, 6.1)</td><td align="char" char="." valign="bottom">2.28 (1.83, 3.03)</td><td align="char" char="." valign="bottom">0.32 (0.25, 0.4)</td><td align="char" char="." valign="bottom">1.59 (1.28, 2.12)</td></tr><tr><td align="left" valign="bottom">Koureas et al.</td><td align="char" char="." valign="bottom">32</td><td align="char" char="." valign="bottom">153</td><td align="char" char="." valign="bottom">50</td><td align="char" char="." valign="bottom">4.78 (3.94, 5.62)</td><td align="char" char="." valign="bottom">2.43 (1.95, 3.23)</td><td align="char" char="." valign="bottom">0.33 (0.25, 0.41)</td><td align="char" char="." valign="bottom">2.14 (1.72, 2.84)</td></tr><tr><td align="left" valign="bottom">Bernardes-Souza et al.</td><td align="char" char="." valign="bottom">40</td><td align="char" char="." valign="bottom">112</td><td align="char" char="." valign="bottom">55</td><td align="char" char="." valign="bottom">2.8 (2.33, 3.27)</td><td align="char" char="." valign="bottom">1.51 (1.23, 1.93)</td><td align="char" char="." valign="bottom">0.49 (0.4, 0.59)</td><td align="char" char="." valign="bottom">1.48 (1.21, 1.9)</td></tr><tr><td align="left" valign="bottom">Posfay-Barbe et al.</td><td align="char" char="." valign="bottom">39</td><td align="char" char="." valign="bottom">111</td><td align="char" char="." valign="bottom">46</td><td align="char" char="." valign="bottom">2.85 (2.54, 3.16)</td><td align="char" char="." valign="bottom">0.99 (0.81, 1.27)</td><td align="char" char="." valign="bottom">0.41 (0.32, 0.51)</td><td align="char" char="." valign="bottom">0.94 (0.77, 1.21)</td></tr><tr><td align="left" valign="bottom">Hsu et al.</td><td align="char" char="." valign="bottom">38</td><td align="char" char="." valign="bottom">96</td><td align="char" char="." valign="bottom">49</td><td align="char" char="." valign="bottom">2.53 (2.12, 2.93)</td><td align="char" char="." valign="bottom">1.27 (1.03, 1.64)</td><td align="char" char="." valign="bottom">0.51 (0.41, 0.61)</td><td align="char" char="." valign="bottom">0.87 (0.71, 1.12)</td></tr></tbody></table></table-wrap><table-wrap id="app1table11" position="float"><label>Appendix 1—table 11.</label><caption><title>Association between infectiousness variation estimated from household transmission models, and other statistics from 17 household studies, based on meta-regression.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Statistic</th><th align="left" valign="bottom">Infectiousness variation (<inline-formula><mml:math id="inf61"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula><xref ref-type="table-fn" rid="app1table11fn1">*</xref>)</th><th align="left" valign="bottom">Standard deviation (SD) of the distribution of number of secondary cases (<inline-formula><mml:math id="inf62"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>)</th><th align="left" valign="bottom">Secondary attack rate (SAR)</th></tr></thead><tbody><tr><td align="left" valign="bottom">Pooled estimates</td><td align="left" valign="bottom">1.33 (0.95, 1.70)</td><td align="left" valign="bottom">1.19 (1.03, 1.35)</td><td align="left" valign="bottom">0.35 (0.28, 0.44)</td></tr><tr><td align="left" valign="bottom"><italic>I<sup>2</sup></italic></td><td align="left" valign="bottom">78.4</td><td align="left" valign="bottom">99.2</td><td align="left" valign="bottom">99.1</td></tr><tr><td align="left" valign="bottom">Factors</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Estimate</td><td align="left" valign="bottom"><italic>β</italic></td><td align="left" valign="bottom"><italic>β</italic></td><td align="left" valign="bottom">exp (<italic>β</italic>)</td></tr><tr><td align="left" valign="bottom">Mean number of contacts</td><td align="left" valign="bottom">0.31 (−0.16, 0.78)</td><td align="left" valign="bottom"><bold>0.35 (0.22, 0.48</bold>)</td><td align="left" valign="bottom">1.09 (0.83, 1.43)</td></tr><tr><td align="left" valign="bottom">SD number of contacts</td><td align="left" valign="bottom">0.55 (−0.12, 1.21)</td><td align="left" valign="bottom"><bold>0.42 (0.15, 0.69</bold>)</td><td align="left" valign="bottom">0.80 (0.51, 1.25)</td></tr><tr><td align="left" valign="bottom">Implementation of lockdown</td><td align="left" valign="bottom">0.16 (−0.61, 0.93)</td><td align="left" valign="bottom">–0.06 (−0.40, 0.28)</td><td align="left" valign="bottom">0.69 (0.43, 1.10)</td></tr><tr><td align="left" valign="bottom">Index cases are confirmed by PCR only</td><td align="left" valign="bottom">0.48 (−0.32, 1.29)</td><td align="left" valign="bottom">0.02 (−0.33, 0.38)</td><td align="left" valign="bottom">1.09 (0.65, 1.85)</td></tr><tr><td align="left" valign="bottom">Secondary cases are confirmed by PCR only</td><td align="left" valign="bottom"><bold>0.78 (0.13, 1.43</bold>)</td><td align="left" valign="bottom">0.03 (−0.30, 0.35)</td><td align="left" valign="bottom">0.88 (0.55, 1.41)</td></tr><tr><td align="left" valign="bottom">Only ancestral strains are circulating in study period</td><td align="left" valign="bottom">0.76 (−0.03, 1.55)</td><td align="left" valign="bottom">0.07 (−0.31, 0.45)</td><td align="left" valign="bottom">0.75 (0.43, 1.30)</td></tr><tr><td align="left" valign="bottom">All household contacts were tested</td><td align="left" valign="bottom">0.03 (−0.87, 0.93)</td><td align="left" valign="bottom">0.28 (−0.04, 0.59)</td><td align="left" valign="bottom">0.96 (0.58, 1.58)</td></tr></tbody></table><table-wrap-foot><fn id="app1table11fn1"><label>*</label><p>Estimates based on results from 14 studies</p></fn></table-wrap-foot></table-wrap><table-wrap id="app1table12" position="float"><label>Appendix 1—table 12.</label><caption><title>Pooled estimates for duration of viral shedding for COVID-19 from 11 systematic reviews.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Study</th><th align="left" valign="bottom">Sampling site</th><th align="left" valign="bottom">Laboratory method</th><th align="left" valign="bottom">Pooled estimates (mean/median)</th><th align="left" valign="bottom">95% CI</th><th align="left" valign="bottom">Range</th><th align="left" valign="bottom"><italic>I</italic><sup>2</sup></th></tr></thead><tbody><tr><td align="left" valign="bottom">Cevik</td><td align="left" valign="bottom">Upper respiratory tract</td><td align="left" valign="top">PCR</td><td align="left" valign="top">17.0</td><td align="left" valign="top">15.5–18.6</td><td align="left" valign="top">6.0–53·9</td><td align="left" valign="top"/></tr><tr><td align="left" valign="bottom">Cevik</td><td align="left" valign="bottom">Lower respiratory tract</td><td align="left" valign="top">PCR</td><td align="left" valign="top">14.6</td><td align="left" valign="top">9.3–20.0</td><td align="left" valign="top">6.2–22.7</td><td align="left" valign="top">97%</td></tr><tr><td align="left" valign="bottom">Cevik</td><td align="left" valign="bottom">Stool</td><td align="left" valign="top">Viral culture</td><td align="left" valign="top">17.2</td><td align="left" valign="top">14.4–20.1</td><td align="left" valign="top">9.8–27.9</td><td align="left" valign="top">96.6%</td></tr><tr><td align="left" valign="bottom">Cevik</td><td align="left" valign="bottom">Serum/blood</td><td align="left" valign="top">Viral culture</td><td align="left" valign="top">16.6</td><td align="left" valign="top">3.6–29.7</td><td align="left" valign="top">10.0–23.3</td><td align="left" valign="top">99%</td></tr><tr><td align="left" valign="bottom">Fontana</td><td align="left" valign="bottom">Respiratory sources</td><td align="left" valign="top">PCR</td><td align="left" valign="top">18.4<xref ref-type="table-fn" rid="app1table12fn1">*</xref></td><td align="left" valign="top">15.5–21.3</td><td align="left" valign="top">5.5–53.5</td><td align="left" valign="top">98.87%</td></tr><tr><td align="left" valign="bottom">Fontana</td><td align="left" valign="bottom">Rectal/stool</td><td align="left" valign="top">PCR</td><td align="left" valign="top">22.1<xref ref-type="table-fn" rid="app1table12fn1">*</xref></td><td align="left" valign="top">14.4–29.8</td><td align="left" valign="top">11–33</td><td align="left" valign="top">95.86%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (nasal swab+throat swab)</td><td align="left" valign="top">PCR</td><td align="left" valign="top">18.29</td><td align="left" valign="top">17.00–19.89</td><td align="left" valign="top">8.33–39.97</td><td align="left" valign="top">99%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Sputum</td><td align="left" valign="top">PCR</td><td align="left" valign="top">23.79</td><td align="left" valign="top">20.43–27.16</td><td align="left" valign="top">15.50–32.00</td><td align="left" valign="top">93%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Blood</td><td align="left" valign="top">PCR</td><td align="left" valign="top">14.60</td><td align="left" valign="top">12.16–17.05</td><td align="left" valign="top">11.00–17.58</td><td align="left" valign="top">88%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Stool</td><td align="left" valign="top">PCR</td><td align="left" valign="top">22.38</td><td align="left" valign="top">18.40–26.35</td><td align="left" valign="top">10.67–51.40</td><td align="left" valign="top">97%</td></tr><tr><td align="left" valign="bottom">Qutub</td><td align="left" valign="bottom">Respiratory tract</td><td align="left" valign="top">Viral culture</td><td align="left" valign="top">28.75/11**</td><td align="left" valign="top">8.5–14.5</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="bottom">Rahmani</td><td align="left" valign="bottom">Respiratory tract</td><td align="left" valign="top">PCR</td><td align="left" valign="top">27.90</td><td align="left" valign="top">23.27–32.52</td><td align="left" valign="top">7.40–132.00</td><td align="left" valign="top">99.1%</td></tr><tr><td align="left" valign="bottom">Xu</td><td align="left" valign="bottom">Respiratory tract (symptomatic cases)</td><td align="left" valign="top">PCR</td><td align="left" valign="top">11.1±5.8***</td><td align="left" valign="top"/><td align="left" valign="top">0–24</td><td align="left" valign="top"/></tr><tr><td align="left" valign="bottom">Xu</td><td align="left" valign="bottom">Gastrointestinal tract (symptomatic cases)</td><td align="left" valign="top">PCR</td><td align="left" valign="top">23.6±8.8***</td><td align="left" valign="top"/><td align="left" valign="top">10–33</td><td align="left" valign="top"/></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Unrestricted</td><td align="left" valign="top">PCR</td><td align="left" valign="top">16.8</td><td align="left" valign="top">14.8–19.4</td><td align="left" valign="top"/><td align="left" valign="top">99.56%</td></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Stool</td><td align="left" valign="top">PCR</td><td align="left" valign="top">30.3</td><td align="left" valign="top">23.1–39.2</td><td align="left" valign="top"/><td align="left" valign="top">92.09%</td></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Respiratory tract</td><td align="left" valign="top">PCR</td><td align="left" valign="top">17.5</td><td align="left" valign="top">14.9–20.6</td><td align="left" valign="top"/><td align="left" valign="top">99.67%</td></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Upper respiratory tract</td><td align="left" valign="top">PCR</td><td align="left" valign="top">17.5</td><td align="left" valign="top">14.6–21.0</td><td align="left" valign="top"/><td align="left" valign="top">99.53%</td></tr><tr><td align="left" valign="bottom">Diaz</td><td align="left" valign="bottom">Stool</td><td align="left" valign="top">PCR</td><td align="left" valign="top">22<xref ref-type="table-fn" rid="app1table12fn1">*</xref></td><td align="left" valign="top">19–25</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="bottom">Chen</td><td align="left" valign="bottom">(Asymptomatic infections)</td><td align="left" valign="top"/><td align="left" valign="top">14.14<xref ref-type="table-fn" rid="app1table12fn1">*</xref></td><td align="left" valign="top">11.25–17.04</td><td align="left" valign="top">11.00–17.25</td><td align="left" valign="top"/></tr><tr><td align="left" valign="bottom">Li</td><td align="left" valign="bottom">Upper respiratory tract (nasopharyngeal/throat swabs)</td><td align="left" valign="top">PCR</td><td align="left" valign="top">11.43</td><td align="left" valign="top">10.1–12.77</td><td align="left" valign="top"/><td align="left" valign="top">75.3%</td></tr><tr><td align="left" valign="bottom">Zhang</td><td align="left" valign="bottom">Stool</td><td align="left" valign="top">PCR</td><td align="left" valign="top">21.8</td><td align="left" valign="top">16.4–27.1</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="bottom">Zhang</td><td align="left" valign="bottom">Respiratory tract</td><td align="left" valign="top">PCR</td><td align="left" valign="top">14.7</td><td align="left" valign="top">9.9–19.5</td><td align="left" valign="top"/><td align="left" valign="top"/></tr></tbody></table><table-wrap-foot><fn id="app1table12fn1"><label>*</label><p>Median estimate, **median/grouped median, ***this study analyzed by cases, and reported mean ± SD.</p></fn></table-wrap-foot></table-wrap><table-wrap id="app1table13" position="float"><label>Appendix 1—table 13.</label><caption><title>Pooled estimates for duration of viral shedding for COVID-19 in subgroups from seven systematic reviews.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Study</th><th align="left" valign="bottom">Sampling site (subgroups)</th><th align="left" valign="bottom">Laboratory method</th><th align="left" valign="bottom">Pooled estimates (mean/median)</th><th align="left" valign="bottom">95% CI</th><th align="left" valign="bottom">Range</th><th align="left" valign="bottom"><italic>I</italic><sup>2</sup></th></tr></thead><tbody><tr><td align="left" valign="bottom">Fontana</td><td align="left" valign="bottom">Respiratory sources (among severely ill patients)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">19.8<xref ref-type="table-fn" rid="app1table13fn1">*</xref></td><td align="left" valign="bottom">16.2–23.5</td><td align="left" valign="bottom">11–31</td><td align="left" valign="bottom">96.42%</td></tr><tr><td align="left" valign="bottom">Fontana</td><td align="left" valign="bottom">Respiratory sources (in mild-to-moderate illness)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">17.2<xref ref-type="table-fn" rid="app1table13fn1">*</xref></td><td align="left" valign="bottom">14.0–20.5</td><td align="left" valign="bottom">8–25</td><td align="left" valign="bottom">95.64%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (nasal swab)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">19.34</td><td align="left" valign="bottom">16.60–22.07</td><td align="left" valign="bottom"/><td align="left" valign="bottom">99%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (throat swab)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">17.85</td><td align="left" valign="bottom">16.43–19.26</td><td align="left" valign="bottom"/><td align="left" valign="bottom">98%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (age &lt; 60)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">16.95</td><td align="left" valign="bottom">13.56–20.35</td><td align="left" valign="bottom">8.62–35.67</td><td align="left" valign="bottom">98%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (age ≥ 60)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">21.24</td><td align="left" valign="bottom">14.06–28.41</td><td align="left" valign="bottom">8.25–40.33</td><td align="left" valign="bottom">99%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (with comorbidities)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">20.26</td><td align="left" valign="bottom">17.60–22.92</td><td align="left" valign="bottom">9.67–34.00</td><td align="left" valign="bottom">93%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (without comorbidities)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">14.66</td><td align="left" valign="bottom">12.63–16.69</td><td align="left" valign="bottom">10.82–27.25</td><td align="left" valign="bottom">85%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (severe patients)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">20.79</td><td align="left" valign="bottom">18.03–23.55</td><td align="left" valign="bottom">14.00–38.33</td><td align="left" valign="bottom">98%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (nonsevere patients)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">16.36</td><td align="left" valign="bottom">14.07–18.66</td><td align="left" valign="bottom">8.00–37.33</td><td align="left" valign="bottom">99%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (severe patients) (for studies with mean age ≥ 40 + comorbidity &gt; 30%)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">21.53</td><td align="left" valign="bottom">17.57–25.50</td><td align="left" valign="bottom">14.00–29.50</td><td align="left" valign="bottom">91%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (severe patients) (for studies with mean age ≥ 40 + comorbidity &gt;30%)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">20.08</td><td align="left" valign="bottom">15.87–24.29</td><td align="left" valign="bottom">13.12–33.67</td><td align="left" valign="bottom">100%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (treated with glucocorticoid)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">19.72</td><td align="left" valign="bottom">17.92–21.52</td><td align="left" valign="bottom">13.87–33.67</td><td align="left" valign="bottom">92%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (treated without glucocorticoid)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">15.64</td><td align="left" valign="bottom">14.18–17.10</td><td align="left" valign="bottom">8.33–31.60</td><td align="left" valign="bottom">96%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (treated with glucocorticoid) (for studies with mean age: 30–60+comorbidity &gt; 50%)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">21.98</td><td align="left" valign="bottom">16.48–27.48</td><td align="left" valign="bottom">14.25–33.67</td><td align="left" valign="bottom">94%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (treated without glucocorticoid) (for studies with mean age: 30–60+comorbidity &gt; 50%)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">16.14</td><td align="left" valign="bottom">12.60–19.68</td><td align="left" valign="bottom">13.22–24.44</td><td align="left" valign="bottom">92%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (Asian)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">18.10</td><td align="left" valign="bottom">16.95–19.25</td><td align="left" valign="bottom">8.33–34.75</td><td align="left" valign="bottom">98%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (European)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">19.27</td><td align="left" valign="bottom">11.59–26.95</td><td align="left" valign="bottom">8.50–39.97</td><td align="left" valign="bottom">100%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (Asian) (for studies with mean age ≥ 40 + comorbidity &gt;40%)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">20.66</td><td align="left" valign="bottom">18.18–23.14</td><td align="left" valign="bottom">12.00–32.00</td><td align="left" valign="bottom">96%</td></tr><tr><td align="left" valign="bottom">Okita</td><td align="left" valign="bottom">Upper respiratory tract (European) (for studies with mean age ≥ 40 + comorbidity &gt; 40%)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">23.68</td><td align="left" valign="bottom">10.85–36.51</td><td align="left" valign="bottom">13.00–39.97</td><td align="left" valign="bottom">100%</td></tr><tr><td align="left" valign="bottom">Qutub</td><td align="left" valign="bottom">Respiratory tract (severe patients)</td><td align="left" valign="bottom">Viral culture</td><td align="left" valign="bottom">47.5/20**</td><td align="left" valign="bottom">9.0–53.0</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Qutub</td><td align="left" valign="bottom">Respiratory tract (severe patients were not specified of excluded)</td><td align="left" valign="bottom">Viral culture</td><td align="left" valign="bottom">10/9**</td><td align="left" valign="bottom">8.0–13.0</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Qutub</td><td align="left" valign="bottom">Respiratory tract (immunocompromised patients)</td><td align="left" valign="bottom">Viral culture</td><td align="left" valign="bottom">54.36/20**</td><td align="left" valign="bottom">9.0–85.98</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Qutub</td><td align="left" valign="bottom">Respiratory tract (immunocompromised patients were not specified of excluded)</td><td align="left" valign="bottom">Viral culture</td><td align="left" valign="bottom">11.67/9**</td><td align="left" valign="bottom">8.2–13.3</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Rahmani</td><td align="left" valign="bottom">Not specific (immunocompetent individuals)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">26.54</td><td align="left" valign="bottom">21.44–31.64</td><td align="left" valign="bottom">7.40–91.20</td><td align="left" valign="bottom">99.3%</td></tr><tr><td align="left" valign="bottom">Rahmani</td><td align="left" valign="bottom">Not specific (immunocompromised individuals)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">36.28</td><td align="left" valign="bottom">21.93–50.63</td><td align="left" valign="bottom">15.90–132.00</td><td align="left" valign="bottom">94.2%</td></tr><tr><td align="left" valign="bottom">Xu</td><td align="left" valign="bottom">Respiratory tract (asymptomatic cases)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">9.4±5.1***</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Xu</td><td align="left" valign="bottom">Gastrointestinal tract (asymptomatic cases)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">16.8±9.8***</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Unrestricted (symptomatic cases)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">19.7</td><td align="left" valign="bottom">17.2–22.7</td><td align="left" valign="bottom"/><td align="left" valign="bottom">99.34%</td></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Unrestricted (asymptomatic cases)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">10.9</td><td align="left" valign="bottom">8.3–14.3</td><td align="left" valign="bottom"/><td align="left" valign="bottom">98.89%</td></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Unrestricted (severe patients)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">24.3</td><td align="left" valign="bottom">18.9–31.1</td><td align="left" valign="bottom"/><td align="left" valign="bottom">91.88%</td></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Unrestricted (nonsevere patients)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">22.8</td><td align="left" valign="bottom">16.4–32.0</td><td align="left" valign="bottom"/><td align="left" valign="bottom">99.81%</td></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Unrestricted (females)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">19.4</td><td align="left" valign="bottom">9.5–39.4</td><td align="left" valign="bottom"/><td align="left" valign="bottom">93.93%</td></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Unrestricted (males)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">11.9</td><td align="left" valign="bottom">8.4–16.9</td><td align="left" valign="bottom"/><td align="left" valign="bottom">87.83%</td></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Unrestricted (adults)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">23.2</td><td align="left" valign="bottom">19.0–28.4</td><td align="left" valign="bottom"/><td align="left" valign="bottom">99.24%</td></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Unrestricted (children)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">9.9</td><td align="left" valign="bottom">8.1–12.2</td><td align="left" valign="bottom"/><td align="left" valign="bottom">85.74%</td></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Unrestricted (with chronic diseases)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">24.2</td><td align="left" valign="bottom">19.2–30.2</td><td align="left" valign="bottom"/><td align="left" valign="bottom">84.07%</td></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Unrestricted (without chronic diseases)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">11.5</td><td align="left" valign="bottom">5.3–25.0</td><td align="left" valign="bottom"/><td align="left" valign="bottom">82.11%</td></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Unrestricted (treated with corticosteroid)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">28.3</td><td align="left" valign="bottom">25.6–31.2</td><td align="left" valign="bottom"/><td align="left" valign="bottom">0.00%</td></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Unrestricted (treated without corticosteroid)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">16.2</td><td align="left" valign="bottom">11.5–22.5</td><td align="left" valign="bottom"/><td align="left" valign="bottom">92.27%</td></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Unrestricted (antiviral treatment)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">17.6</td><td align="left" valign="bottom">13.4–22.2</td><td align="left" valign="bottom"/><td align="left" valign="bottom">98.99%</td></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Unrestricted (mono-antiviral treatment)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">21.2</td><td align="left" valign="bottom">15.3–29.2</td><td align="left" valign="bottom"/><td align="left" valign="bottom">90.04%</td></tr><tr><td align="left" valign="bottom">Yan</td><td align="left" valign="bottom">Unrestricted (multiantiviral treatment)</td><td align="left" valign="bottom">PCR</td><td align="left" valign="bottom">20.3</td><td align="left" valign="bottom">13.7–30.3</td><td align="left" valign="bottom"/><td align="left" valign="bottom">99.46%</td></tr><tr><td align="left" valign="bottom">Chen</td><td align="left" valign="bottom">Unrestricted (asymptomatic infections)</td><td align="left" valign="bottom">PCR or serum antibody</td><td align="left" valign="bottom">14.14<xref ref-type="table-fn" rid="app1table13fn1">*</xref></td><td align="left" valign="bottom">11.25–17.04</td><td align="left" valign="bottom">11.00–17.25</td><td align="left" valign="bottom"/></tr></tbody></table><table-wrap-foot><fn id="app1table13fn1"><label>*</label><p>Median estimate, **median/grouped median, ***this study analyzed by cases, and reported mean ± SD.</p></fn></table-wrap-foot></table-wrap><table-wrap id="app1table14" position="float"><label>Appendix 1—table 14.</label><caption><title>Pooled estimates for duration of infectious period for COVID-19 in subgroups from two systematic reviews.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Study</th><th align="left" valign="bottom">Sampling site (subgroups)</th><th align="left" valign="bottom">Laboratory method</th><th align="left" valign="bottom">Pooled estimates</th><th align="left" valign="bottom">95% CI</th><th align="left" valign="bottom">Range</th><th align="left" valign="bottom"><italic>I</italic><sup>2</sup></th></tr></thead><tbody><tr><td align="left" valign="bottom">Rahmani</td><td align="left" valign="bottom">Replicant competent virus isolation</td><td align="left" valign="bottom">Viral culture</td><td align="char" char="." valign="bottom">7.27</td><td align="char" char="ndash" valign="bottom">5.70–8.84</td><td align="char" char="ndash" valign="bottom">3.40–89.00</td><td align="char" char="." valign="bottom">92.2%</td></tr><tr><td align="left" valign="bottom">Wang</td><td align="left" valign="bottom">Not specific</td><td align="left" valign="bottom">Not specific</td><td align="char" char="." valign="bottom">6.25</td><td align="char" char="ndash" valign="bottom">5.09–7.51</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Rahmani</td><td align="left" valign="bottom">Replicant competent virus isolation (immunocompetent individuals)</td><td align="left" valign="bottom">Viral culture</td><td align="char" char="." valign="bottom">6.33</td><td align="char" char="ndash" valign="bottom">4.92–7.75</td><td align="char" char="ndash" valign="bottom">3.00–13.00</td><td align="char" char="." valign="bottom">92.4%</td></tr><tr><td align="left" valign="bottom">Rahmani</td><td align="left" valign="bottom">Replicant competent virus isolation (immunocompromised individuals)</td><td align="left" valign="bottom">Viral culture</td><td align="char" char="." valign="bottom">29.50</td><td align="char" char="ndash" valign="bottom">12.46–46.53</td><td align="char" char="ndash" valign="bottom">13.80–89.00</td><td align="char" char="." valign="bottom">84.8%</td></tr></tbody></table></table-wrap><table-wrap id="app1table15" position="float"><label>Appendix 1—table 15.</label><caption><title>Probability distributions of the incubation period and relative infectivity levels during the infectious period.</title><p>For the infectious period, day 0 corresponds to the symptom onset day. These two distributions are used to generate the infectiousness profile since infections.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2">Day</th><th align="left" valign="bottom">Incubation period</th><th align="left" valign="bottom"/><th align="left" valign="bottom">Infectious period</th></tr><tr><th align="left" valign="bottom">Mean = 5 days</th><th align="left" valign="bottom">Day</th><th align="left" valign="bottom">Max = 13 days</th></tr></thead><tbody><tr><td align="char" char="." valign="bottom">1</td><td align="char" char="." valign="bottom">0.058</td><td align="char" char="." valign="bottom">−5</td><td align="char" char="." valign="bottom">1.0</td></tr><tr><td align="char" char="." valign="bottom">2</td><td align="char" char="." valign="bottom">0.11</td><td align="char" char="." valign="bottom">−4</td><td align="char" char="." valign="bottom">1.0</td></tr><tr><td align="char" char="." valign="bottom">3</td><td align="char" char="." valign="bottom">0.14</td><td align="char" char="." valign="bottom">−3</td><td align="char" char="." valign="bottom">1.0</td></tr><tr><td align="char" char="." valign="bottom">4</td><td align="char" char="." valign="bottom">0.16</td><td align="char" char="." valign="bottom">−2</td><td align="char" char="." valign="bottom">1.0</td></tr><tr><td align="char" char="." valign="bottom">5</td><td align="char" char="." valign="bottom">0.15</td><td align="char" char="." valign="bottom">−1</td><td align="char" char="." valign="bottom">1.0</td></tr><tr><td align="char" char="." valign="bottom">6</td><td align="char" char="." valign="bottom">0.13</td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">1.0</td></tr><tr><td align="char" char="." valign="bottom">7</td><td align="char" char="." valign="bottom">0.10</td><td align="char" char="." valign="bottom">1</td><td align="char" char="." valign="bottom">1.0</td></tr><tr><td align="char" char="." valign="bottom">8</td><td align="char" char="." valign="bottom">0.068</td><td align="char" char="." valign="bottom">2</td><td align="char" char="." valign="bottom">1.0</td></tr><tr><td align="char" char="." valign="bottom">9</td><td align="char" char="." valign="bottom">0.044</td><td align="char" char="." valign="bottom">3</td><td align="char" char="." valign="bottom">0.8</td></tr><tr><td align="char" char="." valign="bottom">10</td><td align="char" char="." valign="bottom">0.026</td><td align="char" char="." valign="bottom">4</td><td align="char" char="." valign="bottom">0.6</td></tr><tr><td align="char" char="." valign="bottom">11</td><td align="char" char="." valign="bottom">0.014</td><td align="char" char="." valign="bottom">5</td><td align="char" char="." valign="bottom">0.4</td></tr><tr><td align="char" char="." valign="bottom">12</td><td align="char" char="." valign="bottom">0.0072</td><td align="char" char="." valign="bottom">6</td><td align="char" char="." valign="bottom">0.2</td></tr><tr><td align="char" char="." valign="bottom">13</td><td align="char" char="." valign="bottom">0.0034</td><td align="char" char="." valign="bottom">7</td><td align="char" char="." valign="bottom">0.1</td></tr><tr><td align="char" char="." valign="bottom">14</td><td align="char" char="." valign="bottom">0.0015</td><td align="char" char="." valign="bottom">8</td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap></sec></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82611.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wesolowski</surname><given-names>Amy</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Johns Hopkins Bloomberg School of Public Health</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>While it has been demonstrated that for SARS-CoV-2, a small fraction of individuals contributes to the majority of onward transmission, this heterogeneity is driven by multiple factors that span both biological and behavioral causes. By performing a solid meta-analysis of household transmission studies, the authors fit a household transmission model to the curated data to estimate variation in infectiousness which provides a valuable contribution to the existing knowledge base. By collating data from multiple studies, they are able to more fully investigate individual variability.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82611.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Wesolowski</surname><given-names>Amy</given-names></name><role>Reviewing Editor</role><aff><institution>Johns Hopkins Bloomberg School of Public Health</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;The effect of variation of individual infectiousness on SARS-CoV-2 transmission in households&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Miles Davenport as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Both reviewers have highlighted a number of areas where additional clarification (particularly for σ_var) which currently does not have sufficient detail/interpretation to warrant publication.</p><p>2) Questions about parameter identifiability and model validation were not sufficiently addressed – particularly in light of the many individual-level parameters estimated in the analysis.</p><p>3) Additional exploration of empirical relationships (such as individual infectiousness and household size, as an example) should be explored. For example, how much of the heterogeneity is driven by biological factors (such as being the primary case).</p><p>4) Additional work should be done to help disentangle differences between biological or behavioral factors since this will greatly change the interpretation of inferred parameters. In addition, more contextual information should be provided (socio-economic status and the implications of this as a confounder, a more detailed exploration of interventions that were in place and their implications) should be done.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>Tsang et al. evaluate the degree of transmission heterogeneity among COVID-19 cases using data compiled from 17 household transmission studies. Transmission heterogeneity and super spreading are important but incompletely understood drivers of epidemic dynamics. While it is clear that substantial heterogeneity exists among infectors, but the relative contribution of behavior (e.g. the number of contacts), timing (e.g. large number of social interactions near the peak of infectiousness), and intrinsic biological differences in infectiousness are not resolved.</p><p>Tsang et al. compiled household transmission data from 17 published studies. They independently fit a model to each data set in order to quantify transmission heterogeneity arising from intrinsic biological differences in infectiousness, after controlling for differences in the number of contacts (i.e. household size), and timing (via the inferred time since infection). Repeated application of the same model to multiple datasets is a strength of this study because it allows the authors to assess associations between the inferred parameters and aspects of study design that can influence case ascertainment.</p><p>The authors estimate substantial intrinsic transmission heterogeneity via the parameter σ_var, which could be attributed to individual differences in viral loads or differences in the infector's contact intensity with others in the household. They show that intrinsic, within-household variation is associated with other population-level metrics of transmission heterogeneity, including p_80 and p_0.</p><p>Although the study focuses on the household size as a confounder of heterogeneity in infectiousness, the ways that the model controls for household size and the interpretation of the inferred heterogeneity parameter, σ_var could be explained more clearly. Furthermore, it seems that basic empirical relationships between individual infectiousness (δ_i) and household size are not explored. Finally, questions about parameter identifiability and model validation could be addressed more extensively, especially in light of the many individual-level parameters estimated in the analysis.</p><p>Overall, the study design is sound and the analysis of multiple datasets is a strength. However, the modeling approach and the biological interpretation/significance of the results could be more clearly explained. Also, given the large number of individual-level parameters estimated, it would be ideal to see a direct assessment of parameter identifiability (e.g. correlation plots), and model validation on simulated data (i.e. can the model estimate known parameters from simulated data?). The latter shouldn't be too difficult, given that the authors already have a simulation model for tests of model adequacy.</p><p>Specific comments:</p><p>1. Please explain assumptions about the individual infectiousness profile f(.) (from section 2 of the Materials and methods). What is the assumed shape of this function? How is it parameterized? How could the inclusion of this function in the model interact with inferred individual times of infection, especially if times of infection are inaccurate? On a related note, the authors might consider introducing the concept of contact timing as a factor that can influence heterogeneity in transmission.</p><p>2. The household size is a key conceptual focus of the study, but the main text methods/results don't explain clearly how the model accounts for household size or contact number. My interpretation is that the model accounts for household size in two ways. First. the model estimates the per-contact hazard of infection, which implicitly controls for household size/contact number. Second, the model includes a parameter, β, which represents a dilution effect, wherein the transmission hazard might be diluted in larger households due to less per-individual contact intensity. I'm not sure that the dilution effect is currently explained anywhere in the main text, and it could also be explained more clearly that the model is designed to estimate transmission heterogeneity after adjusting for household size.</p><p>2a. It would be helpful if the authors could discuss the distinction between contact number, contact frequency, and contact duration somewhere in the text.</p><p>3. Given the focus on household size and the number of contacts, it seems there are missed opportunities to explore how the inferred level of individual infectiousness (δ_i) co-varies with metrics like household size.</p><p>4. Please explain in more detail the meta-regression sensitivity analyses.</p><p>5. I'm not sure that tables S6-S9 are cross-referenced anywhere in the main text, and their legends aren't sufficiently detailed to fully communicate how to interpret these tables in the context of the broader study.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Transmission heterogeneity and superspreading of SARS-CoV-2 have been demonstrated repeatedly through real-world observational studies, with a small fraction of individuals accounting for the majority of onward transmission. However, this observed transmission heterogeneity is likely a superposition of accumulated variations from multiple factors, including but not limited to host behavioral factors such as the variation in contact numbers contact duration, and contact settings; variations in the adoption of preventive measures (mask-wearing, physical distancing, etc.); the effects of NPIs (case isolations and contact quarantines, population-level lockdowns); as well as biological factors including differences in shedding duration and intensity of the primary case, variation in susceptibility among close contacts. Fewer studies, however, attempted to isolate the effects of individual factors contributing to the overall transmission heterogeneity, while controlling for other factors. In the manuscript entitled &quot;The effect of variation of individual infectiousness on SARS-CoV-2 transmission in households&quot;, the authors aim at characterizing the variation in individual infectiousness of SARS-CoV-2, controlling for other host factors. To achieve this, the authors performed a meta-analysis of household transmission studies conducted during or not too longer after the initial SARS-CoV-2 wave caused by the ancestral strain across the globe. The authors fitted a household transmission model to the curated data and estimated the variation in infectiousness by introducing random effects of individual infectiousness and its population-level distribution.</p><p>The study has several strengths. First, by choosing analyzing data from the household study, the authors were able to control for several key factors contributing to the overall transmission heterogeneity but not variation in individual infectiousness, including the number of contacts as well the setting of transmission (household). The authors also incorporated an additional parameter in the household transmission model to adjust for the impact of household size on household transmission risk, which has been identified as an important risk factor for SARS-CoV-2 transmission within the household across multiple studies. The authors also curated the studies during the early stage of the pandemic so that most household contacts would remain naïve during the study period, and the immune status of the household contact (either due to prior infection or vaccination) would be unlikely to confound the results of the study.</p><p>However, the study also has a few limitations. First, it is difficult to disentangle if the observed variation in infectiousness is due to biological factors or behavioral factors. During the study period of interest, public health agencies across the globe were recommending at-home isolation guidelines aiming at reducing transmission within the household, including mask-wearing when in contact with other household members, using separate bedrooms/bathrooms, avoiding having meals together, etc. The differences in the guidelines across nationals/regions as well as the level of compliance with guidelines at the household level would also impact individual household transmission risk. Second, the risk of acquiring infections from the community could be heavily influenced by the socio-economic status, since multiple studies have clearly demonstrated stark disparity of COVID-19 burden, factors such as occupation (essential workers tend to be low-wage jobs) assess to PPE and healthcare were likely to contribute to the observed disparity. Lastly, it is also difficult to entangle if the observed heterogeneity is due to the biological factors of the primary case (i.e., variation in shedding duration/intensity) or the contact (variation in susceptibility). The current formulation of the transmission model only addresses the former not the latter.</p><p>For the household transmission model concerning imputation of the timing of infection, it is unclear if the timing of infection is partially missing, or if the timing of infection were unavailable for all studies. If it is the former case, the authors should give a more detailed description of the imputation process in a study-by-study fashion and report the proportion of infection time that was imputed. If it is the latter case, I do not understand the benefit of explicitly modeling the temporal infectiousness profile, thus I would recommend the authors use a simpler chain-binomial model fitting to only the binary outcome (of infected or not) unless the authors make a convincing case otherwise.</p><p>Both p80 and p0 are poor statistics to characterize household transmission due to the discrete nature of household contact numbers. For example, it is unintuitive to interpret and compare p80 for a household size of 2 vs 10 (for a household size of 2 conditional on an index case within the household this could only be interpreted as the proportion of households with secondary infections, which is cross-household level statistics, while for a household size of 10, it can be interpreted as a meaningful statistical for each household). Furthermore, the interpretation of p80 as a metric for transmission heterogeneity becomes even murkier if multi-generation transmission within the household is considered, especially for a larger household. For p0, this metric is heavily dependent on household size. For example, one would expect the p0 for a household size of 10 (with on index) to be way smaller than p0 household size of 2 (assuming no dilution effects on transmission with the increase of household size), as in the former case p0 characterize the probability of all 9 uninfected contacts escaping infection from the index, while in the latter p0 characterizes the probability to escape infection by only 1 household contact. Thus, it is meaningless to compare p0 without controlling for household size across studies. For the arguments above, I recommend the authors remove both p80 and p0 from the paper.</p><p>Through the formulation of the household transmission model, the authors essentially assume a lognormal distribution of individual infectiousness, which is a long-tailed distribution by nature. I think this is an important point that needs to be highlighted. Has the author tried a normal distribution instead of a log-normal distribution? Would a normal distribution fit better or worse to the data than the log-normal one? I recommend the authors conduct a sensitivity analysis of a normal distribution of the individual infectiousness (i.e., not taking the exponential of the σ term for the hazard of infection function on page 7).</p><p>Table S5 is cropped.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.82611.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Both reviewers have highlighted a number of areas where additional clarification (particularly for σ_var) which currently does not have sufficient detail/interpretation to warrant publication.</p></disp-quote><p>We have modified the discussion to talk about the interpretation and limitation of infectiousness variation. We clarified that the estimated infectiousness variations measures the variation caused by difference in individuals, which may be contributed by both biological factors and host behaviors, but not other environmental factors. Please see Response 7 for more details.</p><p>We also added a limitation that our approach could not disentangle the observed heterogeneity from biological factors affecting infectiousness and variations in susceptibility of contacts. Please see Response 14 for more details.</p><disp-quote content-type="editor-comment"><p>2) Questions about parameter identifiability and model validation were not sufficiently addressed – particularly in light of the many individual-level parameters estimated in the analysis.</p></disp-quote><p>We have added the correlation plots for the posterior distribution of parameters, and also rerun a longer MCMC chain (with 500K iterations instead of 100K iterations) to ensure that our estimates of infectiousness variations are valid. Please see Response 7 for more details.</p><disp-quote content-type="editor-comment"><p>3) Additional exploration of empirical relationships (such as individual infectiousness and household size, as an example) should be explored. For example, how much of the heterogeneity is driven by biological factors (such as being the primary case).</p></disp-quote><p>The individual infectiousness parameters are nuisance parameter in our work, since there is no individual level information on the case and contacts. However, our model is designed in a way that covariates affecting susceptibility or infectiousness could be added if individual level information is available. Please see Response 11 for more details.</p><p>We also conduct meta-analysis and meta-regression to determine if any factors may be associated with the infectiousness variation. We found that this is not associated with the mean numbers of contacts and household size, and only associated with if the study used PCR to confirm secondary cases only (Table S11).</p><disp-quote content-type="editor-comment"><p>4) Additional work should be done to help disentangle differences between biological or behavioral factors since this will greatly change the interpretation of inferred parameters. In addition, more contextual information should be provided (socio-economic status and the implications of this as a confounder, a more detailed exploration of interventions that were in place and their implications) should be done.</p></disp-quote><p>We have extended our discussion on difference between biological and behavioral factors. In summary, behavioral factors including difference in frequency and duration of contacts caused by different factors, like the role in family, recommendation from public health agencies, among individuals. Biological factors include difference in viral shedding and infectious period among individuals. We also provide more information on other confounding factors, such as social-economic status, recommendation from public health agencies, the implementation of lockdowns that may increase the time spending at home. These may increase of decrease the SAR, which is shown to be negatively correlated with infectiousness variations. Please see Response 7 and 14 for more details.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>Tsang et al. evaluate the degree of transmission heterogeneity among COVID-19 cases using data compiled from 17 household transmission studies. Transmission heterogeneity and super spreading are important but incompletely understood drivers of epidemic dynamics. While it is clear that substantial heterogeneity exists among infectors, but the relative contribution of behavior (e.g. the number of contacts), timing (e.g. large number of social interactions near the peak of infectiousness), and intrinsic biological differences in infectiousness are not resolved.</p><p>Tsang et al. compiled household transmission data from 17 published studies. They independently fit a model to each data set in order to quantify transmission heterogeneity arising from intrinsic biological differences in infectiousness, after controlling for differences in the number of contacts (i.e. household size), and timing (via the inferred time since infection). Repeated application of the same model to multiple datasets is a strength of this study because it allows the authors to assess associations between the inferred parameters and aspects of study design that can influence case ascertainment.</p><p>The authors estimate substantial intrinsic transmission heterogeneity via the parameter σ_var, which could be attributed to individual differences in viral loads or differences in the infector's contact intensity with others in the household. They show that intrinsic, within-household variation is associated with other population-level metrics of transmission heterogeneity, including p_80 and p_0.</p><p>Although the study focuses on the household size as a confounder of heterogeneity in infectiousness, the ways that the model controls for household size and the interpretation of the inferred heterogeneity parameter, σ_var could be explained more clearly. Furthermore, it seems that basic empirical relationships between individual infectiousness (δ_i) and household size are not explored. Finally, questions about parameter identifiability and model validation could be addressed more extensively, especially in light of the many individual-level parameters estimated in the analysis.</p><p>Overall, the study design is sound and the analysis of multiple datasets is a strength. However, the modeling approach and the biological interpretation/significance of the results could be more clearly explained. Also, given the large number of individual-level parameters estimated, it would be ideal to see a direct assessment of parameter identifiability (e.g. correlation plots), and model validation on simulated data (i.e. can the model estimate known parameters from simulated data?). The latter shouldn't be too difficult, given that the authors already have a simulation model for tests of model adequacy.</p></disp-quote><p>Thank you for your suggestions. In brief, we summarized that the estimated infectiousness variations measures the variation caused by difference in individuals, which may be affected by both biological factors and host behaviors but not other confounding factors, such as the difference in number of contacts, pre-existing immunity among contacts or difference in transmissibility among variants. We also added more details on the interpretation of the estimated infectiousness variation.</p><p>We added ‘Given that we focused our analysis on households with known number of contacts in studies conducted in the early outbreaks caused by ancestral strains, the estimated infectiousness variations are corrected for the variations caused by number of contacts and transmission risks in different settings, difference in pre-existing immunity among contacts (almost everyone is naïve and unvaccinated), and the difference in transmissibility among variants. Hence, this estimated infectiousness variation measures the variation caused by difference in individuals, which may be contributed by both biological factors and host behaviors, but not other confounding factors such as…. ‘ in the Discussion section in the revised manuscript.</p><p>We conducted a simulation study, and found there is no important systematic bias, and that 88-100% of 95% credible interval covered the simulation value. We also added the correlation plots in the revised manuscript. The correlation between parameters are moderate. We run long MCMC chain to ensure our results are valid. We conduct a sensitivity by running the MCMC chain with 500,000 iterations and the results are similar to the one with 100,000 iterations. This suggests that 100,000 iterations are enough (our main results).</p><p>We added ‘Simulation studies demonstrated there is no important systematic bias, with 88 to 100% of the 95% credible intervals covering the simulation value (Appendix 1 – Table 8). This suggests that the algorithm could estimate adequately the posterior distribution.’ In the Result section of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>Specific comments:</p><p>1. Please explain assumptions about the individual infectiousness profile f(.) (from section 2 of the Materials and methods). What is the assumed shape of this function? How is it parameterized? How could the inclusion of this function in the model interact with inferred individual times of infection, especially if times of infection are inaccurate? On a related note, the authors might consider introducing the concept of contact timing as a factor that can influence heterogeneity in transmission.</p></disp-quote><p>We apologize for the confusion. We added a table to summarize the assumed values extracted from the reference papers, and a plot for the assumed individual infectiousness profile function f(.). We also moved the exact formula and more details of the model from appendix to the main text, to enhance the readability.</p><p>In the estimation, the infectiousness profile are used to determine the generation time, and it would influence the observed heterogeneity of distribution of number of secondary cases (including all generations). When there is no difference in infectiousness variation among cases, if the generation time is shorter, there will be more generations of cases, and hence the observed distribution of number of secondary cases would be more heterogeneous. Hence, this assumption is setting a ‘baseline’ of observed heterogeneity of observed distribution of number of secondary cases when there is no difference in infectiousness among cases, so that the model could estimate the extra heterogeneity due to variations of individual infectiousness.</p><p>We thank for the reviewer’s suggestion about contact timing, which is a good point and we also added in the Discussion. We added ‘the duration of contact could vary, which could also contribute to the variations in infectiousness of cases.’ in the Discussion section of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>2. The household size is a key conceptual focus of the study, but the main text methods/results don't explain clearly how the model accounts for household size or contact number. My interpretation is that the model accounts for household size in two ways. First. the model estimates the per-contact hazard of infection, which implicitly controls for household size/contact number. Second, the model includes a parameter, β, which represents a dilution effect, wherein the transmission hazard might be diluted in larger households due to less per-individual contact intensity. I'm not sure that the dilution effect is currently explained anywhere in the main text, and it could also be explained more clearly that the model is designed to estimate transmission heterogeneity after adjusting for household size.</p></disp-quote><p>We thank the reviewer’s a comprehensive summary on the way that the model accounts for the household size or number of household contacts. We added this information, including the dilution effect, to the revised manuscript as follows:</p><p>We added ‘the model could estimate the per-contact hazard of infection, which implicitly controls for number of household contacts in households.’ In the Result section of revised manuscript.</p><p>We added ‘In the model, the hazard of infection of individual <italic>j</italic> at time <italic>t</italic> from an infected household member <italic>i,</italic> with infection time <italic>t<sub>i</sub></italic> in household <italic>k</italic>, was <inline-formula><mml:math id="sa2m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo stretchy="false">→</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>h</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mi>X</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>β</mml:mi></mml:mrow></mml:msubsup></mml:mfrac><mml:mtext> </mml:mtext><mml:mo>∗</mml:mo><mml:mi>exp</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>δ</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>∗</mml:mo><mml:mi>f</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> where <inline-formula><mml:math id="sa2m2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> was the baseline hazard, <inline-formula><mml:math id="sa2m3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>δ</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> followed a Normal distribution with mean 0 and standard deviation <inline-formula><mml:math id="sa2m4"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mtext>var</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>, which quantified the variation of individual infectiousness (hereafter denoted as infectiousness variation). The relative infectiousness of case <italic>i</italic> compared with case <italic>j</italic> was exp(<inline-formula><mml:math id="sa2m5"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>δ</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>)/exp(<inline-formula><mml:math id="sa2m6"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>δ</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>).</p><p><inline-formula><mml:math id="sa2m7"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> was the number of household contacts. <inline-formula><mml:math id="sa2m8"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>β</mml:mi></mml:mrow></mml:mstyle></mml:math></inline-formula> was the parameter describing the relationship between number of household contacts and transmission rate. It ranged from 0 to 1, with 0 indicating that the transmission rate was independent of number of household contacts while 1 indicated that the transmission rate was inversely proportional to number of household contacts (i.e. dilution effect of the contact time per contact which was lower when the number of household contacts is higher).’ to the Method section of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>2a. It would be helpful if the authors could discuss the distinction between contact number, contact frequency, and contact duration somewhere in the text.</p></disp-quote><p>Thank you for your suggestion. We agree this is an important point and added to the revised manuscript. We added ‘It should be noted that there are several components in the contacts, including the numbers, frequencies and duration of contacts that may contribute to the infectiousness variations. Previous studies also suggest that their relative importance in transmission may be different among viruses.’ In the Discussion in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>3. Given the focus on household size and the number of contacts, it seems there are missed opportunities to explore how the inferred level of individual infectiousness (δ_i) co-varies with metrics like household size.</p></disp-quote><p>Thank you for your suggestion. We estimated that the posterior correlation between inferred level of individual infectiousness (δ_i) and household size are not significant ( the credible intervals are all covered one). This suggested the inferred individual infectiousness was not correlated with household size.</p><table-wrap id="sa2table1" position="float"><label>Author response table 1.</label><table frame="hsides" rules="groups"><thead><tr><th>Study</th><th>Pearson’s correlation</th><th>Shearman’s correlation</th></tr></thead><tbody><tr><td align="left" valign="top">Lyngse, et al.</td><td align="left" valign="top">0.00 (-0.02, 0.03)</td><td align="left" valign="top">0.00 (-0.03, 0.02)</td></tr><tr><td align="left" valign="top">Carazo, et al.</td><td align="left" valign="top">0.00 (-0.03, 0.04)</td><td align="left" valign="top">0.00 (-0.03, 0.03)</td></tr><tr><td align="left" valign="top">Laxminarayan, et al.</td><td align="left" valign="top">0.00 (-0.07, 0.05)</td><td align="left" valign="top">-0.02 (-0.08, 0.03)</td></tr><tr><td align="left" valign="top">Dattner, et al.</td><td align="left" valign="top">0.01 (-0.07, 0.09)</td><td align="left" valign="top">0.00 (-0.08, 0.09)</td></tr></tbody></table></table-wrap><disp-quote content-type="editor-comment"><p>4. Please explain in more detail the meta-regression sensitivity analyses.</p></disp-quote><p>Sorry for the confusion. Meta-analysis and Meta-regression is conducted to pool the estimates of infectiousness variation, which was estimated separately for 14 identified studies. Furthermore, it allows us to determine the potential association between estimated infectiousness variation and study characteristics, including the following factors: the mean and SD of number of household contacts, implementation of lockdown, ascertainment method of index and secondary cases, only ancestral strains are circulating in study period, and all household contacts were tested. We have clarified in the Method section of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>5. I'm not sure that tables S6-S9 are cross-referenced anywhere in the main text, and their legends aren't sufficiently detailed to fully communicate how to interpret these tables in the context of the broader study.</p></disp-quote><p>These tables summarize the systematic review and meta-analysis about viral shedding of COVID-19 cases, which is a proxy of individual infectiousness of cases. They showed heterogeneity in the level of viral shedding of COVID-19 cases, which support our results about variation of individual infectiousness.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Transmission heterogeneity and superspreading of SARS-CoV-2 have been demonstrated repeatedly through real-world observational studies, with a small fraction of individuals accounting for the majority of onward transmission. However, this observed transmission heterogeneity is likely a superposition of accumulated variations from multiple factors, including but not limited to host behavioral factors such as the variation in contact numbers contact duration, and contact settings; variations in the adoption of preventive measures (mask-wearing, physical distancing, etc.); the effects of NPIs (case isolations and contact quarantines, population-level lockdowns); as well as biological factors including differences in shedding duration and intensity of the primary case, variation in susceptibility among close contacts. Fewer studies, however, attempted to isolate the effects of individual factors contributing to the overall transmission heterogeneity, while controlling for other factors. In the manuscript entitled &quot;The effect of variation of individual infectiousness on SARS-CoV-2 transmission in households&quot;, the authors aim at characterizing the variation in individual infectiousness of SARS-CoV-2, controlling for other host factors. To achieve this, the authors performed a meta-analysis of household transmission studies conducted during or not too longer after the initial SARS-CoV-2 wave caused by the ancestral strain across the globe. The authors fitted a household transmission model to the curated data and estimated the variation in infectiousness by introducing random effects of individual infectiousness and its population-level distribution.</p><p>The study has several strengths. First, by choosing analyzing data from the household study, the authors were able to control for several key factors contributing to the overall transmission heterogeneity but not variation in individual infectiousness, including the number of contacts as well the setting of transmission (household). The authors also incorporated an additional parameter in the household transmission model to adjust for the impact of household size on household transmission risk, which has been identified as an important risk factor for SARS-CoV-2 transmission within the household across multiple studies. The authors also curated the studies during the early stage of the pandemic so that most household contacts would remain naïve during the study period, and the immune status of the household contact (either due to prior infection or vaccination) would be unlikely to confound the results of the study.</p><p>However, the study also has a few limitations. First, it is difficult to disentangle if the observed variation in infectiousness is due to biological factors or behavioral factors. During the study period of interest, public health agencies across the globe were recommending at-home isolation guidelines aiming at reducing transmission within the household, including mask-wearing when in contact with other household members, using separate bedrooms/bathrooms, avoiding having meals together, etc. The differences in the guidelines across nationals/regions as well as the level of compliance with guidelines at the household level would also impact individual household transmission risk. Second, the risk of acquiring infections from the community could be heavily influenced by the socio-economic status, since multiple studies have clearly demonstrated stark disparity of COVID-19 burden, factors such as occupation (essential workers tend to be low-wage jobs) assess to PPE and healthcare were likely to contribute to the observed disparity. Lastly, it is also difficult to entangle if the observed heterogeneity is due to the biological factors of the primary case (i.e., variation in shedding duration/intensity) or the contact (variation in susceptibility). The current formulation of the transmission model only addresses the former not the latter.</p></disp-quote><p>We appreciate the reviewer’s very comprehensive summary of our work and unique insight of the interpretation of our results, and we added many of them in the revised manuscript. We expanded the section of our discussion listing the different limitations, in particular the fact that our approach can not disentangle the observed heterogeneity from biological factors affecting infectiousness and variations in susceptibility of contacts.</p><p>We added the followings in the Discussion in the revised manuscript:</p><p>“Given that we focused our analysis on households with known number of contacts in studies conducted in the early outbreaks caused by ancestral strains, the estimated infectiousness variations do not include the variations caused by number of contacts and transmission risks in different settings, difference in pre-existing immunity among contacts (almost everyone is naïve and unvaccinated), and the difference in transmissibility among variants. Hence, this estimated infectiousness variation measures the variation caused by difference in individuals, which may be contributed by both biological factors and host behaviors, but not other confounding factors.”</p><p>“It should be noted that there are several components in the contacts, including the numbers, frequencies and duration of contacts that may contribute to the infectiousness variations. Previous studies also suggest that their relative importance in transmission may be different among viruses. Individual behaviors may also be influenced by the implemented control measures and recommendation from public health agencies. For example, lockdown and stay-at-home orders may increase the time spending at home. Mask-wearing when in contact with other household members, using separate bedrooms and bathrooms, avoiding having meals together may reduce the transmission in households. Also, social disparity such as occupation may increase or reduce the risk of transmission in households, including the availability of personal protective equipment (PPE), or being healthcare worker. These may have impacted the SAR in households, but also estimated infectiousness variation in this setting.”</p><p>“In addition, we could not include factors affecting susceptibility to infection. Our estimates of infectiousness variation should be interpreted in light of these limitations: they capture heterogeneity in infectiousness due to demographic, host and biological factors. However, in one study that included susceptibility component in the estimation of individual infectiousness, substantial heterogeneity remained with 20% of cases estimated to contribute to 80% of transmission.”</p><p>“Third, we assumed that risks of infection from community for all households are the same, but there were different factors that may affecting this, including occupations, such as healthcare workers, social economic status that related to assess to personal protective equipment”</p><disp-quote content-type="editor-comment"><p>For the household transmission model concerning imputation of the timing of infection, it is unclear if the timing of infection is partially missing, or if the timing of infection were unavailable for all studies. If it is the former case, the authors should give a more detailed description of the imputation process in a study-by-study fashion and report the proportion of infection time that was imputed. If it is the latter case, I do not understand the benefit of explicitly modeling the temporal infectiousness profile, thus I would recommend the authors use a simpler chain-binomial model fitting to only the binary outcome (of infected or not) unless the authors make a convincing case otherwise.</p></disp-quote><p>Sorry of confusion. The timing of infection were unavailable for all studies. The reason of not using a simple chain-binomial model is that it is impossible to add the parameters characterizing individual infectiousness (δ_i) in the model. When there are different types of susceptible in data, chain-binomial model required adding separate probability parameters for each type of susceptible in the model, with each type of transmission (from household members or from outside households).</p><p>We have clarified this by adding ‘Since the data were extracted from publication, the infection time of all cases was unavailable for all studies.’ in the Method section in the revised manuscript. We also added a section in Appendix to explain this.</p><disp-quote content-type="editor-comment"><p>Both p80 and p0 are poor statistics to characterize household transmission due to the discrete nature of household contact numbers. For example, it is unintuitive to interpret and compare p80 for a household size of 2 vs 10 (for a household size of 2 conditional on an index case within the household this could only be interpreted as the proportion of households with secondary infections, which is cross-household level statistics, while for a household size of 10, it can be interpreted as a meaningful statistical for each household). Furthermore, the interpretation of p80 as a metric for transmission heterogeneity becomes even murkier if multi-generation transmission within the household is considered, especially for a larger household. For p0, this metric is heavily dependent on household size. For example, one would expect the p0 for a household size of 10 (with on index) to be way smaller than p0 household size of 2 (assuming no dilution effects on transmission with the increase of household size), as in the former case p0 characterize the probability of all 9 uninfected contacts escaping infection from the index, while in the latter p0 characterizes the probability to escape infection by only 1 household contact. Thus, it is meaningless to compare p0 without controlling for household size across studies. For the arguments above, I recommend the authors remove both p80 and p0 from the paper.</p></disp-quote><p>Thank you. We agree with the reviewer and removed p80 and p0 from the paper.</p><disp-quote content-type="editor-comment"><p>Through the formulation of the household transmission model, the authors essentially assume a lognormal distribution of individual infectiousness, which is a long-tailed distribution by nature. I think this is an important point that needs to be highlighted. Has the author tried a normal distribution instead of a log-normal distribution? Would a normal distribution fit better or worse to the data than the log-normal one? I recommend the authors conduct a sensitivity analysis of a normal distribution of the individual infectiousness (i.e., not taking the exponential of the σ term for the hazard of infection function on page 7).</p></disp-quote><p>Thank you for this suggestion. We conducted a sensitivity analysis for assuming the individual infectiousness followed a Γ distribution, which has a shorter tail compared with lognormal distribution. However, model comparison suggested that assuming γ distribution for individual infectiousness parameter performed substantially worse, compared with the lognormal distribution in the main analysis (Appendix 1 – Table 9).</p><disp-quote content-type="editor-comment"><p>Table S5 is cropped.</p></disp-quote><p>Sorry for the mistake, we revised the table.</p></body></sub-article></article>